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Abstract
The purpose of this study was the development of a technique for the
non-invasive assessment of the 3D spatial distribution of the Ca/P ratio
in bone, which can be applied in a conventional computed-tomography
(CT) system, to investigate the variation of Ca/P ratio in healthy and os-
teoporotic bone, and to potentially enhance osteoporosis understanding
and diagnosis. Three-material mass-fraction decomposition CT dual en-
ergy analysis (CT-DEA) was developed and optimised for the assessment
of Ca/P ratio. As part of this process, density values are provided as
a bi-product. The technique was optimised and experimentally applied
through a microCT system. The target of the optimisation was to achieve
a precision of better than 0.09 in the Ca/P ratio, in order to be able to
distinguish between all healthy and osteoporotic regions. Electron dis-
persive X-ray spectroscopy (EDX) was used to evaluate the performance
of CT-DEA on bone apatite. Ca/P ratio measurements were made on
the same healthy and inflammation mediated osteoporotic (IMO) rabbit
cortical bone surfaces, using CT-DEA and EDX. The mean difference
in the Ca/P ratio between the two techniques was 0.11±0.08 (8±6%)
and the correlation was R2=0.69, suggesting sufficient confidence in the
experimental capabilities of the CT-DEA technique. Healthy and IMO
rabbit, both collagen-free and intact, cortical bone samples were assessed
by CT-DEA. Qualitative analysis of the results involved the production
of Ca/P ratio and density distribution maps. Quantitative analysis in-
volved the quantification of the Ca/P ratio and density across the whole
sample and in volumes of interest, as well as the low Ca/P ratio pro-
portion in each sample. Furthermore, a 3D region growing technique
was used to study the uniformity of Ca/P ratio in the samples. Results
showed differences in both density and Ca/P ratio between healthy and
IMO bone samples, supporting their use as possible osteoporosis indica-
tors and the use of the developed technique for further studies.
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Chapter 1
Osteoporosis and its diagnosis
1.1 Overview
In this chapter osteoporosis and its diagnosis are discussed. In section 1.2, a brief
background on bone is given. In section 1.3, osteoporosis and its consequences are
described and the importance of early osteoporosis diagnosis is explained. Further-
more, the current imaging and mechanical methods of osteoporosis diagnosis and
monitoring are described. In section 1.4, the approach of the current study to the
problem of osteoporosis is given. The study of bone material density and Ca/P ratio
in bone as possible osteoporosis indicators is discussed. Finally, in section 5, the
structure of the rest of this thesis is presented.
1.2 Bone
Bone is a type of dense connective tissue. Tissue types found in bone include osseous
tissue (primary bone tissue), bone marrow, endosteum and periosteum, nerves, blood
vessels and cartilage. Osseous tissue is the type of tissue mostly known to be affected
by osteoporosis.
Osseous tissue is a relatively hard and lightweight composite material, formed
mostly (60%-85% by weight) of Calcium Phosphates (table 1.1) (Miller and Martin
[1968], Bauer and Link [2009], Gong et al. [1964]), Dorozhkin [2009]). Chemically
this is often termed as Calcium hydroxyapatite Ca10(PO4)6(OH)2, which is com-
bined to the organic part of the bone, Type-I collagen (15-40%). The stoichiometric
fraction of Calcium and Phosphorus in hydroxyapatite is Calcium 39.9%, Phospho-
rus 18.5%. Thus the stoichiometric atomic Ca/P ratio is 1.67. However, the exact
composition of bone varies depending on sex, age, type and site, and alterations are
also known to occur in bone metabolic diseases (Akesson et al. [1994]).
Osseous tissue is synthesised by osteoblasts which produce the consequent min-
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Table 1.1: The approximate percentage of the constituents (by weight) of bone; both
inorganic and organic as found in literature (Miller and Martin [1968], Bauer and Link
[2009], Gong et al. [1964]), Dorozhkin [2009]).
Inorganic phases wt% Bioorganic phases wt%
Calcium Phosphates 60-85 Collagen type I 15-40
Water ∼9 Non-collagenous proteins ∼3
Carbonates ∼4 Polysacchrides, lipids, cytokines Balance
Citrates ∼0.9 Primary bone cells Balance
Sodium ∼0.7
Magnesium ∼0.5
Other traces Balance
eralization. Osseous tissue is resorbed by the osteoclasts which are activated by
hormones to secrete substances that break down the bone. Bone turnover is the
combination of bone formation by osteoblasts and resorption by osteoclasts. Bone
formation and resorption are activated at variable rates. There is not any particular
factor that predicts whether bone formation or bone resorption will dominate. The
almost constant bone mass, is achieved by BMUs (bone multicellular units, cells with
which bone renews itself), which counter balance bone formation and resorption.
There are two types of osseous tissue. One of them is the cortical (or compact)
bone, the hard outer layer of bones, with a porosity of 5-30%. The interior of the
bone is the trabecular bone tissue (also called cancellous or spongy bone), which is
a network of rod- and plate-like elements that make the bone lighter and allow room
for blood vessels and marrow. Its porosity is 3-90% (Hall [2006]).
1.3 Osteoporosis diagnosis
1.3.1 The importance of osteoporosis diagnosis and preven-
tion
Osteoporosis is by definition a progressive, systematic skeletal disease characterised
by low bone mass and micro-architectural deterioration of bone tissue, with a conse-
quent increase in bone fragility and susceptibility to fracture (Kanis et al. [1994], Fer-
guson [2004]). The most common osteoporotic fracture sites are spine (120 000/year
in UK), hip (over 60 000/year in UK) and wrist (50 000/year in UK) (van Staa et al.
[2001]). Osteoporosis is multi-factorial in origin and the precise pathogenesis is still
unknown.
The incidence of osteoporosis is known to increase with advancing age. Osteo-
porosis is most common in women after the menopause, but may develop in men
and premenopausal women. During the menopause the ovaries produce lower levels
of the female hormone oestrogen, which is essential for bone health. Thus after the
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menopause the rate of bone loss that starts in the thirties accelerates, increasing the
risk of osteoporosis (Heaney et al. [1978]).
Fractures due to osteoporosis represent a significant social and medical problem
in terms of treatment and rehabilitation and will become an even greater problem,
as the proportion for the elderly increases. The personal cost of the occurrence of a
related fracture is the restriction of activity, mobility and in severe cases the result
of fatality. During the first 12 months after a hip fracture over half of people who
walked unaided prior to the fracture will be unable to walk independently. 55% of
patients will require assistance at home and 33% will experience difficulty sleeping
due to pain (Osnes et al. [2004]).
The number of people suffering from osteoporosis is large. It is estimated that
one in two women and one in five men will suffer a fracture after the age of 50 (van
Staa et al. [2001]). Osteoporosis DALYs (disability adjusted life years) are higher
than cancer DALYs (Johnell and Kanis [2006]). Also, it has been reported that the
lifetime risk of fracture in women at age 50 years is greater than the risk of breast
cancer or cardiovascular disease (WHO Study Group, 1994).
The financial costs in the UK for NHS and government are significant. As an
indication, in the UK, the average hospital stay for hip fracture is 30 days. Osteo-
porosis costs 2.3 GBP billion a year; that is 6 GBP million a day, according to the
National Osteoporosis Society.
Osteoporosis is usually called the “silent epidemic”. It can be present in a patient
for many years without any apparent consequence, either as an apparent symptom
or as a medical condition that would prompt the patient to seek medical advice.
At present there is no widely applicable method of fully restoring skeletal strength
once it has been lost (Kanis et al. [2005], Teegarden et al. [1998]). In common
with a number of disorders, osteoporosis should be viewed as a condition for which
prevention is better than cure. Under the above aspects reliable early diagnosis and
prevention of osteoporosis are of particular importance.
1.3.2 Current imaging methods of osteoporosis diagnosis
Bone mineral density (BMD), an areal parameter with units of g/cm2, describes the
bone mineral within a projected area and is the conventional method of assessing
osteoporosis, in the clinical environment under the scale developed by the World
Health Organisation (WHO). Measurements of BMD are widely recognised as being
effective at identifying patients who are at a higher than the average risk of fracture
(Kanis and Glu [2000]).
The WHO scale is based on comparison of a patient’s BMD with that of a
healthy young adult. A T-score is defined as the patient’s BMD value minus young
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Figure 1.1: Diagnostic thresholds for women based on the distribution of bone mineral
density (BMD) in the young healthy female population (Kanis and Glu [2000]).
reference BMD divided by young-reference standard deviation at the corresponding
anatomical site. The WHO scale is divided into three main different categories:
normal, low bone mass (osteopenia) and osteoporosis. A T-score equal to or less
than -2.5 is taken as an indication of osteoporosis (figure 1.1).
In the early 1960s, routine quantitative BMD was achieved by measuring the
absorption of a highly collimated photon beam from a single-energy radionuclide
source (SPA), such as Iodine-125 or Americium-241. The anatomical site being
measured was generally immersed in a water bath to correct for overlying soft tis-
sue. The difference in attenuation between an image of bone and water and an image
of water only was attributed to bone. The distal radius and calcaneus were the sites
that were generally measured. Later low-dose single X-ray absorptiometry (SXA) re-
placed SPA as it provides a greater photon flux and thus improved spatial resolution
and precision. However, SPA and SXA could not be applied to important fracture
sites and so dual photon absorptiometry (DPA) techniques were introduced. These
utilised Gadolinium-153 which emits gamma radiation with strong peaks at 41 keV
and 102 keV. Bone was assumed to be a two component system; mineral and soft
tissue. When soft tissue absorption was subtracted out, the BMD could be deter-
mined from the absorption of each beam by bone. In 1989, a new instrumentation,
enabled Dual Energy X-ray Absorptiometry (DEXA or DXA) to be conducted using
two energies (usually around 70 and 140 kVp) generated by an X-ray generator and
k-edge filter (Lewis et al. [1994]). The preferred anatomic sites for DEXA measure-
ment of bone mineral include the typical osteoporotic fracture sites of lumbar spine,
proximal femur and distal radius, as well as whole body assessment (Langton [2010],
Kazakia and Majumdar [2006]). Other advantages of DEXA include low effective
radiation dose (around 0.07-5.90 µSv depending on scan mode) compared with dose
entailed by other radiological procedures, low cost, ease of use and speed (2-20 min-
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utes depending on the scan mode) of measurement (Lewis et al. [1994]). DEXA
BMD measurement is the gold standard for T-score assessment and the standard by
which other bone imaging measures are evaluated.
However, many authors have reported inconsistency in WHO classification using
DEXA. It is widely, but not universally accepted. Physicians face the dilemma of
deciding which patients should receive long-term treatments.
One of the major problems that have been reported in the WHO classification is
that classification is based on data collected from epidemiological studies on white,
postmenopausal women. This has to be taken into consideration when looking at
other cohorts of population, such as men. The choice of the corresponding reference
population, bone age and the measurement site have a direct impact on the man-
agement of individual patients in clinical practice (Lu et al. [2001], Grampp et al.
[1997], Kanis and Glu [2000]). The extent to which the threshold based classifica-
tion depends on reference data used, was shown by Lu et al. [2001], who examined
three models with different criteria and reference population for the diagnosis of
osteoporosis.
Similarly, the choice of bone measurement technology has a direct impact on
the management of individual patients in clinical practice (Lu et al. [2001], Grampp
et al. [1997], Kanis and Glu [2000]). Device manufacturers typically use different
reference populations for different machines. Grampp et al. [1997] showed that
there is a small correlation (correlation coefficient, r = 0.10-0.93) among different
commonly available methods of assessing bone mineral, and bone sites as well, for
measuring the BMD and bone mineral content (BMC, the amount of mineral in the
specific site scanned, when divided by the area measured, can be used to derive a
value for BMD).
A false impression or confusion is sometimes created through the WHO classi-
fication. The risk factor is distributed throughout the whole population, leading
to an arbitrary cut-off point that over or under-treats individuals at the extreme
limits of each category. There is also terminology confusion as a T-score of -2.5 or
less is considered to represent osteoporosis, and those with a T-score of between -1
and -2.5 are diagnosed with osteopenia. Subjects with a T-score of -2.5 therefore
meet both definitions. A false impression might also be caused because there may
be other reasons for low BMD, such as osteomalacia, hyper-parathyroidism, or a
combination of two. Finally, there is considerable overlap in bone densities among
normal individuals and those that suffer from bone fractures (Ciarelli et al. [1991]).
Moreover, DEXA calculates BMD using area (aBMD) and it is not an accurate
measurement of true bone mineral density, due to the missing depth value in the
calculation of bone mineral density (Bolotin and Sieva¨nen [2001]). Furthermore,
planar imaging, cannot differentiate between trabecular and cortical bone. Thus,
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BMD measurement is independent of the ratio of trabecular to cortical bone and
therefore does not give a complete picture of the strength of the bone (Kazakia and
Majumdar [2006]).
Finally, in DEXA measurements it is assumed that the composition of imaged
tissue is the same between different people. However, soft tissue is composed of
variable amounts of fat and lean. Variations in fat-lean composition produce differ-
ences in the attenuation coefficients for soft tissue at both energies. Therefore, one
must obtain an estimate of soft tissue composition in order to obtain accurate bone
mineral and soft tissue masses.
1.3.3 Other imaging methods for monitoring osteoporosis
In addition to the established SPA, SXA, DPA and DEXA methods, there are a
number of research methods for diagnosing osteoporosis.
Quantitative ultrasound (QUS) uses high frequency acoustic waves to measure
how much energy is absorbed by the bone, generally referred to as Broadband Ul-
trasound Attenuation (BUA, dB MHz ), or the speed of sound (SOS, ms−1). Then
BUA or SOS are then changed into the density of bone. The advantage of QUS is
that the QUS unit is inexpensive and portable, scans quickly and does not utilise
ionising radiation. It has been clinically demonstrated that BUA measurement of
the calcaneus provides an accurate indication of osteoporosis fracture risk, particu-
larly for hip fractures (Kazakia and Majumdar [2006]). Measurements can also be
made at the phalanges and tibia. However, due to technical difficulties, ultrasound
measurements cannot to date be performed at the common osteoporosis anatomical
sites. In addition, there is a lack of uniformity and sensitivity of reported BUA
measurements. QUS measures are inappropriate for long term monitoring of osteo-
porosis or response to drug therapy. Images are therefore not usually obtained by
QUS systems (Langton [2010]).
A technique that is gaining increasing interest is magnetic resonance imaging
(MRI). Usually associated with soft tissue imaging, it works in bone by measur-
ing the water content of bone marrow and subtracting it by its background, which
is trabecular bone and does not give any signal. From this, a 3D volumetric im-
age of trabecular structure can be obtained and the bone architecture parameters
(trabecular thickness, trabecular number) can be measured. Bone architectural pa-
rameters are becoming popular in osteoporosis research (Cohen et al. [2009], Laib
et al. [2000]). In addition to being non-ionising it is possible to obtain high in-plane
resolution of ∼150 µm and slice thicknesses of ∼300 µm (Majumdar [2008]). In pre-
dicting the existence of vertebral fractures it has been shown that distal radius MR
images perform significantly better than DEXA scans of the same region (Kazakia
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and Majumdar [2006]). However, MRI is only usually performed at peripheral sites
such as the heel, knee and wrist due to signal to noise ratio (SNR) limitations.
Conventional radiography is a projected 2D imaging modality, used with a spatial
resolution of up to 40 µm (Bauer and Link [2009]). Lateral chest radiographs are
performed in many elderly patients and can be used to identify vertebral fractures. It
is attractive because of its ease of use and availability. However, the big disadvantage
is that large amounts of bone loss must be present before an abnormality is detected.
Computed tomography (CT) is used in bone imaging. Quantitative computed
tomography (QCT) uses a conventional X-ray CT scanner, that can achieve in plane
spatial resolution of ∼200 µm, with slice thickness of ∼500 µm. BMC may be deter-
mined separately for the trabecular and cortical bone components via a calibration
phantom scanned adjacent to the subject. Volumetric BMD can then be found by
dividing BMC by the corresponding tissue volume. Voluemtric BMD is a robust
measure for comparisons of bone density between populations. In clinical whole
body CT scanners, QCT is being used increasingly, particularly at the lumbar spine
(Kazakia and Majumdar [2006]).
The advantage of QCT over DEXA or QUS is 3D spatial resolution allowing for
the assessment of volumetric BMD, in addition to macro-architecture. Comparing
CT with MRI, CT has the advantage of directly visualising the bone. Limitations
of QCT include the high radiation dose (approximately 60 µSv), around ten times
higher than DEXA, and bigger expense.
The high capital and running costs associated with conventional CT scanner
QCT assessment of volumetric bone destiny assessment has recently prompted the
development of dedicated peripheral (p-QCT) systems. These can determine the
volumetric density of the cortical and trabecular components at the distal radius
and proximal tibia (Kazakia and Majumdar [2006]). Resolution of images using p-
QCT is of the order of 80 µm. P-QCT inherently delivers a lower dose to the patient
than standard spinal QCT as only the peripheral skeleton is irradiated. Doses are
comparative to spinal DEXA (<2 µSv). P-QCT is often therefore used for detailed
assessment of children, where it is particularly crucial to keep dose low. Peripheral
scanners make QCT technology less expensive, easier to use and more accessible than
traditional whole-body scanners. A disadvantage is that it is confined to peripheral
sites, and it is not capable of generating images or direct measures within the spine
or proximal femur (the typical bone sites of osteoporosis).
Micro-computed tomography (microCT) scanners have the advantages of conven-
tional CT scanners, but in addition they reside at the highest hierarchy of resolution
(up to 4 µm). This allowed for the separate determination of cortical, trabecular or
integral bone architecture, with only a resolution of 150 µm required to visualise the
trabecular network and to quantify morphological parameters (Ulrich et al. [1999]).
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MicroCT has been used to study the trabecular and cortical architecture in humans
(Majumdar [2008], Martn-Badosa et al. [2003], Nuzzo et al. [2003]) and rats (Laib
et al. [2000]). It has also been used for mice, where the thinner bone structures
require very high spatial resolution (Martn-Badosa et al. [2003]). Even though it
is non-destructive, it is not used in vivo (at least not in humans). The reason is is
the long measurement time, the large amount of data for processing and the high
radiation dose (Judex et al. [2003]), even though currently a number of in vivo mi-
croCT scanners are becoming commercially available. A big advantage of the 3D
high resolution microCT images is that they help to monitor the effect of mechanical
loading on structural and compositional changes (section 1.3.4). It was shown that
it can be used to predict mechanical properties (Wachter et al. [2001]). Moreover,
microCT allows the generation of micromechanical models of the scanned sample
by converting bone voxels to mechanical elements that can be analysed by the finite
element analysis method (van Der Linden et al. [2001], Shefelbine et al. [2005]).
1.3.4 The study of mechanical properties of bone for moni-
toring osteoporosis
“We have to hand a plethora of different bone densitometry techniques but often
lose sight of what we are fundamentally trying to achieve, namely identification
and monitoring of subjects at risk of an osteoporotic fracture through surrogates of
mechanical integrity” (Langton [2010]). Bone is a biomaterial that is structurally
adapted to different functions and loading situations (Cowin [1984]). Bone strength
is the determining factor for bone quality and by assessing it one can more ac-
curately gauge a patient’s susceptibility to a fracture. Of course there are some
other factors that contribute to the risk of fracture due to osteoporosis. These are
age, prior fragility fracture, a parental history of fracture, smoking, use of systemic
corticosteroids, excess alcohol intake, rheumatoid arthritis.
Bone mechanical tests have been used to study osteoporosis for different aims
and using different methods. The true gold standard measurement of the mechanical
integrity of a bone is a destructive test, generally performed by compressing either
a regional shaped sample or whole bone. FEA is an alternative to the experimental
test. It is a simulated mechanical test that can be used to predict the stresses and
strains on an object when loading conditions such as forces, moments or supports are
applied to it. It has the advantage that the same bone can be tested under several
different loading conditions, for example, torsion of bending, or different loading
position.
The results from the mechanical compression/simulation tests are usually corre-
lated with the results of imaging techniques in order to correlate a bone indicator,
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for example density, microarchitecture, bone composition which can be assessed in
vivo non-invasively, to bone strength. Studying the effect of an osteoporosis indica-
tor on bone strength can result on the importance of this indicator on bone quality.
If this indicator has a significant effect on bone quality it could then be used to
diagnose osteoporosis.
In a study by Wachter et al. [2001] mineral density and porosity of femoral corti-
cal bone from the mid-diaphysis of 24 patients were determined in vitro by microCT
and then, the strength and the elastic modulus were assessed by a compression
test. Results showed a significant negative correlation between porosity and yield
stress stiffness and elastic modulus, and even stronger positive correlations between
density and the mechanical parameters. Also, more recently, the contributions of
trabecular microarchitecture, of the human lumbar spine, and its regional variation
have been studied (Wegrzyn et al. [2010]) using mechanical compression test. In
this study lumbar vertebrae were harvested fresh from 21 lumbar spines of human
donors. They were tested, before the compression test, for BMD by dual-energy
X-ray absorptiometry (DEXA) and microarchitecture by high-resolution peripheral
quantitative computed tomography (HR-pQCT). A higher correlation was found be-
tween microarchitecture and mechanical behaviour (failure load, compressive stiff-
ness, and work to failure) than BMD and mechanical behaviour. In a similar way,
the correlation of the cortical mineral content of the radius, measured by QCT, to
the compressive strength, measured using a compression test, was assessed (Louis
et al. [1995]). In this study a high correlation was found between the mineral content,
density and thickness of the cortical bone and its maximal stress.
Similarly, imaging and FEA were used together in order to find the correlation
of density, trabecular micro-architecture to mechanical moduli and/or risk of frac-
ture (Boutroy et al. [2008], Pistoia et al. [2002], Baum et al. [2010] Newitt et al.
[2002]). Boutroy et al. [2008] used HR-pQCT to take images at the radius in 33
postmenopausal women with a prior history of fragility wrist fracture and 33 age-
matched controls. The volumetric bone density, microarchitecture and microFE
derived bone mechanical properties were assessed. The Young’s moduli values of
cortical and trabecular bone were found from literature and were assigned to them
after the segmentation of trabecular and cortical bone tissue. Radius areal BMD
was also measured by DEXA. Association between density, microarchitecture, me-
chanical properties and fracture status were evaluated. Their results suggest that
bone mechanical properties assessed by microFE provide information about skeletal
fragility and fracture risk not assessed by BMD or architecture measurements alone
and are therefore likely to enhance the prediction of wrist fracture.
Similarly, Pistoia et al. [2002] reported stronger correlations between microFE
analyses and measured failure load of the distal radius than those provided by bone
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mass or bone structural parameter. In this study 54 embalmed cadaver arms were
imaged using pQCT and structural indices were derived. Using these images mi-
croFE models were produced as well, with loading conditions that simulated real
loading conditions that were later applied to the arms using a testing machine to
produce a Colles-type fracture in the radii. Similar results were found by Baum
et al. [2010] in a similar study.
Ulrich et al. [1999] and Newitt et al. [2002] used microCT and MRI respectively,
to measure the structural parameters of normal and osteoporotic human bones.
Then, microFEA models of these bones were produced using the microCT (Ulrich
et al. [1999]) and MRI (Newitt et al. [2002]) images and reference values for tra-
becular Poisson’s ratio (0.3) and Young’s modulus (GPa). The directional Young’s
moduli, shear moduli and anisotropy ratios were calculated and were correlated to
bone architecture and BMD. It was shown that the determination of mechanical
properties of bone and the diagnosis of osteoporosis can be improved if, in addition,
to BMD, the 3D bone microarchitecture is assessed.
In the studies above it was shown that the mechanical properties of bone, which
determine bone quality, can be predicted by osteoporosis indicators measured using
radiation imaging non-destructively. Correlations were studied between different
osteoporosis indicators for example, bone microarchitecture, mineral content and
density, and bone strength and/or risk of fracture.
1.4 The approach of this study to the problem of
osteoporosis
As described in section 1.1 osteoporosis represents a serious medical and social prob-
lem. The use of aBMD measurements for osteoporosis diagnosis has significant
disadvantages. Thus osteoporosis diagnosis needs to be enhanced. Furthermore,
the pathogenesis of osteoporosis is unknown and multi-factorial in origin therefore
research continues on the effect of other osteoporosis indicators, for example archi-
tectural, physical, chemical and biological factors, on bone quality.
In the current study the bone material density and Ca/P ratio in bone were
studied as possible osteoporosis indicators. In the next section the reasons that sup-
port the study of bone material density and Ca/P ratio in bone for understanding,
preventing and diagnosing osteoporosis are explained.
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1.4.1 Bone mineral material density
As discussed in section 1.3.2 the bone size and bone mass are neglected by DEXA
and the aBMD measurement. But even when these size-related problems are taken
into account, densitometric data rarely interpret the biological processes in the bone.
Increases in “bone density” during growth are often attributed uniformly to “bone
mineralisation”. However, this might really represent greater cortical thickness,
thicker trabeculae or incorporation of additional mineral into existing bone matrix.
To study the effect of biological processes only (and reject any structural pro-
cesses) in the bone quality, BMDmaterial has to be assessed. BMDmaterial represents
mineralization in its physiological sense and is identical for cortical and trabecular
bone (Willnecker [2006]). Bone material is the extracellular bone matrix, whether
mineralised or not. The relevant volume to calculate material density (true bone
density) is the volume occupied by bone matrix and does not include air, marrow
spaces, osteonal canals, lacunae and canaliculi. BMDmaterial can be calculated as
BMDmaterial =
∑
BMDivi (1.1)
where v is the volume fraction of component i in the material.
As shown in table 1.1 the different material components present in the bone
matrix (non-cellular part of the bone) are apatite, organic constituents and water.
Their material densities respectively are in the following ranges 2.85-3.20 g/cm3
(Robinson [1975]), 1.41-1.45 g/cm3 (Gong et al. [1964]) and 1 g/cm3. With an
apatite volume of 40%, a collagen volume of 50% and water volume of 10% bone
material density is ∼2.01 g/cm3.
BMDmaterial has to be distinguished from two different bone mineral density def-
initions (BMD) given in literature: (i) BMDcompartment defined as the mass per unit
volume in a bone’s trabecular and cortical tissue compartments, and (ii) BMDtotal
or apparent density, defined as the mass per unit volume in the entire bone (fig-
ure 1.2). These three different definitions of mineral density represent density at
three different levels. As discussed by Rauch and Schoenau [2001] BMDtotal is a
function of BMDcompartment, which is in turn a function of BMDmaterial. Changes in
BMDcompartment are caused by variations in both BMDmaterial and relative cortical
or trabecular bone volume. Changes in BMDtotal are caused by variations in both
BMDmaterial and relative cortical and trabecular bone volume.
Even though DEXA and QCT can be used to measure BMDcompartment and
BMDtotal at particular bone sites, BMDmaterial has not been assessed with noninva-
sive techniques (Rauch and Schoenau [2001]), until 2011 when Wagner et al. [2011]
developed a grey value calibration approach that takes into account the presence of
collagen, water and hydroxyapatite in bone. In the current study, CT-DEA is used
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Figure 1.2: “Different types of mineral density: BMDmaterial and BMDcompartment (A
and B) in trabecular bone and (C and D) cortical bone. The mass of mineral (in grey)
determining BMDmaterial and BMDcompartment is identical (mass 1 = mass 2), but the
volume (encircled by black lines) differs (volume 2>volume1). Therefore, BMDmaterial
is higher than BMDcompartment. (E) BMDtotal is defined as the mass of mineral divided
by the volume enclosed by the periosteal envelope. This definition can be applied to the
entire bone, part of the bone, or section through the bone” (Rauch and Schoenau [2001]).
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to assess BMDmaterial. For the rest of this thesis, bone density will have the meaning
of BMDmaterial, unless stated otherwise.
1.4.2 The Calcium/Phosphorus ratio in bone
It was always assumed that the chemical composition of osteoporotic bone is the
same as that of normal bone and in osteoporotic bone there is simply less bone (Avi-
oli and Lindsay [1990]). However, more recent work has shown that variations in
the chemical composition of the mineral or organic components of the bone may be
important in understanding fragility fractures (McCreadie et al. [2006]). Such min-
eral composition changes may involve crystallite size and size distribution, structural
rearrangement and/or substitution. At the molecular level, bone chemistry might
have a significant effect on bone quality.
From the mechanical point of view hydroxyapatite (HA) provides the major sup-
port of bones. Bone is considered primarily as a HA reinforced collagen composite,
with the additional secondary effect due to the arrangement of osteons (the funda-
mental function units of compact bone). Comparing the Young’s modulus of HA
(114 GNm−2 ) and that of collagen (1 GNm−2 ), with comparable volume fractions,
HA is the major load bearing component of bone (in the elastic region, it can be
shown that ∼97% of any applied load is supported by the hydroxyapatite) (Bonfield
[1998], Bonfield et al. [1998]). Actually, collagen in bone is considered to provide a
matrix in which the brittle ceramic solid HA is distributed. The values of Young’s
modulus increase with increasing HA volume fraction in bone (Bonfield et al. [1981],
Bonfield et al. [1998]). This shows the importance of studying further the effect of
HA and its constituents.
From the dietary point of view it is believed that both Calcium and Phosphorus
are very important in bone health. They are thought to modify bone and are
related to bone accretion and maintenance. Studies have found a positive correlation
between bone density and Calcium intake during teenage years and early adulthood,
in premenopausal women ranging in age from 20 to 50 years (Teegarden et al. [1998]).
An increase in teenage Calcium intake from 800 to 1200 mg per day is estimated to
increase hip bone density by 6% (Nieves et al. [1995]). Unlike dietary Calcium, the
speculated role of dietary Phosphorus in limiting peak bone mass involves an excess
intake of this nutrient. Consumption of a large excess of dietary Phosphorus, when
Calcium intake is adequate or low, will lead to secondary hyperparathyroidism and
progressive bone loss in a number of species.
The association of osteoporosis with hyperparathyroidism further supports the
effect of Ca/P ratio on bone density. Hyperparathyroidism is the over-activity of the
parathyroid glands, resulting in excess production of parathyroid hormone (PTH).
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This is a hormone that regulates Calcium and Phosphate levels and helps to main-
tain them at suitable levels in the body. Excess parathyroid hormone (PTH) acts
indirectly on osteoclasts whose activation ultimately leads to the removal of Calcium
from the bones in order to increase its levels in the blood. Removing the offending
parathyroid gland restores normal bone density within several years.
Calcium, Phosphorus and the ratio of the two elements was measured by Zaichick
and Tzaphlidou [2002] in cortical bone using neutron activation analysis. A lower
standard deviation and coefficient of variation were obtained for the Ca/P ratio than
for Calcium and Phosphorus respectively, due to the strong correlation between
Calcium and Phosphorus in bone. This correlation for healthy women and men
aged 15-55 year was 0.823 (p<0.001) and 0.747 (p = 0.001), respectively. If their
healthy cortical bone contained only mineral, a strong molar dependence between
Calcium and Phosphorus should exist, i.e. Ca = 1.67P, and the correlation coefficient
would be 1.0. However, bone also consists of organic matter, and the concentration
of Calcium and Phosphorus in organic matter is lower than in mineral and the
Ca/P ratio different than in HA, the individual variation of the organic matter in
cortical bone varies. This results in a decreased correlation between Calcium and
Phosphorus in the whole cortical bone. The lower standard deviation and coefficient
of variation show that the individual variation for Ca/P ratio in the cortical bone
of femoral necks of healthy humans is lower than those for Calcium and Phosphorus
separately, suggesting that the specificity of Ca/P ratio is better. The Ca/P ratio
may be more reliable for diagnosis of bone disorders than the individual Calcium
and Phosphorus concentrations.
A possible explanation of a lower Ca/P ratio is given by Zaichick and Zaichick
[2010]. In that study it was found that Calcium, Phosphorus and Magnesium de-
crease significantly with age in the human femoral neck of males. In female femoral
necks there is a decrease of Calcium and a smaller decrease of Phosphorus, leading
to a lowered Ca/P ratio. A similar phenomenon might happen in osteoporosis.
Some in vitro imaging experiments haves investigated the correlation of the Ca/P
ratio to osteoporosis. Tzaphlidou et al. [2005] and Speller et al. [2005] measured
Ca/P ratio using a synchrotron microCT system and directly mapped the linear
attenuation coefficient to the Ca/P ratio. A statistically significant decrease was
observed in rabbit tibia Ca/P ratio for inflammation mediated osteoporotic samples,
when compared with controls. This suggests that there is a relationship between
bone loss and lowered Ca/P ratio. Also, it was shown that normal bone shows less
variation in the distribution of Ca/P ratio, as demonstrated by the absence of Ca/P
ratio slice contours throughout the bone volume. On the other hand, osteoporotic
examples showed a higher density of Ca/P ratio slice contours in general, but also
displayed regions of significant Ca/P ratio gradient changes. An interesting observa-
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tion was that a sample which was judged to be osteoporotic from the bulk estimate
of the Ca/P ratio showed regions of osteoporotic behaviour and regions of normal
behaviour, suggesting osteoporosis does not affect the whole of a cortical bone. More
recent studies of the Ca/P ratio, using Auger electron and energy dispersive X-ray
spectroscopy (Kourkoumelis et al. [2011]), show similar results.
Bone Calcium or Phosphorus was measured directly in vivo by neutron activation
analysis, and such measurements were optimised for Calcium (Cohn et al. [1977]) or
Phosphorus (Boddy and Glaros [1973]) independently. Also, a dual energy analysis
model has been developed for the 2D quantification of Ca/P ratio in the proximal
phalanx of the middle finger in vivo using a conventional X-ray source (Fountos
et al. [1999]). When conducting measurements of bone, Ca, PO4 and water can be
regarded as the major attenuators of X-rays, given a number of assumptions. These
include assuming that the organic material in the path of the photons has the same
mass attenuation coefficient as that of water, and that by omitting O and H in the
measured Ca/P ratio, the introduced error is trivial. By placing Cerium (Ce) and
Samarium (Sm) filters in the X-ray beam, average photon energies of 39 and 89
keV can be obtained. Fountos et al. [1999] measured the Ca/P ratio of the right
radius in 20 osteoporotic females aged 56-72 years. The diagnosis of osteoporosis
was based on findings of compression fracture(s) of the spine and low BMD values
obtained by conventional DEXA. A average Ca/P ratio of 1.29 was found for the
osteoporotic females. This was significantly lower than that of 1.71 from 50 normal
adult females, aged 26-68 years. Fountos et al. [1999] ’s data though could not
draw any conclusions on whether the observed difference in the average Ca/P ratio
between postmenopausal osteoporotic patients and premenopausal controls is due
to disease or related entirely to aging.
The same DEA model was used to analyse gamma ray absorptiometry rabbit,
lamb and sheep tibia images. A significant decrease (p-value<0.01) in the tibia Ca/P
ratio in animals with inflammation-mediated osteoporosis has been found compared
to controls (Fountos [1997]). Furthermore, severe alterations were detected at the
microstructural level on bone collagen fibrils, studied using electron microscopy,
from inflammation-osteoporotic rabbits (Kounadi et al. [1998]).
All the above studies support the hypothesis that the Ca/P ratio affects bone
quality and also that it can be used as an osteoporosis indicator. Understanding the
effect of Ca/P ratio on bone quality and the effectiveness of the quantification of
the Ca/P ratio in bone merits further investigation for the purposes of osteoporosis
diagnosis.
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1.4.3 The aim of this study
The studies described in section 1.4.2 were only conducted in 2D or have required
the use of facilities not practically available for a clinical environment or long-term
access, such as synchrotrons. The understanding, diagnosis and thus management
of osteoporosis could be enhanced with 3D assessment of the Ca/P ratio. In a
conventional CT scanner, direct mapping is not possible due to the polychromaticity
of the beam. However, this problem can be overcome using a dual energy analysis
(DEA) technique (section 2.4). In this thesis such a method is presented for 3D
Ca/P ratio quantification that can be applied through a conventional CT scanner.
A major advantage of the developed technique over previous techniques for Ca/P
ratio assessment, is the simultaneous assessment of volumetric density (known to be
correlated to bone mechanical properties) in bone.
The ideal case was be to achieve a precision of better than 0.09 in the Ca/P ratio
assessment, given that the min/max difference in Ca/P ratio between healthy and
inflammation-mediated osteoporotic (IMO) bone samples is 0.09/0.43 (Tzaphlidou
et al. [2005], Speller et al. [2005], Kourkoumelis et al. [2011]).
The development of this technique can potentially be used to investigate the
effect of density and Ca/P ratio on bone quality in vitro or in vivo. This can be
achieved by linking density and Ca/P ratio amount and distribution to bone me-
chanical properties. This can be achieved by bone mechanical compressions and/or
FEA.
In addition, the development of this technique can potentially be used to enhance
the prediction of bone fracture in osteoporosis. If the Ca/P ratio affects bone quality
significantly, the assessment of 3D Ca/P ratio spatial distribution could potentially
be used clinically to enhance the diagnosis, and thus prevention, of osteoporosis.
It might be possible to detect a small change in the Ca/P ratio in bone before
its BMD has significantly changed. Furthermore, the Ca/P ratio could provide
additional information for the bone quality of some critical individuals whose BMD
alone is not sufficient for an accurate prediction of bone fracture.
The development of CT-DEA for density and Ca/P ratio assessment in bone
included the optimisation and the validation of the technique. Furthermore, the
technique was applied to healthy and inflammation-mediated osteoporotic bone ap-
atite samples to investigate the effect of the value and distribution of density and
Ca/P ratio, in bone apatite, in osteoporosis. Similarly, CT-DEA was applied to
healthy and inflammation-mediated osteoporotic intact (with collagen) bone sam-
ples to investigate the feasibility of the technique on bone samples with collagen,
and the effect of the value of density and Ca/P ratio, in intact bone, in osteoporosis.
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1.5 Structure of the rest of this thesis
In this chapter, the motivation for this work was explored. Osteoporosis and the
importance of its early diagnosis were discussed, the current methods of osteoporosis
diagnosis were explained and the approach of this study to the problem of osteo-
porosis was analysed.
The structure of the rest of the thesis is as follows:
- Chapter 2 describes the materials and methods used for the development, opti-
misation, validation and application of CT-DEA, including the microCT system,
scanning electron microscopy system, DEA technique and bone phantoms and sam-
ples.
- Chapter 3 presents the optimisation performed to the technique, including the
optimisation of the sample magnification parameter and the X-ray spectral pair.
- Chapter 4 describes the methodology and the results of the validation of the tech-
nique, in bone phantoms and bone samples (using a scanning electron microscope).
- Chapter 5 presents the results of the application of the technique on collagen-free
healthy and inflammation-mediated osteoporotic bones samples.
- Chapter 6 presents the results of the application of the technique on intact healthy
and inflammation-mediated osteoporotic bone samples.
- Chapter 7 summarises the work completed so far on CT-DEA and its applica-
tion to bone samples, and discusses possible potential use of the technique for the
improvement of the understanding and diagnosis of osteoporosis.
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Materials and Methods
2.1 Overview
This chapter describes the methods and materials used for the purposes of this study.
In section 2.2, the principles of a microCT system and its possible applications are
explained, and the system used in this study, X-Tek benchtop microCT is described.
In section 2.3, the scanning electron microscope system, used for the evaluation
of the performance of CT-DEA Ca/P ratio assessment in bone, is introduced and
described.
In section 2.4, a brief historical background is given on the use of Dual En-
ergy Analysis (DEA), with more emphasis on its use in bone decomposition. The
theoretical framework of DEA and Computed-Tomography Dual Energy Analysis
(CT-DEA) are described. Furthermore, different types of CT-DEA are explained.
Two different CT-DEA mathematical algorithms are analysed for the assessment
of density and Ca/P ratio: (i) applied to the mineral content of bone, in vitro for
collagen-free bone samples (section 2.4.4); (ii) applied to intact (with collagen) bone,
in vitro or in vivo (section 2.4.5).
In section 2.5.3, the bone phantoms and samples used for the validation of the
developed technique (chapter 3) and the study of density and Ca/P ratio effect in
osteoporosis, using collagen-free (chapter 4) and intact (chapter 5) bone samples are
described.
2.2 Micro-computed tomography
2.2.1 X-ray interactions with matter
X-rays interact with matter in several different ways. Relevant to the diagnostic
energy range (20-150 keV) are the photoelectric effect and Compton scattering.
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These are briefly described below. More information can be found in Beutel et al.
[2000].
In photoelectric interaction, the incident X-ray interacts with an electron in mat-
ter. The incident X-ray is completely absorbed, and all of its energy is transferred
to the electron. The electron is then ejected from the atom, causing ionisation and
excitation in the atom. There are two ways in which the relaxation of the atom
can happen: (i) characteristic X-ray and (ii) a characteristic Auger electron. The
energy of the X-ray or Auger electron is then the difference between the energies
of the two excited states and this is characteristic of the particular atomic species.
The dependence of photoelectric interaction probability, τ , (relevant to diagnostic
energy range) on the effective atomic number, Zeff and effective density ρeff of the
material and the X-ray beam energy, E can be approximated as follows:
τ ∝ Z3effE−3ρeff (2.1)
In Compton scattering, an X-ray of energy greater than the binding energy of
the atomic electron interacts with the atomic electron. A scattered electron and a
scattered X-ray photon emerge, causing ionisation. The dependence of Compton
interaction probability, σ, (relevant to diagnostic energy range) on the density, ρeff
of the material can be approximated as follows:
σ ∝ ρeff (2.2)
The Compton scattering probability is almost independent of the atomic number
Zeff. At a given energy the probability of Compton interaction is effectively constant.
The probability, per cm thickness of matter, that an X-ray photon will be at-
tenuated is described by the linear attenuation coefficient, µ(Zeff, ρeff, E) in cm
−1.
This is the sum of τ and σ (for the diagnostic energy range) and is thus energy and
material dependent.
The mass attenuation coefficient, m = µ(Zeff, ρeff, E)/ρeff of unit g/cm
2 is usu-
ally used to compensate for the dependency of µ(Zeff, ρeff, E) on ρeff. Figure 2.1
shows the variation with energy of the mass attenuation coefficient for the two main
constituents of bone: apatite (in the chemical form of hydroxyapatite) and collagen.
The attenuation of hydroxyapatite is decomposed into the attenuation of its com-
ponents: Ca, PO4, OH. The data for figure 2.1 was provided by XMuDat software
(Nowotny [1998]).
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Figure 2.1: Variation of the mass attenuation coefficient with photon energy for the two
main bone components: apatite in the chemical form of hydroxyapatite (blue line) and
collagen (red line). The attenuation of hydroxyapatite is decomposed into the attenuation
of its components: Ca (circles), PO4 (diamonds), OH (squares).
2.2.2 Principles of computed tomography
In a CT system, X-rays are produced in an X-ray tube, which consists of an oil-filled
housing containing an evacuated envelope of heat-resistant glass, within which are
mounted a filament (cathode) and an anode. An electric current heats the filament,
which then fires accelerated electrons, in a narrow beam, that finally strikes the
anode. The electrons interact with the material of the anode, in which they release
heat and 1% of X-rays in a beam. The X-ray beam is then attenuated by the sample
(as described in section 2.2.1) and at the end it reaches the image receptor, which
forms an image by the absorption of energy from the X-ray beam.
Computed tomography (CT) is the term that characterises the imaging technique
in which transmission measurements of a narrow beam are made at several different
angles (projections) around an object. Then these measurements are used to re-
synthesise (or reconstruct) slices (‘tomos’) within the object.
A 2D map of X-ray attenuation is produced for each 2D slice of the subject, thus
there is no compression of 3D data into a 2D plane. This is the advantage of CT
over planar radiography, where many anatomical planes or slices may be considered
superimposed upon each other, which can distract the viewer from a small lesion or
fracture.
Various types of CT systems have been developed so far. Their differences are
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mainly different combinations of motion(s), geometric design and detector types.
The first generation used a single scanning beam and a single detector. The beam
was first translated across the object, before rotating 1 degree before repeating
the process. The second generation systems used several detectors, instead of one,
like in first generation, monitoring a single X-ray source with a limited fan X-ray
beam. The third generation system used a fan-beam geometry and a large number
of detectors designed to rotate in synchronisation with the X-ray tube moving in
single continuous rotational motion. The difference in the fourth generation was
that there were several hundred detectors, which were kept fixed on a stationary
ring and the X-ray source only moved. More details about each CT generation can
be found in Beutel et al. [2000] and Webb [1988].
Nowadays, third- and fourth- generation geometry achieve full 360 degrees ro-
tations in 1 second or less, therefore reducing patient motion problems. The slice
thickness reduction since the original CT is 13 000 µm to 500 µm.
The reconstruction of slices is achieved by reconstruction algorithms. The pro-
jection tells you that the beam was attenuated somewhere along the path, but has
no information about where. This averages you can smear the projection out with
equal probability all along the ray path. This is back-projection. Back-projection
though suffers from blurring. The X-rays passing through the diameter of a homo-
geneously solid cylindrical object in a CT system will be attenuated most, while
the X-rays grazing the edges of the cylinder will be attenuated least. There will
be blurring around the edges as the signal strength varies inversely with the radial
coordinate in the image space. This is known as the star effect. This problem is
overcome by filtering the profiles by a Kernel filter (a function that has negative
side lobes) before back-projecting them.
An alternative reconstruction method is the iterative technique. In this, the pro-
jection image profiles are acquired, back-projected, and then successively modified
until the modified data are consistent to within pre-defined limits of all their X-ray
profiles. Successive approximations and changes are made after each iteration to
make the profile converge to a solution.
The product of the reconstruction algorithms are the CT images, expressed in
Hounsfield or CT numbers (in each voxel; the volume element represented by pixel
size×pixel size×slice thickness), which is a function of the linear attenuation coeffi-
cient, µ(Zeff, ρeff, E) is expressed as follows:
CTi = 1000
µ(E, ρi, Zeff)− µ(E, ρwater, Zwater)
µ(E, ρwater, Zwater)
(2.3)
where i represents the attenuating material.
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Figure 2.2: Construction of an image intensifier (Webb [1988]).
2.2.3 X-Tek benchtop micro-computed tomography system
X-ray micro-tomography is a miniaturised version of computerised tomography, the
main difference being its smaller focal spot (a few µm) providing a resolution of the
order of µm. This makes its use common in the study of trabecular and cortical
architecture in humans (Majumdar [2008], Martn-Badosa et al. [2003], Nuzzo et al.
[2003]), rats (Laib et al. [2000]) and mice (Martn-Badosa et al. [2003]). Other ap-
plications of the microCT in bone studies include the prediction of bone mechanical
properties either by correlating microCT bone density and porosity measurements
to bone stress, stiffness and Young’s modulus (Wachter et al. [2001]) or by gener-
ating micromechanical models of the scanned sample by converting bone voxels to
mechanical elements that can be analysed by the FEA method (van Der Linden
et al. [2001], Shefelbine et al. [2005]).
For the purposes of this study a bench-top cone-beam microCT system (Nikon
Metrology, X-Tek, United Kingdom); serial number: J00001, was used (figure 2.3).
The device is equipped with a microfocus X-ray tube, of 12 µm focal spot size in an
energy range from 0 up to 125 kVp, and a maximum current of 500 µA.
The detector is a high resolution image intensifier, a high-gain device for imaging
X-rays. It consists of an evacuated tube, with two intensifying screens, a photocath-
ode and electron optics (figure 2.2). The X-rays pass through the entry window,
strike the fluorescent screen, situated on the inner surface of the window, from where
light fluorescent photons are emitted. These hit the photocathode, where photelec-
trons are emitted. The electrons are accelerated through a potential diffence, guided
by electron optics, and strike an exit fluoresence screen, in order to produce further
fluorescent photons. These are viewed by a charged-coupled device (CCD) camera.
The field of view of the entry window is 160 mm×160 mm field of view and the pixel
size is 170 µm.
The effective resolution of the system, is dependent on sample magnification
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Figure 2.3: The X-Tek microCT system.
parameter. This is discussed in section 3.2.The source to detector distance is fixed
(682 mm). In imaging, the samples are positioned onto the manipulator (a turn-up
table) of the instrument (figure 2.3). CT image reconstruction was performed on the
images using the in-built, filtered back-projection X-Tek software (Nikon Metrology,
X-Tek, United Kingdom).
2.3 Scanning electron microscope
The scanning electron microscope (SEM) uses a focused beam of electrons to pro-
duce signals at the surface of solid samples. The interaction of electrons with the
sample produces information about surface topography and chemical composition,
and crystalline structure and orientation of materials making up the sample.
In most applications, data are collected over a selected area of the surface of
the samples and a 2D image is generated that displays spatial variations in these
properties, revealing details of less than 1 nm is size. It is impossible to produce the
overall analysis of the whole sample without damaging it.
SEM was used in this study to determine the composition of regions of interest in
the surface of eight (four healthy and four IMO) rabbit tibia cortical bone samples
(section 2.5.3). Using the composition results, the Ca/P ratios of these areas were
calculated and were compared to the Ca/P ratios of the same areas found using
CT-DEA (section 4.4). In this section, a brief overview is made on how the SEM
system works.
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Figure 2.4: Some of the signals which can be used in an SEM system (Goodhew et al.
[2001]).
2.3.1 Electrons interaction with matter
Electrons interact elastically or inelastically with matter. Elastic scattering does not
change the energy of the primary electron, but might change its direction. Elastically
scattered electrons produce a diffraction pattern (spatial distribution of the scattered
electrons) from which a great deal of information about the arrangement of the atoms
in the sample can be deduced. Diffraction patterns were not of use in this study,
therefore elastic scattering will not be discussed further.
In inelastic scattering the primary electron loses a detectable amount of its kinetic
energy, which ends up as heat in the sample or as secondary effects; the emission
of secondary electrons, backscattered electrons and X-rays. All these end up being
very useful for both imaging and analysis in SEM (figure 2.4).
In this study, backscatter imaging was used in SEM to acquire images of the
samples. Backscattered electrons are primary electrons that leave the surface before
giving up all their energy after inelastic collisions. The number of backscattered elec-
trons emitted from the sample for each incident electron varies monotonically with
atomic number. Using SEM images the composition of the sample was produced
and the areas of compositional interest were identified by backscattered imaging and
the phase compositions were then determined by analysis of the X-ray signal.
Phase composition is achieved using the relaxation of excited atoms in the sam-
ple, when a localised electron is knocked out of an atom. The two ways in which the
relaxation of the atom can happen are the same as in the case of X-ray interaction
with matter: (i) characteristic X-ray and (iii) a characteristic Auger electron. The
energy of the X-ray is then the difference between the energies of the two excited
states and this is characteristic of the particular atomic species. Therefore, informa-
tion on the elements present and their amount can be retrieved. Further information
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Figure 2.5: The parts of an SEM system (Goodhew et al. [2001]).
on how this is done in an SEM system are given in section 2.3.2.
2.3.2 Principles of scanning electron microscopy
SEM consists of an electron gun, a system of condenser lenses, a vacuum system
and a signal detector (Figure 2.5).
In the electron gun, thermionic emission from a heated, tungsten filament is used
to encourage electrons to a leave a solid and be accelerated towards the sample, to
an energy which is usually between 1 keV and 30 keV.
The beam of electrons is then focused by an electrostatic or a magnetic field.
Two or three condenser lenses focus the electron beam until, as it hits the sample,
it has a diameter of only 2-10 nm.
Backscattered electrons travelling in the appropriate direction are detected by
a scintillator detector. The electrons strike the scintillator e.g. a phosphor, which
emits light. The light is transmitted through a pipe, and into a photomultiplier
which converts the photons into pulses and electrons, which are then amplified.
Secondary electrons, which are independent of the sample atomic number (thus do
not give any useful information on sample composition) are of too low energy (10-
50 eV) to excite the scintillator, therefore they are excluded from the detector, and
backscattered signal only is obtained.
The detector for the energy dispersive detection (figure 2.6) consists of a small
piece of semiconducting silicon. Its resistivity is increased by doping silicon with
a small concentration of lithium and by making the whole detector p-i-n junction,
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Figure 2.6: Parts of an energy dispersive spectrometer (Goodhew et al. [2001]).
which is reverse biased, using thin layers of gold on both surfaces of the detector.
The gold coated outer surface is protected from contamination by a thin window of
beryllium or a polymer. The whole detector is cooled at liquid nitrogen temperature
(-196 ◦C) to preserve the detector crystal and to reduce noise in the system.
Each incoming X-ray excites a number of electrons into the conduction band of
the silicon leaving the same number of positively charged holes in the outer electron
shells. The energy required for each of these excitations is only 3.8 eV; consequently
the number of electron-hole pairs generated is proportional to the energy of the X-
ray photon being detected. If a voltage is applied across the semiconductor a current
will flow as each X-ray is absorbed in the detector and the magnitude of the current
will be proportional to the energy of the X-ray. It is impracticable to detect X-rays of
energy less than 1 keV with this type of detector; therefore all elements lighter than
sodium are eliminated. Finally, a multichannel analyser (MCA) is used to register
the current (pulse) into different channels, and produce a histogram (spectrum).
In the SEM system it is necessary for the surface of the sample to be electrically
conducting. During operation there is a surplus of electrons building up on the
sample surface. Therefore electrons have to be conducted away to earth to prevent
the sample surface from becoming negatively charged and the incoming primary
electrons to be repelled and deviated from their normal path. There is no difficulty
in studying clean metal samples. However, usually non-conductors such as biological
materials present a problem. In this case it is usual to coat the sample with a thin
(about 10 nm) conducting layer of gold or carbon. Coating was not required in this
study, since collagen was removed from the bone samples (section 2.5.3), thus they
only contained minerals which are ionising. Furthermore, the sample should ideally
be flat, since on rough samples some X-rays might not reach the detector due to
44
2. Density and Ca/P ratio assessment using CT-DEA
scatter.
2.4 Dual energy analysis
2.4.1 Historical background of dual energy analysis in bone
decomposition
Interest in decomposing bone components using DEA has existed since the early
1960s. In 1963, Cameron and Sorenson proposed a 2D DEA model for finding
the concentrations of the elements present in bone, with projection radiography
(Cameron and Sorenson [1963]). The model was tested with radioactive sources
(Iodine-125 at 27.3 keV and Americium 241 at 59.6 keV) on blocks of paraffin and
Calcium Carbonate (CaCO3), homogeneously mixed in known proportions. The
measurements resulted in determination of the percentage of CaCO3 over a wide
range of compositions, to an average accuracy of 3%. Their model however was
never tested experimentally with X-rays and/or on bone phantoms/samples, for its
potential clinical application.
In 1976, CT-DEA was first conceived. In the late 1970s and 1980s, a large
amount of work was completed on the techniques and clinical applications of material
decomposition imaging with CT-DEA (Alvarez and Macovski [1976], Kelcz et al.
[1979], Chapman et al. [1980], Lehmann et al. [1981], Goldberg and Cann [1982]
and Kalender et al. [1986]). Attempts were made to quantify the amount of the
mineral content in bone using CT-DEA. Burgess [1987] assessed the mineral content
of human vertebral trabecular bone using CT-DEA, with a correlation of 95% to
the actual mineral content of the samples (Burgess [1987]).
In 1997, Fountos developed a new DEA system and model to assess, quantita-
tively, the amount of Ca/P ratio in animal and human bone in 2D, using radioactive
sources (Fountos [1997]) and a commercial X-ray source (Fountos et al. [1999]).
Limitations in generator powers, tube heat capacity, tube cooling, and spatial
and temporal resolution of earlier X-ray imaging systems put a limit to the potential
of the DEA in clinical applications. Today, the main success of DEA is bone mineral
density quantification. To the best of the knowledge of the author, there have not
been any new results on bone elemental mineral decomposition using DEA since
1999.
However, interest in bone composition and especially the study of the Ca/P ratio
still exists today. Other techniques, including neutron activation analysis (Zaichick
and Tzaphlidou [2002]), synchrotron linear attenuation coefficient mapping (Tza-
phlidou et al. [2005], Tzaphlidou et al. [2006], Speller et al. [2005], Postnov et al.
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[2003]), SEM (Kourkoumelis et al. [2011], Kourkoumelis et al. [2011]), the study of
human diet (Teegarden et al. [1998]), as discussed in section 1.4.2 have been used to
determine the importance of Calcium and Phosphorus and/or Ca/P ratio in osteo-
porosis understanding and diagnosis. All the above studies have shown that research
on the Calcium/Phosphorus in bone, and its relation to bone quality are justified.
Recently, CT (Wang et al. [2008]) and CT-DEA have regained focus in terms
of both basic technology and new potential clinical applications, some of which are
the quantification of iron in a fatty liver (Liu et al. [2009]), the quantification of
iron in arteries for identifying vulnerable plaque (Wang et al. [2011]), the determi-
nation of urinary stone composition, the quantification of renal masses, urolithiasis
and disorders of uroepithelium (Hartman et al. [2012]) and angiography (Watanabe
et al. [2009]). Further clinical potential applications of CT-DEA are described by
Karc¸aaltncaba and Akta [2011]. However, no work has been completed before, on
the use of CT-DEA for Ca/P ratio assessment.
2.4.2 Principles of dual energy analysis technique
DEA imaging involves the acquisition of images acquired at two different X-ray
beam energies: one at a low-kVp and another at a high-kVp. Quantification of a
defined set of material components can be achieved by appropriate processing of
the pair of images. For example, in an X-ray image consisting of bone and soft-
tissue, eliminating bone yields an image and quantification of soft-tissue, and vice
versa. Figure 2.7 shows a typical case of DEA. The information from the two images
acquired at the two different energies is decomposed into their component materials
using the energy-dependent differences in their attenuation coefficients.
It is possible to conduct dual energy within a single exposure (SE) technique
(Stewart and Huang [1990]). In the SE the X-ray detector is made of two lay-
ers, separated by a filter. Each layer is responsive to a different energy to allow
simultaneous acquisition of two images of the same sample.
The conventional DEA technique involves a successive voltage change of the X-
ray beam during the image acquisition process. This method is more efficient in
terms of energy separation, and showed great increase in accuracy in the calculation
of the measured quantity, compared with SE (Burgess [1987], Genant and Boyd
[1977]). However, it assumes that the object is static during the acquisition of the
two images. For the purposes of this study the DEA technique was used due to the
single layer detector of the microCT system.
There are several models of DEA. The best choice of DEA model depends on
the specific application of the considered problem. The %Z decomposition method
(Alvarez and Macovski [1976]) can be used to identify the materials present in the
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Figure 2.7: Dual energy imaging of the chest. (a) Low kVp and (b) High kVp images
are decomposed into (c) soft tissue and (d) bone images (Toutountzis [2009]).
sample, and produce a material specific image. The two photon-matter interactions
of the diagnostic energy range, the photoelectric effect and Compton scattering
interactions, and their relative contribution to the total attenuation are energy de-
pendent. The contribution of effective density and effective atomic number of the
material to each type of X-ray interaction is known. Therefore, acquiring images at
two different energies, and separating the two X-ray interactions, provides informa-
tion for the effective density and effective atomic number of the sample.
Alternatively, the basis material decomposition method (Lehmann et al. [1981],
Kalender et al. [1986], Arvanitis and Speller [2009]) is a technique that can be used
to quantify the amount of a known component (its thickness or its concentration)
present in a sample. Any material’s mass attenuation coefficient, excluding K-
edges, can be expressed as a linear combination of the attenuation coefficients of its
components. This technique decomposes the image of a sample into two components
by linearly combining the images acquired at the two different energies.
2.4.3 Computed tomography dual energy analysis (CT-DEA)
As for planar DEA, there are different ways of CT-DEA. The %Z method and the
basis-material decomposition method are the two main methods. The basic equa-
tions used in them are mathematically described below.
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As mentioned above, in the %Z method, the photoelectric effect and Compton
scattering interaction effect are separated thus allowing determination of density and
Zeff. For the CT %Z method the line integral over the linear attenuation coefficient
of a CT measurement is given by
∫
µ(r, E)ds = α
∫
ρeff
Zkeff
En
ds+ β
∫
ρeffφKN(E)ds (2.4)
where φKN is the Klein-Nishina function, k≈3-4 and n≈ 3-3.5, and α and β are
constants (Cho et al. [1975]).
In the basis material decomposition method the attenuation of the known sample
components are separated and the amount of each material is quantified. The line
integral over the linear attenuation coefficient of a CT measurement is given by
∫
µ(r, E)ds =
∫
ρefff1m1(r, E)ds+
∫
ρefff2m2(r, E)ds (2.5)
where µ(r, E) is the local linear attenuation coefficient, f1 and f2 are the mass frac-
tions of basis materials 1 and 2, and m1(r, E) and m2(r, E) are the mass attenuation
coefficients of basis materials 1 and 2, respectively.
Both the %Z and the basis material decomposition methods described above can
be implemented either in pre-reconstruction space and post-reconstruction space.
The advantage of the pre-reconstruction implementation is that raw data can be
preprocessed, for example to correct for beam hardening. The advantage of a post-
reconstruction implementation is its relatively ease of implementation and fast exe-
cution time.
Examples of pre-reconstruction implementations include Alvarez and Mackovski’s
(Alvarez and Macovski [1976]) %Z method Lehmann Lehmann et al. [1981]) and
Kalender’s (Kalender et al. [1986]) basis material decomposition method. In 2003,
Heismann et al implemented their %Z method in post-reconstruction space (Heis-
mann et al. [2003]). Liu et al described the implementation of a general material
basis method in post-reconstruction space (Liu et al. [2009]). Table 2.1 summarises
the currently known main DEA methods.
Liu et al. [2009]’s method was experimentally validated using a dual-source CT
system and phantoms containing mixtures of water, hydroxyapatite and aqueous
iron nitrate solutions. The advantage of this method in clinical situations is that
it can determine the effective density, the effective atomic number and the mass
fraction of two materials of a mixture using two image acquisitions.
The method quantifies the effective density of the mixture and the fractions of the
sample components, from the same dual-energy CT images, in two steps. The first
step is a post-reconstruction %Z approach, and therefore determines the Zeff and ρeff
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Table 2.1: Summary of the studies of the main CT-DEA material decomposition algo-
rithms.
DEA approach
Reconstruction Method %Z Material basis
Prereconstruction Alvarez and Mackovski (Al-
varez and Macovski [1976])
Lehmann et al (Lehmann
et al. [1981])
Kalender et al (Kalender et al.
[1986])
Postreconstruction Heismann et al (Heismann
et al. [2003])
Liu et al (Liu et al. [2009])
of the sample. The second step, is a post-reconstruction material decomposition ap-
proach. The ρeff result produced in step one is used as known information in step two
to obtain the fractions of the sample components. This approach is semi-analytical
as it requires prior-knowledge of the sample components and an approximation of
how a change in the component proportion affects X-ray attenuation.
A basis material decomposition method, similar to the one introduced by Liu
et al. [2009], was used in this study and adapted for bone mineral decomposition.
The Zeff, ρeff of bone apatite and intact bone and the proportions of Calcium and
Phosphorus are quantified in the two-step process.
2.4.4 CT-DEA for density and Ca/P ratio assessment in
bone mineral content
In principle, CT-DEA cannot decompose more than two constituent materials in a
mixture because it only provides two independent measurements. Bone is a complex
structure, consisting of more than two components. Three of the main components
in bone apatite, Ca, PO4 and OH, are at the same time the three main X-ray
attenuators in bone apatite. The rest of the elements in bone apatite are of reduced
quantity, therefore their effect in X-ray attenuation is insignificant (Fountos [1997])
and bone apatite can be decomposed into these three components only.
For a three-material decomposition using two different spectral measurements,
one additional condition must be provided to solve for three unknowns. One possible
solution is the assumption of volume conservation in the mixture or sample, i.e. to
assume that the sum of the volumes of three constituent materials is equivalent to
the volume of the mixture (Burgess [1987]). However, this assumption is not always
true. For example, the volume of a salt-water mixture is not equal to the sum of the
individual volumes of salt and water. Instead, mass conservation can be assumed.
This is based on the same principle i.e. to assume that the sum of the masses of
three constituent materials is equivalent to the total mass of the mixture.
Two spectral measurements and a mass-conservation based, 3-material decom-
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position CT-DEA algorithm were used to determine the material density of bone
apatite (BMDmaterial, as defined in section 1.4.1) and the proportions of the three
main components in bone apatite: Ca, PO4 and OH (figure 2.1). This algorithm is
mathematically described below.
Assuming a 100% efficient detector, the average linear attenuation coefficient, µ,
is expressed by:
µ(Zeff, ρeff, E) = m(Zeff, E)ρeff (2.6)
where as defined above, E is energy and ρeff, Zeff and m are the effective density,
effective atomic number and average mass attenuation coefficient of the sample, re-
spectively. If the X-ray spectrum is known, the average mass attenuation coefficient
m can be calculated as:
m =
∫
P (E).E.m(E).dE∫
P (E).E.dE
(2.7)
where P is the number of photons. At low (EL) and a high (EH) energies,
µL(Zeff, ρeff, EL) = mL(EL, Zeff)ρeff (2.8)
µH(Zeff, ρeff, EH) = mH(EH , Zeff)ρeff. (2.9)
The ratio of these two gives the fraction of the average linear attenuation coeffi-
cients, at the low and high energy, which will be referred to in the remainder of this
study as ‘F’:
µL
µH
=
mL
mH
= F (Zeff). (2.10)
For two particular spectra, the theoretical values of mL(Zeff), mH(Zeff) and
F (Zeff) can be calculated for a specific Zeff. Therefore, based on the ratio of the
effective linear attenuation coefficients, F (Zeff), obtained from the CT image data,
Zeff, mL(Zeff) and the effective density, ρeff of the sample can be determined (using
equation 2.6).
Liu et al. [2009] constructed a numerical lookup table for the theoretical values
of mL(Zeff), mH(Zeff) and F (Zeff) (Liu et al. [2009]). All previous work has used the
lookup table apprach.
In this study, mL(Zeff) was determined in two steps using mathematical relations
of F (Zeff) to Zeff and Zeff to mL. At present, these approximations of the mathe-
matical relations are required in CT-DEA for bone material decomposition. This
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is because the exact chemical composition of biological apatite is diverse and not
known with sufficient accuracy to enable the construction of a precise look-up table
of F (Zeff) to Zeff and Zeff to mL.
These relations (figure 2.8) were approximated by second order polynomials (with
R2 = 0.99 each), using the chemical formulae of bone apatite phantoms of different
Ca/P ratio (table 2.2) and the XMuDat software (Nowotny [1998]). The resulting
relation of F (Zeff) to Zeff is
Zeff = 0.3169F
2 − 1.4382F + 5.9591;R2 = 0.99 (2.11)
and of Zeff to mL is
mL = 0.0138Z
2 − 0.2140Z + 1.231;R2 = 0.99 (2.12)
There is nothing physical to suggest what order of the polynomial is correct,
therefore ideally the one that best gives the best fit to the data (the highest order
polynomial) should have been chosen. However, the advantage of an approximated
second order polynomial for F (Zeff) to Zeff and Zeff to mL relations, compared to a
higher order polynomial, is that for the second order polynomial there is a smaller
error of propagation from F (Zeff) to Zeff to mL and finally to the assessed quantities
(ρeff and Ca/P ratio). In this study, an order of polynomial higher than the second
order propagated a significantly high error in the assessed quantities.
After determining ρeff using the knowledge of mL, found using the F (Zeff) to Zeff
and Zeff to mL mathematical relations, the fractions of the sample components can
be quantified. Assuming that Ca, PO4 and OH are the only components in bone
apatite (equation 2.13), the fractions of Ca, PO4 and OH can be determined by
solving equations 2.13 - 2.15 below.
1 = fCa + fPO4 + fOH (2.13)
where fi is the fraction by weight of each component i.
At the low, L, and high, H, energies the average linear attenuation coefficient, µL, H
can be expressed by:
µL
ρeff
= mCa,LfCa +mPO4,LfPO4 +mOH,LfOH (2.14)
µH
ρeff
= mCa,HfCa +mPO4,HfPO4 +mOH,HfOH (2.15)
Finally, knowing fCa, fPO4 and fOH allows the Ca/P ratio to be calculated. The
molecular weight ratio (PO4/P) is 3.0679, and the ratio of the molar masses of Ca
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Figure 2.8: Relations of (a) F (Zeff) to Zeff and (b) Zeff to mL for bone mineral content
composites of different Ca/P ratio.
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and P is 1.2940, thus the atomic Ca/P ratio is given by:
Ca/P ratio =
fCa
fPO4
3.0679
1.2940
. (2.16)
The above algorithm was custom-built in MATLAB for the purposes of this
study.
2.4.5 CT-DEA for density and Ca/P ratio assessment in
intact bone
As shown in table 1.1, in addition to bone apatite, intact (with collagen) bone also
contains mainly collagen. For the in vivo use of the technique, the presence of
collagen also needs to be taken into account, due to its significant weight proportion
(≥ 15% by weight) in bone.
However, using two energy beams the maximum number of sample constituents
to be decomposed are three. The proportion of collagen is bigger than the proportion
of OH in bone. Therefore, the third component of the mineral content of bone, OH,
is replaced by collagen for intact bone.
As above, two spectral measurements and a mass-conservation based, three-
material decomposition CT-DEA algorithm can be used to determine the propor-
tions of Ca, PO4 and collagen in intact bone.
The mathematical relations of F (Zeff) to Zeff and Zeff to mL (figure 2.9), were
approximated as above by different second order polynomials (with R2 = 0.99 each),
using the chemical formulae of the bone phantoms (table 2.2) and assuming collagen
is also present in them in a weight proportion of 15%. The resulting relations are
the following:
Zeff = 0.4371x
2 − 0.7389x+ 6.9898;R2 = 0.99 (2.17)
and for the low energy image the calibration equation is
mL = 0.0134x
2 − 0.2020x+ 1.1476;R2 = 0.99 (2.18)
ρeff can be determined using equation 2.13. Assuming that Ca, PO4 and collagen
are the only components in bone (equation 2.19), the fractions of Ca, PO4 and
collagen can be determined by solving equations 2.19 - 2.21 below.
1 = fCa + fPO4 + fcoll (2.19)
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Figure 2.9: Relations of (a) F (Zeff) to Zeff and (b) Zeff to mL for bone composites (85%
mineral and 15% collagen by weight) of different Ca/P ratio.
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where fi is the fraction by weight of each component i.
µL
ρeff
= mCa,LfCa +mPO4,LfPO4 +mcoll,Lfcoll (2.20)
µH
ρeff
= mCa,HfCa +mPO4,HfPO4 +mcoll,Hfcoll (2.21)
Finally, the atomic Ca/P ratio is given by equation 2.16, as above.
The above algorithm was custom-built in MATLAB for the purposes of this
study.
2.5 Samples
2.5.1 Di-potassium phosphate solutions
Di-Potassium Phosphate, K2HPO4, has similar attenuation to bone apatite (Genant
and Boyd [1977]) (µK2HPO4,L = 2.50, µHA,L = 2.32 and µK2HPO4,H = 0.78, µHA,H =
0.64). Five K2HPO4 solutions of different concentration (1-5 g/cm
3) were prepared
using de-ionised water and K2HPO4 powder (Sigma-Aldrich Ltd). These solution
were used in the calibration of the CT grey value of the microCT system (section
3.6.2) and in the evaluation of the experimental precision of density of CT-DEA
(section 4.3).
2.5.2 Bone phantoms
For the evaluation of the precision CT-DEA in density and Ca/P ratio assessment
in bone apatite, ten bone phantoms of known Ca/P ratio were used. Commercially
available Calcium Phosphate powder (Sigma-Aldrich Ltd), of five different chemical
formulae, was compressed using a Specac hydraulic presser into small cylindrical
pellets (of 8 mm diameter and 2-4 mm height) of different densitytotal (being equiva-
lent to the mass over the total volume of the sample, not the mass over the volume
of the material) (figure 2.10). Some of the samples had the same chemical formula,
and thus the same Ca/P ratio. The reason they were all assessed was to test re-
peatability in Ca/P ratio assessment, when densitytotal is different, and thus µ(Zeff,
ρeff, E) is different. Table 2.2 shows details for the phantoms, including their purity,
as provided by Sigma-Aldrich Ltd.
For the determination of the total density of a phantom its mass was measured
using a weighting scale and its volume was found using the microCT image of the
phantom (after thresholding, as will be discussed in section 4.3). For the determi-
nation of the Ca/P ratio of a phantom its chemical formula was used.
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Figure 2.10: Typical bone phantoms.
Table 2.2: Details of phantoms used in CT-DEA precision evaluation.
Chemical Formula Purity Ca/P ratio Densitytotal CT-DEA decomposition
Ca(H2PO4)2(H2O) > 85.0% 0.5 2.54 Ca, PO4, H2O
Ca(H2PO4)2(H2O) > 85.0% 0.5 2.39 Ca, PO4, H2O
CaHPO4 98.0% 1 2.97 Ca, PO4, H
CaHPO4.2H2O 98.0% 1 2.95 Ca, PO4, H2O
CaHPO4.2H2O 98.0% 1 2.81 Ca, PO4, H2O
Ca3(PO4)2 96.0% 1.5 2.10 Ca, PO4
Ca3(PO4)2 96.0% 1.5 2.21 Ca, PO4
Ca5OH(PO4)3 99.9% 1.67 2.08 Ca, PO4, OH
Ca5OH(PO4)3 99.9% 1.67 2.27 Ca, PO4, OH
Ca5OH(PO4)3 99.9% 1.67 1.81 Ca, PO4, OH
2.5.3 Bone samples
Healthy and inflammation-mediated osteoporotic bone samples were used to: (i)
evaluate the performance of CT-DEA on Ca/P ratio assessment in real bone apatite,
using collagen-free bone samples (section 4.4), (ii) study the effect of density and
Ca/P ratio on osteoporosis in bone apatite, using collagen-free bone samples (chapter
4), and intact bone (chapter 5).
Bone samples were obtained from the same animal species, female New Zealand
white rabbits. For the purposes of this study 12 rabbits were housed in groups of
two and were bred in natural conditions, allowed to freely take a diet of solids and
tap water. Throughout the animal experiments, which were performed at Ioannina
University, care was taken to minimise pain and discomfort. All study protocols were
approved by the Ioannina University Institutional Animal Care and Use Committee.
In half of the animals, inflammation-mediated osteoporosis (IMO) was induced.
The first animal model of generalised osteoporosis resulting from inflammation that
closely resembled the chronic inflammatory bone loss seen in human patients was
developed by Minne et al. [1984] in the rat. It is one of the five manipulations that
have been used in experimental animals to induce excessive bone loss in order to
produce a model for osteoporosis, since no mammalian species, other than humans,
fractures when it loses bone. The other mechanisms are the immobilisation by
plaster casting, nerve, or tendon sectioning leads to severe bone loss, ovariectomy
induced bone loss and various dietary manipulations (Grynpas [1993]).
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In IMO, the inflammation in the animals is provoked by injections of nonspecific
irritants such as cotton wool or talkum (magnesium silicate solution of density 1
gram magnesium silicate per 2.5 grams physiologic saline), typically on the back
of the rat at sites distant from the skeleton, to stimulate an acute phase response
(Armour and Armour [2003]). In this study, the IMO model was applied using
talkum (Sigma-Aldrich Ltd) on the rabbits. More details for the induction of IMO
to the animals can be found in the protocol document of the model (Armour and
Armour [2003]).
Very few attempts have been made to verify that in these models the bone that
remained was indeed more fragile (Grynpas [1993]). However IMO bones have been
used several times as representatives of osteoporotic bones and the results were
characteristic of osteoporosis. Minne et al. [1984] observed a decrease in trabecular
bone volume of the tibia in IMO rats of about 30%. Granulomatous reactions were
noticed at the injection sites along with the accumulation of chromic inflammatory
cells. In addition, significant decreases in osteoblast number and trabecular volume
were observed at bone sites away from the inflammatory lesion. These are major
features of inflammation-mediated osteoporosis (Pfeilschifter et al. [1987], Vukicevic
et al. [1988], Krempien et al. [1988]). In rats, decreases in osteoprogenitor (cells
from which osteoblasts arise) number and bone elongation were also found (Krem-
pien et al. [1988]). Osteclast numbers and osteoclastic resorption were found to be
generally unchanged (or transiently decreased) in this model (Minne et al. [1984],
Pfeilschifter et al. [1987], Vukicevic et al. [1988], Krempien et al. [1988]). This is in
agreement with the observations in humans with chronic nonosseous inflammation
(Ralston et al. [1990], Deodhar and Woolf [1996]).
Furthermore, a statistically significant decrease in Ca/P ratio in inflammation-
mediated osteoporosis treated rabbit bones (Fountos [1997]) and aged/osteoporotic
human bone (Fountos et al. [1999]) compared to healthy bone was reported. Similar
results were found by Speller et al. [2005], Tzaphlidou et al. [2005] and Kourkoumelis
et al. [2011]. Kounadi et al. [1998] results also showed an anarchic arrangement of
rabbit bone fibrils and a disrupted architecture in IMO rabbits compared to control
rabbits. Moreover, the diameters of the fibrils from treated rabbits varied, in contrast
to the uniform size of normal ones.
All animals were euthanised under light ether anesthesia at 8 months of age.
Titanium and glass tools were used to clean samples of soft tissues and blood. A
titanium scalpel was use to cut cortical bone samples into 4-10 mm lengths. Cortical
sections of all samples from the diaphysis of the bones were dissected and cleaned
free of muscles and tendons (figure 2.11). No signs of metabolic alterations of the
bone tissues were noted.
From each animal, sections were cut from three different bone sites of the rabbits;
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Figure 2.11: A typical bone sample.
rear tibia (RT), front tibia (FT) and femur (F), giving 36 samples in total (table
2.3). Eighteen of the samples were heated at 350 ◦C for 48 hours to remove collagen
(Miculescu and Ciocan [2011], Raspanti et al. [1994]), to limit any error its presence
might introduce on the outcome of CT-DEA on bone apatite. After heating, the
shape of the bone samples was preserved. As shown by Raspanti et al. [1994]),
heat treatment at below 500 ◦C has no detectable effect on the size, crystallinity, or
lattice spacing of the crystals of bone apatite while at the same time it effectively
removes most of the organic part.
Table 2.3: Numbers of bone samples for each bone type and each bone site.
Bone Site Collagen-free Intact
Healthy IMO Healthy IMO
RT 3 3 3 3
F 3 3 3 3
FT 3 3 3 3
The usage of the 36 bone samples is discussed in table 2.4. For the evaluation
of the performance CT-DEA technique on real bone samples, collagen-free bone
samples were used to limit any problems its presence might introduce in the SEM
imaging, due to the non-conducting nature of collagen. Since for SEM imaging
bone samples with flat and parallel surfaces are required, the eight (four healthy
and four IMO) most parallel and flat-surfaced collagen-free samples (set 1a; part of
set 1) were selected. The samples were carefully polished using a polishing paper of
grit size 58.5±2 µm, to make the surface even more flat and parallel. A diamond
wheel saw could have been used instead; however, due to the high fragility of the
collagen-free samples it was avoided.
Eighteen collagen-free bone samples (set 1) were used to study density and Ca/P
ratio in bone apatite. Nine of them were healthy and nine of them IMO; three rear
tibiae, three femurs and three front tibiae for each bone type. The exact analysis
performed and the results of the study of set 1 are discussed in chapter 5.
Similarly, eighteen intact (nine healthy and nine IMO; three rear tibiae, three
femurs and three front tibiae for each type) bone samples (set 2) were used to study
density and Ca/P ratio in intact bone. Details on the analysis performed and the
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results of the study of set 2 are discussed in chapter 6.
Table 2.4: Bone samples sets and usage.
Set Samples number Type Usage
Healthy IMO
1a 4 4 Collagen-free Evaluation of CT-DEA on bone apatite
1 9 9 Collagen-free Analysis of density and Ca/P ratio in bone apatite
1 9 9 Intact Analysis of density and Ca/P ratio in intact bone
2.6 Summary
In this chapter the imaging system used for the application of CT-DEA in this
study, X-Tek benchtop microCT, and for the evaluation of the precision in Ca/P
ratio assessment by CT-DEA, SEM, were described. Two different CT-DEA math-
ematical algorithms were analysed for the assessment of density and Ca/P ratio:
(i) applied to the mineral content of bone, in vitro for collagen-free bone samples
(section 2.4.4); (ii) applied to intact bone, in vitro or in vivo (section 2.4.5). Finally,
the preparation of the bone phantoms and samples used for the validation of the
developed technique (chapter 3) and the study of Ca/P ratio effect in osteoporosis,
using collagen-free (chapter 4) and intact (chapter 5) bone samples was described.
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Chapter 3
CT-DEA optimisation
3.1 Overview
In this chapter the optimum conditions selected for the production of the density
and Ca/P ratio bone results, in sufficient precision and resolution, are described.
In section 3.2, the method and the results of the optimisation of the magnification
parameter, so that CT-DEA results are produced with sufficient resolution, are
described.
In section 3.3, the method and the results of the selection of the energy spectral
pair, so that CT-DEA results are produced with sufficient precision, are described.
3.2 Optimisation of the magnification parameter
An ‘optimum sample position’ in an imaging system is defined as the position of
the sample along the line from the X-ray tube to the detector where the achieved
resolution is at its maximum. For the developed technique to be potentially applied
to trabecular bone, a minimum resolution of 150 µm is required, since, according
to Ulrich et al. [1999], Majumdar et al. [1997] and Laib et al. [1997] the trabecu-
lar thickness varies between 150-500 µm. The corresponding sample position and
magnification to achieve this resolution needed to be found.
A framework for the optimisation of the geometry of the system, accounting for
the effects of both the focal spot and the detector, determined simultaneously from
one set of measurements, was developed and applied to the microCT system to find
the optimum sample position.
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Figure 3.1: The geomatric blurring or penumbra, Uf due to the focal spot.
3.2.1 Unsharpness
Unsharpness refers to the degree of blurring among the boundaries between different
regions of the image. The components of an imaging system that contribute to
unsharpness are the focal spot of X-ray tube, the detector and the sample/patient
movement. In microCT in vitro experiments there is not any movement unsharpness,
thus overall unsharpness in the image, U, is given by the sum of squares method
(Webb [1988]).
U =
2
√
Us
2 + Ud
2 (3.1)
where U s is the geometric blurring or penumbra and Ud is the intrinsic detector
resolution.
Us, the geometric blurring (or penumbra), is caused by the finite area of the focal
spot; the region of an X-ray tube from which the X-rays emanate. More precisely,
the spatial distribution of the focal spot caused by electrons impinging onto the
surface of the target. This can be kept to a minimum by employing a tube with a
small focal spot. This requires the use of a small filament (producing the electrons)
and a small area over which the electrons hit the target. However, the filament size
cannot be too small as it may overheat and melt; and the area is restricted by the
ability to keep the target cool.
The geometrical unsharpness is also dependent on the ratio of sample-detector
distance, d2, to source-sample distance, d1 (figure 3.1),
Us = s
d2
d1 + w
= s.m (3.2)
In the detector, the X-ray photons exiting the sample do not necessarily interact
at the same point at which they enter the detector. The particles that form the image
may spread inside the detector and be recorded at a distance from the interaction
site. This is known as the intrinsic detector resolution or unsharpness, Ud.
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For an object that is imaged under magnification the effect of the detector on
unsharpness gets bigger with smaller magnification. This is because more pixels fit
into the object when it is magnified. Thus, the further away the object is from the
detector, the smaller the unsharpness due to the detector. But, then, the closer the
object to the source the bigger is the geometric unsharpness. A compromise between
the distance from the source and the distance from the detector has to be made to
find the optimum sample position.
Therefore, the magnification, M (achieved using the conventional X-ray cone-
beam), is expressed by:
M =
d1 + w + d2
d1
. (3.3)
Equation 3.1 can then be expressed as:
U =
2
√
(s.m)
M2
2
+
D2
M2
(3.4)
or,
U =
2
√
(s.(M − 1))
M2
2
+
D2
M2
(3.5)
By demanding dU
dM
= 0 the optimal magnification and thus the optimal position
can be found (Gayer et al. [1990]).
3.2.2 Edge imaging
The common methods to determine the total, geometric or detector resolution are
the slit and the edge methods (Beutel et al. [2000], Fujita et al. [1992], Samei et al.
[1998]). The slit method assesses the response of the system to an impulse function
by imaging a slit that represents a delta function. The response of the system,
Line Spread Function (LSF) is thus given by the convolution of the Point Spread
Function (PSF) with the slit. The edge method uses an edge and the pixel value
versus distance from the edge is plotted to form the Edge Response Function (ERF).
One of the advantages of the edge method is its simplicity and easy access to
an edge. Comparing the edge and slit methods, the edge method requires a much
lower level of exposure for sufficient irradiation of the detector and it theoretically
requires less precise alignment (Samei et al. [1998]). Also, for a system with an
expected high resolution, very small slits are required, placing great demands on
fabrication and alignment.
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Several alternatives have been suggested for the quantification of unsharpness.
The overall width of the LSF; which is the derivative of the ERF, could be used
but in many cases it has no definite width. The FWHM of the LSF provides a
good practical measure of the unsharpness especially when the LSF has a Gaussian
form (Kandarakis [2001]). Unsharpness has also been defined as the distance over
which the response goes from 16.5% to 83.5% of the maximum (Shuping and Judy
[1978]). Additionally, the MTF, the Fourier transformed LSF, a typical method of
describing resolution gives an indication of unsharpness at some specified spatial
frequency (Day [1976], Lubberts and Rossmann [1967], Rossmann [1964]). This
method of measuring the MTF has gained popularity recently, due to its simplicity
and appropriateness especially for imaging (Cunningham and Reid [1992], Samei
et al. [1998]).
In this study the edge method was used to quantify the total unsharpness and to
separate the contributions of the focal spot and the detector. The edge unsharpness
was quantified as the FWHM of the LSF of the edge. To find the unsharpness due
the edge, it was required to acquire images of the edge, determine the orientation
of the edge, apply appropriate sampling of the pixel data and process the resulting
edge response function (ERF) to obtain the LSF.
As an edge, the International Electrochemical Commission (IEC) recommends
using a 4 mm thick test object consisting of 1 mm of tungsten and 3 mm of lead.
Several authors though have used test objects completely made of lead, completely
opaque to X-rays (Koutalonis et al. [2008]). Blurring of the ERF obtained is thus
kept to a minimum. However, complete opacity leads to the reduction of quantum
noise in one tail of the ERF relative to that in the other. On the other hand, too
high a transmission results in an unacceptably small signal to noise ratio. In this
experiment a semi-opaque (transition measured to be about 50%), uniform density,
0.1 mm metallic titanium sharp edge was thus used.
The titanium edge was positioned parallel to the X-ray tube window surface and
the detector, and its edge was imaged. Usually, the orientation of the edge is deter-
mined with the help of a laser beam (Samei et al. [1998]), but this was technically
difficult to use within the microCT. Therefore, a titanium object whose top and
bottom edges were sharp, straight and parallel, was tightly fixed in a holder. The
holder was positioned parallel to the X-ray window surface by carefully measuring
the distances from different places across it to the edge using a micrometer. The
angle of misalignment, θ, of edge surface was later calculated using the image as
0.83 degrees. This was determined by finding the distances at which there is the
maximum point of the line spread function at the two sites of the image, and sub-
tracting these distances to find q (figure 3.2). The value of p was also calculated
from the image and trigonometry was used to calculate θ.
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Figure 3.2: Method of calculation of the angle of missalignment θ.
For the acquisition of the edge images the microCT system tungsten source was
operated at 55 kVp and 55 µA. Images of the edge were captured at 26 different
positions in a range of 0.60 mm to 130 mm from the X-ray tube window. For each
position four images were captured. Distance and magnification of the edge in each
position, were calculated using the manipulator position value, as given by Inspect
X software.
The exact position of the focal spot within the X-ray tube was not known. The
distance between the focal spot and the tube window, w (figure 3.1), could create a
large error in focal spot calculation if not taken into consideration, especially when
the edge was near the source. Calculation of w could not be conducted within
the microCT because of practical limitations. Therefore, an isolated X-ray source
(identical to the one in the microCT system) was used . It consisted of the electron
drift tube, the target and the window assembly. A laser beam was passed through
the path where the electrons normally pass, and a spot of light was produced at the
same height on the target where the electrons normally hit. Knowing this point it
was possible to measure using a micrometer the distance w and consider it in the
calculation of the position and magnification. The distance from the focal spot to
the window of the source, w was measured as 5.3±0.7 mm.
3.2.3 Unsharpness analysis
Custom-built MATLAB codes processed images to extract the results. Flat-field
corrections were applied to all of the images. Subtraction of the dark image (back-
ground) allows for correction of spatial inhomogeneities of the detector, while di-
viding by the white data allows for corrections of the spatial inhomogeneities of the
X-ray beam. Flat fielding is expressed by the equation below (Moy et al. [1999]).
Image =
Raw −Dark
White−Dark (3.6)
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Figure 3.3: (a) The edge image at a magnification of 6. The selected area shows the
area of interest (20×pixels×150 pixels) used for the production of the ERF, and in (b) the
magnified area of interest, showing the blurring at the edge.
The width of the area of interest in the edge images was selected to be 20 pixels
in the middle of the image, in order to avoid the error in the misalignment of the
edge. The length of the area of interest was chosen as 150 pixels so that it covers
all the unsharpness area.
The grey value of the pixels for each of the 20 perpendicular lines in the area
of interest was plotted versus the length of the area of interest for the formation
of the ERF. The 20 ERFs were then averaged together. The length measurements
given from this image in pixels were converted to mm using the measured detector
pixel pitch (168 µm). Differentiating the ERF produced the LSF (figure 3.4) whose
FWHM was used to define the unsharpness. The FWHM at each position was the
average of the four FWHMs measured from the four images at that position.
The quantified unsharpness due to the edge, Ue, at a position is given by the sum
of the geometric unsharpness at that position and the intrinsic detector resolution
(Shuping and Judy [1978]).
Ue =
2
√
(s.m)2 + Ud
2 (3.7)
where all symbols have been defined previously.
Each FWHM was plotted versus the corresponding d2
d1
value. The chi-square, χ2,
(equation 3.8), is usually used to define the agreement between the experimental
and expected distributions (Taylor [1997]). It was used in reverse in this study to
find the best or expected fit of (equation 3.7) on the plot of FWHM versus d2
d1
.
χ2 =
n∑
1
FWHM − 2√(s.m)2 + U2d
σn2
;n = 26 (3.8)
65
3. Dual energy analysis optimisation
(a)
(b)
Figure 3.4: (a) The profile of the edge object ERF. (b) Following differentiation, the
LSF and thus the FWHM (given by the open circle points) can be found.
where σn is the standard deviation of the observed FWHM and n is the number of
measurements (i.e. the number of positions at which the edge was imaged).
A MATLAB code was developed that fitted equation 3.8 with different values of
s (between 1-100 µm) and Ud (between 100-900 µm), and for each combination the
χ2 factor was calculated. The combination of s and Ud that resulted in the minimum
value of χ2 and thus the minimum variation between the experimental and expected
distribution, are the actual real s and Ud of the microCT system.
The intrinsic detector resolution was also quantified using the MTF to confirm
the results of the χ2 test. A direct measurement of the intrinsic detector resolution
Ud can be made by imaging an object of very small thickness which is touching the
detector, thus having magnification equal to one. The LSF was Fourier transformed
to find the MTF that characterises the detector (Price et al. [2008]). The MTF was
fitted to a Gaussian curve, resulting in a coefficient of determination R2 of 99%.
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Figure 3.5: FWHM versus d2d1 . The crosses represent the measured FWHM values of the
LSF of the edge, while the smooth line shows the fitting of equation 3.7 (f = 12 µm and
Ud = 630 µm, calculated using the χ
2 test) through these points.
Conventionally, the value of the spatial frequency which corresponds to an MTF of
0.1 is defined as the spatial resolution (Kandarakis [2001]). Some writers use the
values which correspond to MTFs of 0.01-0.05 (Koutalonis et al. [2008]), but for the
purpose of this study the threshold was considered 0.1.
Finally, using the values found for the focal spot size and the intrinsic detector
resolution the total unsharpness of an object under magnification in our system was
calculated using equation 3.4. A graph of total unsharpness, U, versus magnifica-
tion, M, was plotted and the value of M which corresponds to the minimum total
unsharpness is the optimum magnification, giving the optimum sample position in
the microCT system.
3.2.4 Results: optimum sample magnification
The results of the edge unsharpness (FWHM) versus d2
d1
are represented in figure 3.5
by crosses. At small d2
d1
values (1 to 20) the unsharpness results are approximately
constant due to the small effect of geometric unsharpness near the detector. Thus
it can be concluded that Ud is around 630 µm. As expected, as magnification value
increases the FWHM increases too because the effect of the focal spot increases.
The smooth line in figure 3.5 shows the fitting of equation 3.7, with s = 12
µm and Ud = 630 µm, through the points. In order to fit equation 3.7 through
the points, the values of the intrinsic detector resolution (Ud) and of the focal spot
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Figure 3.6: Plot of χ2 value versus focal spot size versus intrinsic detector resolution.
The black arrow represents the minimum χ2 value which indicates the focal spot size and
intrinsic detector resolution values that provide the best fitting of (equation 3.7), to the
measured results of unsharpness (FWHM).
size (s) had to be found. These were determined by inputting different values of
s and Ud in equation 3.7, until it best fitted through the points. A line that best
satisfies equation 3.7, and takes into account the measured unsharpness results in
all positions was produced using the χ2 factor. Figure 3.6 shows the results of the
χ2 test for s being in the range of 1-20 µm and Ud in the range of 550-650 µm.
The focal spot size found (s = 12 µm) is an acceptable value for a microCT system
(expected value was about 15 µm). Any uncertainty in the value of focal spot size
suggests that there might be a systematic error in d1, d2 or w measurements. It was
technically difficult to accurately measure w because of its very small dimensions
and the finite diameter of the spot of the laser beam produced on the target of the
X-ray source.
The intrinsic detector resolution result (Ud = 630 µm), agrees to 3.2% with the
direct measurement of the intrinsic detector resolution, 620 µm, given by the MTF.
This validates the results given by the χ2 test. The MTF of the detector, is shown
in figure 3.7.
The propagation of d2
d1
error on focal spot and detector resolution calculation was
analysed. Error in d2
d1
derived from errors in d2 + d1 (fixed X-ray source to detector
distance), w and d1. A combination of these errors concluded in the error in
d2
d1
for
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Figure 3.7: Detector MTF. The spatial frequency value which corresponds to 0.1 (dotted
line) of the response of the detector represents the intrinsic detector resolution.
each position of the object. So, using again the χ2 test it was found that taking
into account the maximum d2
d1
error the focal spot changed only by 1 µm and the
detector unsharpness by 7 µm.
The total unsharpness, calculated using equation 3.5, was decoupled into focal
spot and detector unsharpness versus magnification, M. This is shown in figure 3.8.
Using this plot, the optimum position of a sample in the microCT system under
magnification was defined. A magnification higher than 4.1 (corresponding to a
source window-sample distance, d1 of 161 mm) gives an effective system resolution
higher than 150 µm. This is sufficient to visualise the trabecular network and to
quantify morphological parameters (Ulrich et al. [1999]). An example of a microCT
image of trabecular bone, acquired M = 10 (i.e. effective system resolution is 63
µm), is shown in figure 3.9.
3.2.5 Conclusions on the optimum magnification parameter
The χ2 test successfully allowed for the development of a framework for the si-
multaneous calculation of the focal spot size (s = 12±1 µm) and intrinsic detector
resolution (Ud = 630±7 µm). The result of Ud has been confirmed using the MTF
of the detector resolution.
It has to be noted here though that this is the optimum position only at 55 kV
and 55 µA (Power = 3.03 W). The focal spot size changes with voltage and current
(Chaney and Hendee [1974]). For every 1 Watt the focal spot changes by 1 µm.
The power of the X-ray source, at the conditions used throughout the remainder
69
3. Dual energy analysis optimisation
Figure 3.8: The total unsharpness (black) or effective system resolution, versus magni-
fication, M, of an image of an object in the microCT. The effect of the focal spot (blue)
and the detector (red) are shown separately. For a U< 150 µm an M>4.1 is required.
Figure 3.9: A microCT image of the femur of the hind leg of a sheep, implanted with
9 mm synthetic Hydroxyapatite (HA). The image was acquired at M = 10 (i.e. effective
system resolution is 63 µm). The trabecular structure of the bone can be resolved.
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of the current study, differs by a maximum of 6.97 Watts (7.50 W and 10.0 W,
section 3.7). This changes the focal spot size by 6.97 µm. However, this only affects
the optimum magnification by less than 0.01, which is insignificant. Therefore, the
sample position optimisation as described in this chapter remains valid.
These results were then used to calculate the effective resolution of the system at
different magnifications. An effective resolution of 150 µm is sufficient to visualise
the trabecular network and to quantify morphological parameters (Ulrich et al.
[1999], Majumdar et al. [1997], Laib et al. [1997]). A magnification higher than
4.1 (which corresponds to a source window-sample distance, d1 of 161 mm) give an
effective system resolution higher than 150 µm. This averages the microCT system
resolution is sufficient to study the microarchitecture of trabecular bone, and CT-
DEA can be used for both cortical and trabecular bone.
Due to the a minimum distance between the X-ray source and sample, d1, of 1
mm for the filters and 4 mm for the sample rotation (maximum sample radius), the
sample magnification selected to be used was M = 10.
3.3 Optimisation of the X-ray spectral pair
Measurements of X-ray attenuation at two different beam energies should allow the
separation of the attenuation into its two or three basic components. However, as
for any quantitative measurement, all possible sources of error have to be minimised
to ensure that uncertainty on final results is not greater than the required accuracy
in the measured quantity.
In planar DEA, assuming that the scattered radiation can be effectively removed,
then the uncertainty in the measured quantity, σf , will be
σf =
√
σ2s + σ
2
add + σ
2
Res (3.9)
where σs is the sum of the noise in the two original (logarithmic transformed) images,
σadd is the total additive electronic noise of the detector and σRes is the residual back-
ground noise, which is related to the two spectra separation (Arvanitis and Speller
[2009]). In CT-DEA additional sources of uncertainty in the measured quantity
include CT artefacts and image reconstruction.
The optimum imaging conditions have to be met in order to minimise the un-
certainty of the above factors. These conditions include the selection of the spectra
pair with the lowest σRes, sufficient beam filtering, high voltage and current for high
output intensity and high integration time. In addition, the appropriate corrections
are required for eliminating CT artefacts and the maximum number of projections
for limiting reconstruction uncertainties.
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However, experimentally there is a limit to each of the above conditions, usually
introduced by the imaging system. Furthermore, usually most of the above condi-
tions are related. For example, the energy spectra shape is related to SNR and SNR
is related to system power limits. It is usually intuitive to choose the two average
energies as far from each other as possible, but a too low energy would induce low
SNR image. This can be overcome by increasing the X-ray source current, but the
power of the source has an upper limit. In addition, the spectra shape is related to
beam hardening, scatter reduction is related to SNR and SNR is related to imaging
time. For application of the technique in vivo, the spectra shape, SNR, CT artefacts
reduction are also related to patient dose.
Compromises are required to be made on the selection of the imaging conditions.
Sometimes, ensuring that uncertainty on final results is not greater than the required
accuracy in the measured quantity might be non reachable (Johnson et al. [2007]).
For the evaluation of the potential effectiveness of the CT-DEA technique, in
the assessment of Ca/P ratio and density in bone, compromises were made on the
imaging conditions. To make the right compromises all the different combinations of
spectra could have been tested experimentally. To simplify this process, a simulation
of DEA was initially used, to find σRes for different combinations of energies. The
optimum average energies were prioritised and using the process of elimination, aver-
age energies that induced a significantly high uncertainty, due to CT artefacts, were
rejected. Finally, the SNR of the raw images was tested and varied experimentally,
until the required σf was reached. The steps followed were as follows:
1. Theoretical identification of the optimum combination of average energies, to
minimise σRes. This was performed in a simulation, in which the relation of
spectra shape to SNR was separated.
2. Identification and elimination of spectra of insufficient/unstable experimental
flux, to eliminate CT ring artefacts. This was performed by experiment.
3. Identification and elimination of spectra that produce beam hardening arte-
facts. This was performed by experiment.
4. The consideration of reducing scattering in the sample.
5. The optimisation of the number of projections, to minimise image reconstruc-
tion uncertainty.
6. The optimisation of the number of frames, taking into account the required
SNR in the original images, to minise error in σs, and the acquisition time.
The total additive electronic noise, σadd, was assumed to be small compared
with the other sources of noise. Dose was not a compromising condition for the
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application of the technique through the use of the microCT system. However, dose
will need to be one of the most important factors that will affect the selection of
optimum conditions, in the potential in vivo use of the technique.
3.4 Optimum average energies
3.4.1 Theoretical optimum average energies
The mathematical demonstration of the DEA optimum average energies pair selec-
tion method is described by Rebuffel and Dinten [2007], for a two-material decom-
position and with monochromatic energy beams. This optimisation method was
adapted in this study for a three material decomposition, and was applied to the
Ca/P ratio calculation in bone apatite. This is described below.
The X-ray absorbance, S, at the detector, at a low, L, and a high, H, energy, E,
after the attenuation of X-rays by bone apatite is expressed by:
SL = µCa,LtCa + µPO4,LtPO4 + µOH,LtOH (3.10)
SH = µCa,HtCa + µPO4,HtPO4 + µOH,HtOH (3.11)
where ti is the thickness of a component i in the sample and µi,E has been defined
previously.
Substituting the total sample thickness equation
T = tCa + tPO4 + tOH (3.12)
gives
SL = ∆µCa,LtCa + ∆µPO4,LtPO4 + ∆µOH,LtT (3.13)
SH = ∆µCa,HtCa + ∆µPO4,HtPO4 + ∆µOH,HtT (3.14)
where tT is the total thickness of the sample.
∆µi,E = µi,E − µOH,E (3.15)
Solving the equations 3.13 and 3.14 for tCa
tCa = α.SH − β.SL −
∆µPO4,H .tT .µOH,H + tT .µOH,H
∆
(3.16)
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where
α =
∆µPO4,L
∆
(3.17)
β =
∆µPO4,H
∆
(3.18)
∆ = ∆µCa,H∆µPO4,L −∆µPO4,H∆µCa,L (3.19)
and
SL,H = − log N
No
(3.20)
where is No is the number of photons emitted by the X-ray source, and N is the
number of photons reaching the detector.
The photon number, N, can be considered as a random variable that has a
Poisson distribution of variance N. Variance of the thickness estimate can be derived
by differentiating tCa with respect to the number of photons, N.
σtCa =
(∆µPO4,H)
2σ2(SL) + (∆µPO4,L)
2σ2(SH)
∆2
. (3.21)
The above equation gives the dependence of σtCa on µCa,L, µPO4,L, µOH,L, µCa,H ,
µPO4,H and µOH,H , and thus its dependence on the spectra pair, for a particular
number of No at the low and high energy.
By omitting the error introduced due to 3D image reconstruction, equation 3.21
can also express the error in fCa, the measured quantity in CT-DEA. The same
method can be used to calculate the absolute error in tPO4 and fPO4 . The error in
the Ca/P ratio was calculated by propagating the errors of fCa and fPO4 in equation
2.16, for different combinations of average energies.
By choosing typical material proportions for tCa (0.40), tPO4 (0.57) and tOH
(0.03) present in hydroxyapatite, for each pair of energies, a 2D function of the two
energy values was obtained. Figure 3.10 shows the absolute error in the Ca/P ratio
as a function of the low-high energy combination, for an input No of 10
8 photons.
Provided the initial number of photons, No , is the same for both the high and low
average energies, the relative distribution of absolute error shown in figure 3.10 will
remain constant. To simplify this process this optimisation method was performed
under the assumption of No being the same at the low and high average energy.
From the plot the theoretical optimum imaging conditions were obtained. The
theoretical optimum combination of energies is the one that gives the lowest σfCa/P
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Figure 3.10: Absolute error in Ca/P ratio for different energy combinations.
(dark blue areas in figure 3.10), 25 keV for the low average energy and 40 keV for
the high average energy.
However, in a conventional CT scanner the number of possible energy combi-
nations is restricted. In the next sections, the compromises on the selection of the
optimum energy pair are discussed.
3.4.2 Beam filtration
When using a polychromatic beam, beam filtration is required to produce a par-
ticular average energy. Furthermore, beam filtration has the advantage of reducing
beam hardening.
The different possible filter combinations for DEA are described by Sorenson
et al. [1989]. Filtration can be added to the high energy beam to remove lower
energy photons, and/or to the low energy beam to lower the average energy and
resulting in greater energy difference between the two spectra.
Advantage can be made of the different absorption K-edge of the filtering ma-
terials. For example, filters made of Tin (K-edge 29.2 keV), Caesium (K-edge 36.0
keV), Tellurium (K-edge 31.8 keV), Cerium (K-edge 40.4 keV), Samarium (K-edge
46.8 keV) and Gadolinium (K-edge 50.2 keV) can be used to absorb the photons in
these energy ranges and thus increase the average energy of the spectrum. Lower
energy photons can be eliminated using Copper (K-edge 9.0 keV) and Aluminium
(K-edge 1.6 keV).
In some cases advantage can be made of the K-edge of the sample component of
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Table 3.1: Examples of filtration added to a 100 kVp beam using Samarium (Sm),
Gadolinium (Gd), Tin (Sn) and Copper (Cu) of different thicknesses. The average energy
(E) is shown and the presence of ring artefacts is stated. In all cases the number of
projections was 360 and the number of frames was 256.
Voltage (kVp) Current (uA) Filter K-edge (keV) t (mm) E (keV) Ring artefact
100 200 Gd 50.2 0.35 86 Yes
Sm 46.8 0.40
Sn 29.2 0.50
100 200 Gd 50.2 0.10 78 Yes
Sm 46.8 0.10
Sn 29.2 0.50
100 100 Sn 29.2 0.5 71 No
100 100 Sn 29.2 0.2 67 No
Cu 29 0.2
100 100 Cu 9 0.5 63 No
interest. Filters of K-edges close to the K-edge of the sample component of interest
can be used to produce two average energies, one below and one above the K-edge
of the component of interest (Arvanitis and Speller [2009]). This approach though,
could not be used for the purposes of this study because the K-edges of Calcium
and Phosphorus are 4.04 keV and 2.15 keV respectively. This is much too low for
diagnostic imaging.
There are some restrictions to the selection of the appropriate filters. The filter
materials must be non-toxic, uniform, low-cost and easily accessible. Additionally,
the fraction of incident intensity transmitted through the filter and the scatter sig-
nature of each filter have to be considered.
3.4.3 System power
An important constraint to the average energies to be used in DEA is set by the
power limits of the imaging system. Using the microCT system, average energies
lower than 30 keV were practically impossible to achieve due to insufficient flux
for an image to be produced at these energies. Therefore, the theoretical optimum
combination (figure 3.10) of energies, 25 keV for the low average energy and 40
keV for the high average energy, were rejected. The next optimum imaging average
energies are 30 keV (as low as possible), and 100 keV (as high as possible).
The higher the average energy selected, the higher the X-ray source current or the
longer the acquisition time required. This is due to the large amount of filtration
required to achieve a high average energy. Examples of the amount of filtration,
added in a 100 kVp beam, required to produce average energies higher than 63 keV,
are presented in table 3.1.
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It was found that at current values above 200 µA, when the voltage was set at
90-100 kVp, the average energy produced by the X-ray source deviated significantly
from the expected average energy. Figure 3.11 shows an example of the effect of
current on the average energy. The measurement of average energy was made at
95 kVp and using 0.2 mm Samarium, 0.35 mm Gadolinium and 0.5 mm Tin, for
filtration and an ion chamber for the measurement of Air Kerma (Gy). Ten Alu-
minium filters (t = 1 mm) were used for the calculation of the half-value layer and
the average energy of the spectrum (Webb [1988]). At each current, five measure-
ments of average energy were measured and averaged. The expected average energy
at the above conditions was 81 keV, as calculated using a simulated spectrum by
SpeKCalc software (Poludniowski et al. [2009]). However, at a current higher than
200 uA the average energy was decreased by 6%.
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Figure 3.11: Example of the effect of current on the average energy. The measurement
of average energy was made at 95 kVp and using 0.2 mm Samarium, 0.35 mm Gadolinium
and 0.5 mm Tin for filtration. The expected average energy was 81 keV as shown by the
red line. The errors represent the standard deviation.
It was found that a current value of 500 µA, when the voltage was set at 95
kVp, the microCT system source presented a decrease in dose with time. A possible
reason for this phenomenon is that the characteristics of X-ray source might change
with temperature. Figure 3.12 shows the measurements of dose made at 95 kVp
and 500 µA and a beam filtration of 0.35 mm Gadolinium and 0.4 mm Samarium,
using a dose meter, positioned just in front of the detector. The dose (in µSv/hour)
was measured every 5 seconds and the average of every successive 50 seconds was
calculated for a period of 1000 seconds.
Additionally, it was found that at current values 200-500 µA, when the voltage
was set at 90-100 kVp, the reconstructed microCT image included ring artefacts.
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Figure 3.12: The average dose measurements, made every 50 seconds, at 95 kVp, 500
µA and a beam filtration of 0.35 mm Gadolinium and 0.4 mm Samarium. The plot
demonstrates the instability in dose with time when the microCT is used at a high power.
The error bars represent the standard deviation.
Figure 3.13 shows an example of an image of a bone phantom acquired at 95 kVp,
500 µA, 0.4 mm Samarium, 0.35 mm Gadolinium and 0.5 mm Tin.
Figure 3.13: Example of a slice of a microCT image of a bone phantom, acquired at 95
kVp and 500 µA and with an external filtration to source window of 0.35 mm Gadolinium
(Gd) and 0.5 mm Tin (Sn). Ring artefacts being present.
It was beyond the scope of this study to investigate further the source of the
above problems. However, conditions needed to be found that eliminated them,
since their presence could affect the CT grey value, at the low (GL) and high energy
(GH).
It was concluded that at 90-100 kVp, a current higher than 100 µA could not
produce a stable flux and/or images with no ring artefacts. Using a current lower
than 100 µA ensured that the average energy remained stable (figure 3.11). However,
the subsequent images then suffered from insufficient SNR because of low current
and high filtration. The higher average energy that could be delivered, with a low
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Figure 3.14: Absolute error in Ca/P ratio for different energy combinations. The high-
lighted light-grey areas represent the energies eliminated for practical reasons such as flux
instability with time and the production of ring artefacts in the images.
current (<100µA), was 71 keV (table 3.1). At average energies lower than this,
there was no error introduced on GL and GH due to flux/average energy instability
and ring artefact.
In conclusion, the system power limited the range of possible average energies.
average energies below 30 keV could not be delivered, while the high energy was
limited to 71 keV because of a combination of current, flux stability and SNR.
Deliverable energies, together with the necessary filtration, are defined in table 3.1.
The restricted energy range has been highlighted in light-grey in figure 3.14.
3.4.4 Beam hardening
Beam hardening causes a decrease in the linear attenuation coefficient, µ(E, ρeff, Zeff),
with increasing sample thickness, due to more low energy photons being absorbed,
narrowing the spectrum and causing a subsequent increase in the average energy.
In a CT image of a cylindrical homogeneous sample, a decrease in the grey value
appears in the centre of the sample, producing a ‘cupped appearance’ in the line
profile of a CT slice. Figure 3.15 shows (a) a slice through a CT image of a bone
phantom with a line profile selection, and (b) its corresponding profile plot.
The presence of beam hardening under different imaging conditions was tested
experimentally. The lowest average energy was 30 keV, corresponding to a peak
voltage of 50 kVp. As such, a cylindrical homogeneous bone phantom was imaged
at 50 kVp and 60 kVp, for investigating the presence of beam hardening. Results
showed that the average energy range 30-35 keV was affected by beam hardening
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Figure 3.15: (a) A slice through a microCT image of a bone phantom with a line
profile selection, and (b) its corresponding profile plot. Beam hardening is shown by the
‘cupped appearance’ of the line profile. The red line represents the expected appearance
attenuation coefficient.
Table 3.2: Examples of filtration added to a 50 kVp and 60 kVp beam using Aluminium
(Al) of different thicknesses, t. The average energy (E) is shown and the presence of beam
hardening is stated. In all cases the number of projections was 360 and the number of
frames was 256.
Voltage (kVp) Filter K-edge (keV) t (mm) E (keV) Beam hardening
50 none − 0 30 Yes
60 none − 0 33 Yes
50 Al 1.6 3.00 35 Yes
50 Al 1.6 5.00 36 No
60 Al 1.6 5.00 40 No
artefacts, as shown in the first three rows of table 3.2. The highest average energy
of 71 keV, produced by a peak voltage of 100 kVp, did not demonstrate any beam
hardening because of the filtration.
For the reduction of beam hardening, filtration is usually used to pre-harden the
X-ray spectrum. Alternative beam hardening corrections are calibration correction
(Liu et al. [2009]) and beam hardening correction software. However, in this study,
due to the use of quantified analysis of the images, the last two beam hardening
correction methods were avoided.
As shown in table 3.2, beam hardening becomes negligible when sufficient exter-
nal filtration (e.g. 5 mm Aluminium) is added to a 50 kVp beam, resulting in an
average energy of 36 keV for the low energy beam. The effect of beam hardening
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Figure 3.16: Absolute error in Ca/P ratio for different energy combinations. The high-
lighted light-grey areas represent the energies eliminated for practical reasons such as flux
instability with time and ring artefacts in the images. The highlighted dark-grey areas
represent the energies eliminated due to the presence of beam hardening in the microCT
images.
therefore put some further restrictions on the possible average energies that could
be used. These are shown in the bottom two rows in table 3.2 and are highlighted
in dark-grey in figure 3.16.
3.5 Scattering
Scattering is unavoidable in imaging and makes quantification diffucult (Dinten
[2001]). If the sample is close to the detector, the scatter contribution may reach
two or three times the direct flux (Rebuffel and Dinten [2007]).
Usually, for medical applications, anti-scattering grids are used to minimise scat-
ter. This requires the estimation of scatter from a set of points (behind the grids)
and then its subtraction from the sample image (Endo et al. [2001], Ning et al.
[2004]). However, this requires an additional acquisition, increasing acquisition time
(and dose to patient in any potential clinical application of the technique) and it
does not fully eliminate scatter either. Usually compromises need to be made be-
tween the effect of scatter in the grey value of the image and the disadvantages
introduced by the use of anti-scattering grids.
The scatter magnitude decreases as the sample to detector distance increases,
until it reaches a point where the scatter continues plateaus. In this study the sample
was placed at a distance as far as possible away from the detector (section 3.6.2),
therefore scatter contribution was minimised and no anti-scattering grids were used.
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3.6 Signal to noise ratio
3.6.1 Noise in CT dual energy imaging
The DEA experimental feasibility in decomposing a specific material, using a partic-
ular imaging system at particular imaging conditions, is dependent on the noise (σs)
in the original low and high energy image (Fabbri et al. [2002]). The noise in the
original low and high energy image would define the accuracy with which CT-DEA
can assess the Ca/P ratio. As discussed in section 1.4.3 the ideal case would be to
achieve a precision of better than 0.09 in the Ca/P ratio assessment, given that the
min/max difference in the Ca/P ratio between healthy and IMO bone samples is
0.09/0.43 (Tzaphlidou et al. [2005], Speller et al. [2005], Kourkoumelis et al. [2011]).
At different average energies (and thus different mi,L and mi,H) the maximum
noise (minimum signal to noise ratio (SNR)) in the low and high energy images
needed to achieve the required accuracy in the measured quantity is different. Once
the average energies that introduce beam hardening and ring artefacts are elimi-
nated, and a possible optimum spectral pair is known, a simple calculation can be
performed to estimate the maximum noise and minimum SNR needed to achieve
the required accuracy in the measured quantity. The minimum SNR can then be
used to test the experimental feasibility of the technique at the optimum imaging
conditions.
This calculation is a simulation process and is performed in two steps. In the first
step a typical sample (of known chemical composition) is irradiated at the optimum
imaging conditions, for the calculation of the linear attenuation coefficients at the low
and high energies. The linear attenuation coefficients form the inputs of the second
step, in which CT-DEA decomposes the sample into its material components. An
uncertainty (noise) is added to the linear attenuation coefficient, and the error in
the measured quantity is calculated.
A typical bone apatite sample, of known chemical composition (Ca6(PO4)10(OH)2),
Ca/P ratio (1.67) and density (ρeff = 3.0 g/cm
3) was irradiated, at 50 kVp and 100
kVp, with filtration 5 mm Al and 0.5 mm Sn respectively (producing average ener-
gies of 36 keV and 71 keV). The low and high energy linear attenuation coefficients
were calculated. The decomposition of the sample, using CT-DEA, was performed
several times, each time introducing a different uncertainty (up to ± 0.06) in the
variables (µL and µH).
Figure 3.17 shows the absolute error introduced in the Ca/P ratio of a typical
bone apatite sample, by an uncertainty in µL and µH . The plot shows that the higher
the deviation from the correct µL and µH value, the higher the error introduced in
the measured quantity. The optimum number of projections and frames would
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Figure 3.17: Aboslute error in Ca/P ratio for different combinations of noise in µL and
µH .
finally define the uncertainty in µL and µH , thus the error in Ca/P ratio. These are
discussed below. But, firstly, the definition of the µL and µH as a function of the
CT grey value had to be studied.
3.6.2 CT grey value calibration
To allow for the absolute Ca/P ratio quantification in bone, the experimentally-
measured inputs (µL and µH) to the DEA equations should have a realistic physical
meaning. This required calibration of the CT grey value, at the low (GL) and high
energy (GH).
This was calculated using five di-Potassium Phosphate (K2HPO4) solutions of
different concentrations (1-5 g/cm3). These samples were chosen because of their
uniformity and similar X-ray attenuation to bone apatite (Genant and Boyd [1977])
(section 2.5.1).
At the imaging conditions described above the theoretical linear attenuation
coefficient, µ, of each solution was calculated (Burgess [1987]).
µ(E, ρeff, Zeff) = mK2HPO4(E)cK2HPO4 +mH2O(E)cH2O (3.22)
where mi and ci are the average mass attenuation coefficient and concentration (in
g/ml) of component i, respectively.
Linear relationships (R2= 0.99) were found between the theoretical and measured
values of average linear attenuation coefficient and CT grey value.
Figure 3.18 shows calibration of the microCT grey value to the theoretical linear
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(a)
(b)
Figure 3.18: Calibration of the microCT grey value to the theoretical linear attenuation
coefficient (in cm−1) at the (a) low energy and (b) high energy imaging conditions. The
calibration was performed using five K2HPO4 solutions of different concentrations. The
red line through the points represents the resulting equation of the calibration procedure.
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attenuation coefficient (in cm−1) at the (a) low energy and (b) high energy imaging
conditions. The calibration curves provided a physical meaning to the CT grey value,
with high correlation coefficient providing high confidence. The red line through the
points represents the line of best fit. For the low energy image, the calibration
equation is
µL = 3.58GL − 1.03;R2 = 0.99 (3.23)
and for the high energy image the calibration equation is
µH = 5.24GH − 0.55;R2 = 0.99 (3.24)
All images acquired for the purposes of this study were processed using the
calibration equations above, before further analysis.
3.6.3 Number of projections
There is a minimum number of projections required to reconstruct a volume. At a
minimum there is a requirement of one projection ray to pass through each voxel. At
the centre of rotation this is not a problem. However, as the distance from the centre
of the sample increases, less rays pass through the voxel. Therefore, the furthest
point from the centre of rotation needs to be taken into account when calculating
the minimum number of projections. The minimum number of projections in a CT
acquisition, Pmin can be calculated using
Pmin =
C
Vd
(3.25)
where C is the sample circumference and Vd is the voxel resolution.
Voxel binning (6×6×6 voxels) was used to increase the signal to noise ratio of
the images and reduce image acquisition and processing time. This provided a voxel
resolution of 96 µm, sufficient to resolve trabecular structures (section 3.2). For
a sample of radius 4 mm, voxel resolution of 96 µm, the above equation gives a
minimum number of projections of 262. Any number of projections bigger than this
would require a compromise with image acquisition time, flux stability and in case
of clinical use of the technique, patient dose. In this study 360 projections were
used, a typical value for CT imaging.
3.6.4 Number of frames
The CT frame number is the number of images acquired and averaged at each
projection during an image acquisition and it is proportional to the integration
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time of an image acquisition. The optimum number of frames is dependent on the
absolute deviation from the expected µL and µH , and the image acquisition time,
as well as dose (if the technique is to be applied in vivo).
The K2HPO4 solutions (section 2.5.1), were imaged at the optimum low and high
energies, using 360 projections and 128 frames. This number of frames was chosen
as it has an acceptable acquisition time (35 minutes). The average µL and µH of
10 random volumes of 6×6×6 binned voxels (8.9×10−4 mm3), in the reconstructed
microCT image, was calculated. The maximum deviation from the expected µL and
µH was found. This was 0.06 for µL and 0.02 for µH . According to figure 3.17, the
maximum absolute error in the Ca/P ratio with these deviations from the expected
µL and µH is 0.12. This is considered sufficient for distinguishing between most of
the healthy and IMO regions in bone.
3.6.5 Correction of the centre of rotation
The reconstruction algorithm expects the projections image to be perfectly centred
on the rotation axis. If it is not a ring is produced around the sample in its recon-
structed image. It is physically very difficult to align the centre of the sample with
the X-ray central axis. The projection images need to be shifted to correct for this
displacement before reconstructing the microCT image.
In this study, CT Pro software ‘automatic’ method was used to correct for the
misalignment of the COR (Nikon Metrology, X-Tek, United Kingdom), which would
affect µL and µH , and thus the Ca/P ratio precision. In this method, two selected
slices, one near the top and one near the bottom of the sample, were reconstructed.
The contrast of the sample with its background was assessed to determine the
amount of correction needed in each. For each slice, the projections were then
shifted to one side by one pixel, the reconstruction was repeated and contrast was
reassessed. After many repetitions of the same procedure and iterative movement
of the sample, the required shift was estimated once the slice reached its required
quality. No details were provided in the system manual as to precisely how this was
completed, but it was clear from visual assessment.
The two values of misalignment from the two slices at the top and bottom of the
sample indicated the shift needed to correct all of the projections. CT reconstruction
was then performed using the in-built X-Tek software (Nikon Metrology, X-Tek,
United Kingdom).
Figure 3.19 shows an example of a reconstructed bone phantom microCT image
(a) without and (b) with the correction of the COR. It worth noting that after
the correction of the image using CT Pro software, there is an increase to the grey
value of the image by a factor of 100. Therefore, in order to convert the grey value
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(a) (b)
Figure 3.19: A reconstructed bone phantom microCT image (a) without and (b) with
the correction of the COR, using CT Pro software.
coefficient to its usual unit, cm−1, the grey value of the COR-corrected image needs
to be divided by 100.
3.7 Conclusions on the optimum imaging condi-
tions
After compromising between the theoretical optimum spectra and the ring and beam
hardening artefacts of the microCT, the number of projections, the SNR in the low
and high energy microCT images, image acquisition time and the required accuracy
in the Ca/P ratio, the optimum average energies were found to be: 36 keV and
71 keV. These are produced with a tube voltage pair of 100 kVp and 50 kVp, and
respective tube currents of 100µA and 150µA, after filtering with 5.00 mm Al and
0.50 mm Sn. Figure 3.20 shows the simulated energy spectra used in the CT-DEA,
calculated using the SpekCalc Software (Poludniowski et al. [2009]) and taking into
account the inherent filtration (1.3 mm Aluminium) of the X-ray source. Scanning
parameters were: magnification = 10, 360 projections. For each projection 128
frames were acquired and averaged. Dose is a subject of imaging conditions and
imaged body part, and needs to be taken into account, but only when the developed
technique is applied in vivo. The above conditions are expected to give an accuracy
in the Ca/P ratio of 0.12 (section 3.6.4). With this accuracy the CT-DEA technique
should identify most of the osteoporotic regions in bone.
Table 3.3 summarises the experimental imaging conditions, for the low and high
energy images, used in this study. These conditions represent the optimum imaging
conditions for the assessment of the Ca/P ratio in bone using the X-Tek benchtop
microCT system (serial number: J0001). The optimum conditions will vary between
different systems since they are a subject of system power. All the low and high
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Figure 3.20: Simulated X-ray energy spectra used in CT-DEA.
energy images acquired for the purposes of the remainder of this study were produced
at the conditions below, unless stated otherwise.
Table 3.3: Experimental imaging conditions used for all the imaging performed using
the X-tek benchtop microCT system in this study.
Imaging Condition Low E Image High E Image
Voltage (kVp) 50 100
Current (µA) 150 100
Filter material Al Sn
Filter thickness (mm) 5.00 0.50
Average energy (keV) 36 71
Magnification 10 10
Projections 360 360
Frames 128 128
3.8 Summary
Using the measurements of unsharpness (Full Width at Half Maximum (FWHM) of
the Line Spread Function (LSF)) of the system from an edge at different positions
along the source-detector line and the χ2 factor (a factor that is usually used to
define the agreement between the observed and expected distributions), the focal
spot size and the intrinsic detector resolution of the microCT were calculated. The
result of intrinsic detector resolution was confirmed using the Modulation Transfer
Function (MTF). Using the focal spot size and the intrinsic detector resolution, the
total unsharpness of an object under magnification at different positions along the
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source-detector was calculated and the optimum sample magnification was identified.
This was M =10, corresponding to a system resolution of 63 µm, sufficient to resolve
the trabecular architecture.
Furthermore, the optimum spectra, for a sufficient precision in the Ca/P ratio
calculation were identified. The optimum theoretical spectral pair was firstly iden-
tified. Then the X-ray spectra that produce CT artefacts were eliminated. The
number of projections and frames that give an accuracy of 0.12 in the Ca/P ratio
were chosen. All the imaging conditions that were selected for the purposes of this
study, and will be referred to in the rest of this thesis, are summarised in table 3.3.
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Chapter 4
Evaluation of CT-DEA
4.1 Overview
In this chapter the evaluation of CT-DEA for density and Ca/P ratio 3D assessment
in bone are described.
In section 4.2 the theoretical precision of the technique in the calculation of
density and Ca/P ratio was assessed in a simulation of CT-DEA. In section 4.3 the
method and results of the experimental precision of CT-DEA, using di-Potassium
Phosphate solutions and bone phantoms, of known density and/or Ca/P ratio, are
discussed.
The feasibility of the technique on real bone apatite was tested using healthy
and IMO rabbit collagen-free cortical bone samples. The quantitative abilities of
the technique on real bone were assessed by comparing it with the a 2D Ca/P ratio
assessment method, electron-dispersive X-ray spectroscopy. The methods used and
the results are presented in section 4.4.
In section 4.5, a summary of the chapter is made.
4.2 Theoretical precision of CT-DEA
4.2.1 Simulation method
The simulation of CT-DEA was used to find its theoretical precision in density, and
Ca/P ratio (as a result of an error in the weight fraction of Ca (fCa) and the weight
fraction of P (fP )).
The simulation included two steps: i) the irradiation process, and ii) the de-
composition process. In the irradiation process, the X-ray attenuation by the ten
different bone phantoms (section 2.5.2) was calculated. The chemical formula of
each phantom and a range of densities of 1.81-2.95 g/cm3 (equal to the total sample
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Table 4.1: Simulation results. Deviation from the expected density for ten phantoms of
different Ca/P ratio. All phantoms of same chemical formula (but different density) had
identical density errors.
Chemical Formula Densitytotal Density error (g/cm
3)
Ca(H2PO4)2(H2O) 2.54 0.02
Ca(H2PO4)2(H2O) 2.39 0.02
CaHPO4 2.97 0.03
CaHPO4.2H2O 2.95 -0.02
CaHPO4.2H2O 2.81 -0.02
Ca3(PO4)2 2.10 -0.01
Ca3(PO4)2 2.21 -0.01
Ca5OH(PO4)3 2.08 0
Ca5OH(PO4)3 2.27 0
Ca5OH(PO4)3 1.81 0
density, assuming they are equal to the sample material density, table 2.2) were used
to calculate the theoretical average linear attenuation coefficients, µ(Zeff, ρeff, E), at
the two X-ray beam energies, used in CT-DEA, using equation 2.6.
In the decomposition process, the CT-DEA algorithm (section 2.4.4) was used
for the calculation of density and Ca/P ratio in bone apatite. The theoretical
µ(Zeff, ρeff, L) and µ(Zeff, ρeff, H) of each phantom was input to the CT-DEA al-
gorithm and the phantom was decomposed into its heaviest materials (maximum
three), as described in table 2.2. The actual density, fCa, fP and Ca/P ratio of each
phantom were compared to the CT-DEA theoretical density, fCa, fP and Ca/P ratio
results.
4.2.2 Results: theoretical precision
The theoretical precision in the calculation of density of ten bone phantoms, of five
different chemical formula is shown in table 4.1. Two/three phantoms of the same
chemical formula and different density have the same error in density calculation.
The reason for this is discussed below. The density results suggest a mean/maximum
precision in density of 0.01/0.03 g/cm3 or 0.63%/1.14%.
Similarly, the theoretical precision in the calculation of fCa and fP , is shown
in figure 4.1. The results suggest a mean/maximum precision of 0.01/0.02 or
3.71%/12.58% for fCa and 10.38%/24.41% for fP . These errors are propagated into
the calcuation of Ca/P ratio. As can be seen in figure 4.2 phantoms of the same
chemical formula but different density give the same error in Ca/P ratio calculation.
This shows that the Ca/P ratio results are independent of the density results. The
mean/maximum precision in Ca/P ratio calculation in bone phantoms is 0.10/0.28
or 14.21%/45.00%. This would be low enough to distinguish between some, but not
all, healthy and osteoporotic bone samples, since in literature a minimum/maximum
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Figure 4.1: Simulation results. Deviation from the expected fCa (blue triangles) and fP
(pink squares) for phantoms of different Ca/P ratio. All phantoms of same Ca/P ratio
had identical fCa and fP errors.
difference of 0.09/0.43 in Ca/P ratio is reported between healthy and IMO bone
samples Tzaphlidou et al. [2005], Kourkoumelis et al. [2011]).
In a simulation usually zero error is expected in the result of the measured
quantity. One source of error in the Ca/P ratio is the presence of a fourth component
in the bone phantoms (table 2.2). However, even phantoms that are made up of
three components still give a non-zero error. This shows that the main source of the
errors is the non-perfect fit of the relations of F (Zeff) to Zeff and Zeff to mL of each of
the phantoms. This is further supported by the fact that two phantoms of the same
Ca/P ratio, but different density, and thus different µ(Zeff, ρeff, L) and µ(Zeff, ρeff, H),
have the same errors in density (since density is a function of F (Zeff) to Zeff and Zeff
to mL relations). As shown in table 4.1 the error in density calculation by CT-DEA
is independent of density, and it is a subject of the calibration of F (Zeff) to the
chemical formula of the sample.
At present, these approximations of the mathematical relations are required in
CT-DEA for bone material decomposition. This is because the exact chemical com-
position of biological apatite is diverse and not known with sufficient accuracy to
enable the construction of a precise look-up table of F (Zeff) to Zeff and Zeff to mL.
92
4. Dual Energy Analysis Validation
Figure 4.2: Simulation results. Deviation from the expected Ca/P ratio for phantoms
of different Ca/P ratio. The red line represents the minimum difference between healthy
and IMO bone samples found in literature.
4.3 Experimental precision of CT-DEA
4.3.1 Experimental methods
Five K2HPO4 solutions (section 2.5.1), of different, known (material) density, and
ten bone phantoms (section 2.5.2), of known Ca/P ratio and total density, were
imaged using the microCT system (2.2.3) at the optimum imaging conditions (table
3.3). The bone phantoms were used for the calculation of the experimental precision
in density and Ca/P ratio, and the K2HPO4 solutions (section 2.5.1) were used for
further testing the density precision result.
CT reconstruction was performed on the images using the in-built X-Tek soft-
ware (Nikon Metrology, X-Tek, United Kingdom) at a slice thickness of 16 µm. Any
centre of rotation artefacts were corrected using CT Pro software (Nikon Metrol-
ogy, X-Tek, United Kingdom). The microCT system grey values were converted
to µ(Zeff, ρeff, E) values using the calibration equations (section 3.6.2). Finally, all
K2HPO4 solutions and bone phantom images were binned into 6×6×6 voxels, thus
providing a resolution of 96 µm in all dimensions.
The density of the K2HPO4 solutions was assessed using CT-DEA to compare
with their expected density, to assess the precision of the technique in the (material)
density calculation. K2HPO4 solutions were chosen for the density validation as
they have no air gaps, that would introduce errors in the calculation of the expected
(material) density.
Similarly, the density and Ca/P ratio of the bone phantoms was assessed by CT-
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Figure 4.3: (a) Density colour map, and (b) its corresponding density map after thresh-
olding, produced after the analysis of a phantom (Ca(H2PO4)2(H2O)) CT slice for phan-
tom volume and density calculations. The yellow and red voxels were rejected from further
analysis.
DEA. The first step of CT-DEA provided results for the density of the phantoms.
Threshold limits were applied to the density values of the CT-images to reject all
background voxels and sample-edge voxels. The threshold density limits applied
were; background: density <0 g/cm3, phantom-edge: density = 0-1 g/cm3 and
phantom: density >1 g/cm3. Density colour maps were plotted for each phantom.
Figure 4.3 shows (a) a density colour map, and (b) its corresponding density map
after thresholding, produced after the analysis of a phantom (Ca(H2PO4)2(H2O))
CT slice. The yellow and red voxels were rejected from further analysis. The average
density of each phantom was found using CT-DEA and was compared to the actual
total density of the phantom (table 2.2).
Each phantom was decomposed using CT-DEA into its heaviest materials (max-
imum three), as described in table 2.2. The Ca/P ratio of a volume of 4.5 mm3
(32×32×5 voxels), away from possible cracks and non-homogeneities, in each phan-
tom was averaged for Ca/P ratio quantification. The CT-DEA Ca/P ratio results
were compared to the expected Ca/P ratios of the phantoms (table 2.2).
4.3.2 Results: experimental precision
Plots of density colour maps of the five K2HPO4 solutions, with a resolution of 96
µm, are shown in figure 4.4 at a given slice. All maps have the same colour scale
to allow direct comparison. The higher the density in the phantom, the lighter the
colour in the density maps.
Figure 4.5 shows the results of the densities of the five K2HPO4 solutions versus
their CT-DEA measured densities. An overestimation of 0.01 g/cm3 in the calcu-
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Figure 4.4: Density colour map plots extracted from five K2HPO4 solutions of known
density of (a) 1.39, (b) 1.59, (c) 1.94, (d) 2.36 and (e) 2.68 g/cm3. All maps are 2.3
mm×2.3 mm. Each voxel is 96 µm3.
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Figure 4.5: Experimental results. CT-DEA average density results of K2HPO4 solutions
shown in green circles. The red line expresses the relation of a CT-DEA density result to
the actual density of the sample. Error bars represent the standard deviation.
lation of density is made, with R2 = 0.99. The mean/maximum precision of in the
apparent density of the K2HPO4 solutions was 0.04/0.08 g/cm
3. Assuming perfect
solubility of K2HPO4 powder in water, with no non-uniformities in its distribution,
the standard deviation reflects the noise in the the low and high energy microCT
images, propagated in density.
The experimental results of the bulk density of bone phantoms were plotted
versus their total densities (figure 4.7). The coefficient of determination, calculated
using linear regression analysis, is equal to R2 = 0.88, for a linear fit of points with
a gradient of 0.98 and a y-intercept of 1.08.
The explanation of the 1.08 g/cm3 offset is the presence of air pockets in the
phantoms. When compressing the phantoms it is difficult to remove all air pock-
ets, between powder granules. The presence of air in the phantom is shown in
the histogram of the grey values from a backscatter electron image of a phantom
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(a)
(b)
Figure 4.6: (a) SEM backscatter image of a phantom (CaHPO4.2(H2O)), and (b) the
histogram produced for the whole surface. The peak at ∼0 grey value shows the presence
of air.
(CaHPO4.2(H2O)) surface, acquired using the SEM system (figure 4.6).
The impact the presence of air has, is explained as follows. The grey value of the
system was calibrated with a liquid (K2HPO4 solutions), which assumes there are
no air pockets. It only considers the amount of attenuating material present. In the
calibration procedure, the grey value, changed only when the amount of attenuating
material changed, with no consideration of air. When a phantom containing air
is imaged, the grey value is lower, therefore the estimations of µ(Zeff, ρeff, L) and
µ(Zeff, ρeff, H) are underestimated. At a lower energy, µ(Zeff, ρeff, E) is more affected
by the presence of air, so µ(Zeff, ρeff, L) is underestimated more than µ(Zeff, ρeff, H).
Therefore, F (Zeff) is underestimated. This leads to an underestimation of Zeff and
mE. Density is calculated as µ(Zeff, ρeff, E)/mE, both of which are underestimated,
but in equal proportions. As such, density is almost unaffected by the presence
of air, if air proportion is less than 15% by weight (case of cortical bone). This
conclusion was validated in a simulation with different weight proportions of air in
a given voxel, with results in table 4.2. This shows that for a bone of (material)
density ∼1.9 g/cm3, the deviation from the expected density increases, with the
proportion of air increasing in the voxel. For a weight fraction of air less than 15%
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Table 4.2: Simulation results. Deviation from expected density with different weight
proportions of air in a given voxel of bone.
Air proportion (%) Density error (%)
15 5.08
30 7.88
50 13.87
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Figure 4.7: Experimental results. CT-DEA average density results of bone phantoms
shown in green. The red line expresses the relation of a CT-DEA density result to the
actual density of the sample. Error bars represent the standard deviation.
the density is within 5%.
The CT-DEA density represents the density of the attenuating material only,
as detailed in section 1.4.1. So, in the phantom studies, where the granules have
not been packed sufficiently well, the relevant volume in the CT-DEA density mea-
surement is the volume of the granules only. This lower volume produces a higher
density than the total density of the phantom.
Plots of Ca/P ratio maps of four phantoms, of different Ca/P ratio, with a
resolution of 96 µm, are shown in figure 4.8 at a given slice. All maps have the same
colour scale to allow direct comparison. The higher the Ca/P ratio in the phantom,
the lighter the colour in the Ca/P ratio maps.
The expected results of Ca/P ratio for all ten phantoms are plotted versus the
measured average values in figure 4.9. The average Ca/P ratio results of the ten
samples show a mean/maximum deviation from the expected of 0.24/0.35. As dis-
cussed above, this is low enough to distinguish between some, but not all, healthy
and osteoporotic bone samples. The coefficient of determination, calculated using
linear regression analysis, is equal to R2 = 0.92, for a linear fit of points with a
gradient of 1.14 and a y-intercept of -0.36.
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Figure 4.8: Ca/P ratio maps plots extracted from phantoms of known Ca/P ratio of (a)
0.5, (b) 1.0, (c) 1.5 and (d) 1.67. All maps are 3 mm×3 mm. Each voxel is 96 µm3.
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Figure 4.9: Experimental results. Phantom CT-DEA average Ca/P ratio results shown
in blue circles. The red line expresses the relation of a CT-DEA density result to the
actual density of the sample. Some samples had similar/identical results, therefore they
overlap of the graph: there are two results at 0.70 and 0.71, and two results at 1.21. Error
bars represent the standard deviation.
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The increased error in the experimental results compared to the simulated results
could be due to an error in the measured CT numbers and thus in µ(E, ρeffZeff).
CT systems of increased power and more efficient detectors might allow different
optimum imaging conditions and thus higher accuracy in results. The X-Tek recon-
struction algortihm is expected to be trivial as it is part of the trivial error found in
the CT grey value calibration (3.6.2). A possible source of error in the Ca/P ratio
is an error in the expected Ca/P ratio due to the uncertainty of maximum 15% in
chemical formula of the phantoms (table 2.2).
4.4 Evaluation of CT-DEA performance for Ca/P
ratio assessment in bone apatite
Further to the evaluation of the precision of CT-DEA using bone phantoms there was
the requirement to assess its precision when used on real bone apatite. However,
unlike a bone phantom, the variation of the value and distribution of the Ca/P
ratio in a bone is unknown. Therefore, Ca/P ratio measurements made using the
developed technique were compared to measurements made using EDX, which is
regularly used for Ca/P ratio measurements on bone surfaces (Kourkoumelis et al.
[2011]).
SEM (section 2.3) was used to determine the composition of areas of interest in
eight (four healthy and four IMO) rabbit tibia cortical bone samples (set 1a, table
2.4). The Ca/P ratios of these areas were calculated and were compared to the
Ca/P ratios of the same areas found using CT-DEA.
In this section, the methods of the experiments are described and the results and
presented and discussed.
4.4.1 CT sample imaging and CT-DEA analysis
The eight collagen-free bone samples were imaged using the microCT system (section
2.2.3) at the same conditions, and processed in the same way, the phantoms in section
4.3 were imaged and processed.
By analysing all acquired images using CT-DEA (section 2.4.4), 2D Ca/P ratio
colour maps were produced for all slices in all samples, to allow visual differentiation
of areas of low and high Ca/P ratio (figure 4.10). A total of 58 regions of interest
(ROIs) from all the sample surfaces, that covered a wide range of Ca/P ratio, were
selected for validation using Energy Dispersive X-ray Spectroscopy (EDX). The
average Ca/P ratio for each ROI was calculated.
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Figure 4.10: Original low energy CT images ((a) and (c)) and the corresponding Ca/P
ratio 2D maps ((b) and (d)) for rear tibia rabbit bone samples. The samples are healthy
((a) and (b)) and IMO ((c) and (d)) The selected areas represent ROIs in the samples.
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4.4.2 SEM sample imaging and EDX analysis
The eight collagen-free bone sample surfaces were imaged using a scanning electron
microscope system (Hitachi model S-3400N, Japan); serial number: 340621-04. The
imaging conditions for all samples were: 20 Volts, emission current 128 µA and
magnification ×27. At the same conditions, three bone phantoms (section 2.5.2) of
different, known Ca/P ratio were imaged for the validation of EDX measurements.
Backscatter SEM image of the surface of interest in each bone phantom and
sample was acquired. The regions of interest (ROIs) of each bone surface, as selected
on the Ca/P ratio colour maps, produced using CT-DEA, were identified on the SEM
backscatter images.
The chemical composition information of the ROIs was accomplished by a ‘se-
lected area analysis’. The electron beam was stopped and positioned on the ROI,
which had been selected (in a rectangle) on the SEM screen, while the image was still
being displayed. The spectrum of the selected area was produced by the software,
together with a table showing quantitative information of the sample composition.
Finally, results for the atomic Ca/P ratio were produced using
Ca/P =
αCa
αPO4
(4.1)
where αCa and αPO4 are the atomic fraction of Ca and P respectively.
4.4.3 Image registration and analysis
For a more accurate mapping of the CT-DEA Ca/P ratio map to the SEM image,
image registration was performed. This is a process of transforming different sets
of data into one coordinate system. NifTK, a translational imaging platform, de-
veloped at the centre for medical image computing (CIMIC) of University College
London, was used. In particular, NiftyReg software package was used via the viewer
NiftyView. NiftyReg contains programs to perform rigid, affine and non-linear reg-
istration of medical images. NiftyView is a cross platform graphical user interface,
providing an entry point to NifTK packages, and in addition, many of the usual
features one would find in any medical image viewer.
The Ca/P ratio map image and the SEM image of the same sample produced
from the two imaging systems were of different magnification, pixel size and some-
times orientation. Initially, manual mapping was required for the two images. The
necessary scaling, rotation and translation amendments were made to the CT-DEA
Ca/P ratio map image until its geometry mapped sufficiently well on top of the SEM
image. In the next step, the images were mapped more precisely by Nifty software
(figure 4.11).
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(a) (b)
(c)
Figure 4.11: (a) Backscatter SEM image, (b) CT-DEA Ca/P ratio colour map of the
surface of an IMO bone sample. The mapping of the two images in NifTK is shown in (c).
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Figure 4.12: A case where there was a misalignment of the pixels of CT image to the
pixels of the SEM image, due to the different orientation of the sample to the detector in
the two systems.
Image registration reproduced the CT-DEA Ca/P ratio map with the grey val-
ues of the original CT-DEA Ca/P ratio map image and the SEM pixel size and
coordinates. The coordinates of each ROI were determined on the registered Ca/P
ratio map image and the corresponding coordinates were found on the original Ca/P
ratio map. The average Ca/P ratio by CT-DEA of the ROI was calculated.
In some cases, the coordinates of the CT-DEA Ca/P ratio map registered image
were only an approximation to the CT-DEA Ca/P ratio map original image (figure
4.12). This was due to the different alignment of the pixels with respect to the
sample, which resulted from the different orientation of the sample to the detector
in the two imaging systems. In these cases, the selection of the CT Ca/P ratio map
original image ROI coordinates was made such that it includes all the pixels falling
within ROI, plus the minimum number possible extra pixels around it.
The eight sample images were analysed, giving a total of 26 ROIs from four
healthy bone samples and 32 ROIs from four IMO bone samples. The average
Ca/P ratio of the ROIs was compared to the corresponding SEM Ca/P ratio, using
linear regression analysis. Furthermore, a two-sample Student’s t-test was used to
investigate the statistical significance in the difference of the Ca/P ratios of the
healthy and IMO areas, using the two different techniques. For the Student’s t-test
a one tail normal distribution and unequal variance were assumed for the Ca/P ratio
of the samples.
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(a)
(b)
Figure 4.13: (a) SEM backscatter image, with a selection of the ROI, and (b) its corre-
sponding EDX spectrum, acquired using a bone phantom of Ca/P ratio = 0.5.
4.4.4 Results: Areal Ca/P ratio assessment using EDX
Three bone phantoms were used for the validation of the EDX Ca/P ratio assess-
ment. A typical example of an SEM backscatter bone phantom (of Ca/P ratio =
0.5) image is shown in figure 4.13(a), with a selection of the ROI. Its correspond-
ing spectrum, is shown in figure 4.13(b). The height of the peaks in the spectrum
is proportional to the atomic fraction of each element present in the sample. The
presence of Calcium, Phosphorus and Oxygen can be observed as expected. Carbon
is also present in this sample spectrum, same as in all other phantom spectra. This
is probably due to residual carbon in the SEM system from earlier coated samples,
carbon contamination of the sample or from carbonates present in the sample.
The precision in the assessment of fCa, fP in phantoms, by EDX, is shown in
figure 4.14. In all phantoms fP was overestimated more than fCa. A possible reason
for this is fluorescence. X-rays or high energy electrons emitted from the sample may
subsequently hit other areas of the sample and excite X-rays by fluorescence from
these regions. Fluorescence is one of the effects which make accurate quantitative
analysis difficult. It is not a very efficient process, since only a few per cent of
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Figure 4.14: EDX measurements. Deviation from the expected fCa (blue triangles) and
fP (pink squares) for phantoms of different Ca/P ratio.
the higher energy rays will successfully excite the lower energy radiation. However,
it may significantly alter the relative amounts of characteristic radiation coming
from alloys or compounds, particularly when elements with quite similar atomic
numbers are present (P = 15, Ca = 20) (Goodhew et al. [2001]). For example,
in a bone phantom the Calcium Kα X-rays (energy 4.04 keV) can excite extra
Phosphorus Kα X-rays whose energy is less (2.15 keV). This produces misleading
analysis. Florescence is particularly important for rough samples (Goodhew et al.
[2001]).
The errors in fCa and fP are propagated into the calculation of the Ca/P ratio.
Due to an overestimation fP in comparison with fCa, an underestimation is always
made on the calculation of the Ca/P ratio, resulting in a mean/maximum precision
of -0.07/-0.11 to the Ca/P ratio (figure 4.15). The correlation of the measured to
the expected Ca/P ratios gave an R2=0.96, reflecting a high confidence in the Ca/P
ratio calculation by the SEM system.
Figure 4.16 shows an example of a backscatter SEM image of one bone sample
and the ROIs selected on it. Figure 4.17 shows examples of the spectra acquired from
(a) a healthy bone sample and (b) an IMO bone sample. EDX shows the presence
of the chemical components in the sample; Calcium, Phosphorus, Carbon, Oxygen,
Magnesium and Sodium are all expected to be present in bone apatite (table 1.1).
The Ca/P ratio in a healthy bone apatite is expected to be around 1.67. The
Ca/P ratio results in healthy bone samples using EDX were within the range of
1.39-1.62. This underestimation of Ca/P ratio by the SEM system is not surprising
since, as shown by the bone phantom results of EDX, fP is overestimated due to
fluorescence. Bone samples Ca/P ratio underestimation is higher than the underes-
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Figure 4.15: Experimental results. Expected phantom Ca/P ratio versus EDX-measured
average Ca/P ratio. The red line expresses the expected relationship.
Figure 4.16: SEM backscatter image of a healthy bone sample. The rectangular selections
represent the selected areas analysed in this sample.
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(a)
(b)
Figure 4.17: Examples of the spectra acquired from (a) a healthy bone sample and (b)
an IMO bone sample.
timation made in phantoms. This is possibly due to the more rough surfaces of the
bone samples, compared to bone phantoms, causing increased fluorescence and thus
fP overestimation.
Another possible reason for observing Ca/P ratio values lower than 1.67 ratio
is the non-perfectly uniform mineralised bone. Ca and PO4 move where they are
needed in the body. For example, carbonate groups replace a fraction of phosphates
and/or hydroxyl groups in the mineralised hydroxyapatite (Ca10(PO4)6(OH)2), thus
varying its crystallinity (Wilson et al. [2005], Pasteris et al. [2008], Wopenka and
Pasteris [2005]), which depends on the stage in the mineralisation process and age
(Rauch and Schoenau [2001]). In IMO bone samples the Ca/P ratio range (1.20-
1.52) was lower than the healthy samples Ca/P ratio range.
Comparing the difference of the Ca/P ratios of the healthy and IMO areas,
using a Student’s t-test, a p-value of < 0.05 (table 4.3) was given. From this it can
be concluded that there is a statistically significant difference in the Ca/P ratios
of the healthy and IMO bone sample areas. These results are in agreement with
other studies, where a statistically significant difference was found in the Ca/P
ratio between healthy and IMO bones (Tzaphlidou et al. [2005], Kourkoumelis et al.
[2011]).
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4.4.5 Results: CT-DEA performance for Ca/P ratio assess-
ment in bone apatite
The Ca/P ratio results using CT-DEA were within the range of 1.43-1.77 and 1.24-
1.59 (y-axis of plot in figure 4.18) for healthy and IMO bone samples respectively.
Comparing with the EDX results; 1.39-1.62 for healthy samples and 1.20-1.52 for
IMO samples, it can be concluded that an overestimation is made by CT-DEA. This
systematic error is due to the approximations used for the F (Zeff) to Zeff and Zeff to
mL relations as discussed in section 4.2.
CT-DEA gave correct Ca/P ratio values within an average deviation from the
EDX Ca/P ratio of 0.11±0.08 (8±6% deviation of the CT-DEA 58-regions average
Ca/P ratio from the EDX 58-regions average Ca/P ratio). Linear regression analysis
in the plot of CT-DEA Ca/P ratio results versus EDX Ca/P ratio results of the same
areas, provided the value for the coefficient of determination; R2 = 0.69. This means
that 69% of the samples express a linear relation between the CT-DEA Ca/P ratio
to EDX Ca/P ratio of gradient 1.17 and y-intercept of -0.13.
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Figure 4.18: CT-DEA Ca/P ratio versus EDX Ca/P ratio of 58 regions of interest in 8
samples; 4 healthy (blue) and 4 osteoporotic (red).
The noise in CT-DEA low and high energy images, introduces an error in the
Ca/P ratio results. This error partly expresses the error bars in figure 4.18. The error
bars magnitude is also expressed by the non-homogeneities of Ca/P ratio in bone.
As can be observed on the graph, in IMO bone sample areas (red) the variation of
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Ca/P ratio is larger than that in healthy bone areas (blue). This suggests a higher
non-homogeneity of Ca/P ratio in IMO areas, which agrees with previous studies
(Tzaphlidou et al 2005).
The results of the precision of CT-DEA of Ca/P ratio measurements in bone
apatite were very dependent on the successful mapping of the images from the two
imaging systems. Therefore, one of the causes of the lack of 0.31 in the coefficient of
determination of the plot in figure 4.18, is the non-perfect mapping of the images.
It was not possible to evaluate the error the non-perfect mapping introduced on the
CT-DEA precision calculation. In addition, it is unknown to what sample depth the
EDX Ca/P ratio results correspond to. The volume which is being analysed, and
the fraction of the X-rays which are emitted from the sample depend critically on
(a) the energy of the electron beam, (b) the energy (wavelength) of the X-rays being
studied and (c) the local atomic weight of the sample. Therefore, it was difficult to
predict the depth of X-ray interaction in EDX and compare it with the CT-DEA
X-ray interaction depth (96 µm). If the interaction depths were different in the two
systems, their results are expected to be different.
Table 4.3 shows the results of a Student’s t-test on the assessment of the statis-
tical significance the two imaging systems can provide in distinguishing healthy and
IMO areas in bone apatite. Both systems show that they can differentiate a healthy
from an IMO bone sample, with a statistical significance (defined as p<0.05). CT-
DEA p-value is sufficiently low to distinguish the same healthy and IMO areas that
EDX does.
Table 4.3: Details of collagen-free bone samples.
SEM CT
Variable Healthy IMO Healthy IMO
average 1.51 1.36 1.68 1.42
Observations 26 32 26 32
p-value <0.0001 <0.0001
In conclusion, due to the undetermined uncertainties introduced in the analysis
by fluorescence in EDX, image mapping and depth interaction of electrons, it cannot
be concluded to what absolute precision the Ca/P ratio can be measured in real bone
apatite using CT-DEA. However, a value of R2=0.69 in the fit of CT-DEA Ca/P
ratio versus EDX Ca/P ratio and an average difference in the Ca/P ratio between
the two techniques of 0.11±0.08 suggests sufficient confidence in the experimental
capabilities of the developed technique.
CT-DEA compared with the EDX method has the advantage of non-invasively
assessing a bone sample in 3D. The 3D capabilities of the technique will be presented
and discussed in the next chapters.
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4.5 Summary
The evaluation of CT-DEA for the quantification of density and Ca/P ratio was
performed using bone phantoms and bone samples.
In a simulation of the developed technique on bone phantoms, the theoretical
density and Ca/P ratio mean/maximum accuracy were found to be 0.01/0.03 g/cm3
or 3.71%/1.14%, and 0.10/0.28 or 14.21%/45.00% respectively. These errros are the
result of the uncertainty of the relations of F (Zeff) to Zeff and Zeff to mL used in
CT-DEA.
In the experimental application of CT-DEA on bone phantoms, of known density
and Ca/P ratio, concluded on a mean/maximum precision of in the apparent density
of the sample of 0.04/0.08 g/cm3 and a mean/maximum precision of 0.24/0.35 in the
Ca/P ratio assessment. The increased error compared to the theoretical accuracy
is a result of the uncertainty in the grey value and in the reconstruction of the
microCT low and high energy images, as well as in the uncertainty of the actual
chemical composition of the samples. This accuracy would be enough to distinguish
between some, but not all, healthy and osteoporotic bone samples.
The Ca/P ratio in 58 bone sample surfaces, from four healthy and four IMO
bone collagen-free samples were assessed with EDX and CT-DEA and compared. A
value of R2=0.69 in the fit of CT-DEA Ca/P ratio versus EDX Ca/P ratio and an
average deviation of 0.11±0.08 (8±6%) from the EDX results in the CT-DEA Ca/P
ratio suggests sufficient confidence in the experimental capabilities of the developed
technique. The sources of this error is the imperfect mapping of the images from the
two imaging systems, as well as an uncertainty in CT-DEA and EDX Ca/P ratio
calculation.
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Chapter 5
Density and Ca/P ratio
assessment in healthy and
osteoporotic cortical bone apatite
5.1 Overview
In this chapter the results of the application of CT-DEA on bone apatite are pre-
sented.
Set 1 samples (table 2.4), eighteen collagen-free healthy (nine) and inflammation-
mediated osteoporotic (nine) rabbit bone samples were imaged using the microCT
system and analysed using CT-DEA. The density and Ca/P ratio results of the two
bone types were compared to investigate the difference in magnitude and distribution
of density and Ca/P ratio in healthy and IMO bones. A secondary aim was to
investigate different analysis methods, providing different density and Ca/P ratio
parameters, in a given set of data. In this chapter the quantitative and qualitative
results of different analysis methods, of set 1 samples, as well as their statistical
analysis are presented and discussed.
In section 5.2, information on the experimental and analytical methods is pro-
vided. In section 5.3 the results of different density and Ca/P ratio parameters
in the bone samples are presented. Bulk density and bulk Ca/P ratio results are
shown. Slice by slice density and Ca/P ratio maps and 3D Ca/P ratio maps are
presented, together with quantitative analysis of density and Ca/P ratio. Statisti-
cal analysis on the comparison of the different density and Ca/P ratio parameters
between healthy and IMO bone samples are presented. In section 5.4, comparison
is made between the density and Ca/P ratio parameters in different bone sites. In
section 5.5, statistical analysis of each bone site separately are shown. In section
5.6, a summary of the chapter is given and the advantages and disadvantages of
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the different analysis methods of density and Ca/P ratio, in collagen-free bone are
discussed. Conclusions are made on how the magnitude and distribution of density
and Ca/P ratio in cortical bone apatite, change in osteoporosis.
5.2 Experimental methods
5.2.1 Collagen-free bone imaging
Set 1, cortical collagen-free rabbit, nine healthy and nine IMO bone samples (table
2.4) (three rear tibiae (RT), three femurs (F) and three front tibiae (three FT) for
each bone type) were prepared as described in section 2.5.3. All 18 bone samples
were imaged using the microCT system (section 2.2.3) at the optimum imaging
conditions found (table 3.3). CT reconstruction was performed on the images using
the in-built X-Tek software (Nikon Metrology, X-Tek, United Kingdom) at a slice
thickness of 16 µm. Any centre of rotation artefacts were corrected using CT Pro
software (Nikon Metrology, X-Tek, United Kingdom) (section 2.2.3). Figure 5.1
shows a typical low-energy CT image of one rear tibia healthy bone sample, of
cortical wall thickness ∼ 1mm and lenght ∼ 8 mm.
Figure 5.1: A typical 3D image of one healthy rabbit rear tibia bone sample, acquired
using the microCT system.
The microCT system grey values were converted to µL and µH , using the calibra-
tion equations (section 3.6.2). Finally, all phantom images were binned into 6×6×6
voxels, thus providing a resolution of 96 µm in all dimensions. CT-DEA (section
2.4.4) provided simultaneous results on the density (bone material density, section
1.4.1) and Ca/P ratio for each voxel in the sample images. The different methods
of analysis performed are described in detail in the next section.
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5.2.2 Qualitative and quantitative analysis
CT-DEA was used to provide qualitative and quantitative information for healthy
and IMO bone samples. For qualitative analysis, 2D and 3D colour maps of density
and Ca/P ratio for all samples were produced, which allowed visual differentiation
of possible healthy and IMO areas.
For quantitative analysis, density and Ca/P ratios were assessed in different
volumes in the samples. Threshold limits were applied to the Ca/P ratio values of the
CT-images to reject all background voxels and sample-edge voxels, subject to partial
volume effect. The threshold Ca/P ratio limits applied were; background: Ca/P
ratio≤0, sample-edge: 0≤Ca/P ratio<1.00 and bone sample: 1≤Ca/P ratio< 1.80.
There were no voxels with Ca/P ratio bigger than 1.80. Furthermore, low Ca/P
ratio range was defined as 1.00-1.49, according to Fountos et al. [1999], who found
that low Ca/P ratio in an osteoporotic or aged bone is expected to be in that range.
Figure 5.2 shows (a) a Ca/P ratio colour map, and (b) its corresponding Ca/P ratio
map after thresholding, produced after the CT-DEA analysis of an IMO rear tibia
bone sample microCT slice.
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Figure 5.2: (a) Ca/P ratio map of a rear tibia bone sample, and (b) its corresponding
Ca/P ratio map after thresholding. Yellow (Ca/P ratio≤0) and red (0<Ca/P ratio≤1.00)
areas were rejected, while green (1.00<Ca/P ratio≤1.49) and blue (1.5<Ca/P ratio≤1.80)
were used for bone analysis.
3D analysis allows the selection of regions of interest in the 3D volume. Different
quantitative analysis methods of both density and Ca/P ratio were performed in
different scales in all samples. Each analysis method provided the quantification of
a different parameter. These are described below:
1. The average density and Ca/P ratio across the whole bone sample (volume
varies between 61-172 mm3 in the 18 collagen-free bone samples). These pa-
rameters will be referred to as to as bulk density and bulk Ca/P ratio.
113
5. Bone 3D assessment
2. The average density and Ca/P ratio in volumes of possible healthy and osteo-
porotic regions, of volume 0.03 mm3 (6×6×1 voxels), located using the density
and Ca/P ratio maps.
3. The proportion of voxels with a low Ca/P ratio (1.00-1.49).
4. The interconnected-low Ca/P ratio proportion, quantified using a region grow-
ing technique. The region growing technique is a 3D image segmentation
method, which was used to assess the distribution of low Ca/P ratio in the
bone samples and identify the regions of interconnected-low Ca/P ratio. The
region growing technique examined the neighbouring voxels of an initial seed
voxel of low Ca/P ratio. Iteratively, all voxels within the Ca/P ratio range of
1.24-1.25 (the middle of the defined low Ca/P ratio range) were selected as
the seed voxel. The region grew if the neighbouring voxels were in the range
1.00-1.49. The biggest region grown in each sample (by testing different seed
voxels) was used for the quantification of the interconnected-low Ca/P ratio
volume.
5. The degree of low Ca/P ratio homogeneity, defined as the ratio of the inter-
connected low Ca/P ratio volume to the low Ca/P ratio volume of the whole
bone sample.
5.2.3 Statistical analysis
All the above listed parameters were compared between healthy and IMO bone sam-
ples. The Student’s t-test was used to determine the significance of any differences of
the studied parameters between all healthy and all IMO samples. Any differences in
Ca/P ratio and density parameters between healthy and IMO bone samples would
support the use of these parameters as possible osteoporosis indicators. For the
Student’s t-test a one tail normal distribution and unequal variance were assumed
for the density and Ca/P ratio of the samples.
The Student’s t-test was also used to study the difference of the studied param-
eters between different bone sites (rear tibia, femur, front tibia). The significance
of this analysis lies in the context of comparing the density and/or Ca/P ratio pa-
rameters in one possible osteoporotic bone site to the corresponding healthy bone
site, to diagnose osteoporosis. As discussed by Kanis and Glu [2000], the compari-
son between different bone sites for osteoporosis diagnosis should be avoided, since
there is a biological and mechanical (Cowin [1984]) variability between sites. The
reflection of this variability in density and Ca/P ratio parameters, was investigated
in section 5.3 of this chapter.
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Finally, the Student’s t-test was used to analyse all the parameters, between
healthy and IMO, in each bone site separately. A summary of the statistical anal-
yses performed, using the Student’s t-test, on all parameters of collagen-free bone
samples, described in this chapter, is presented in table 5.1.
Table 5.1: Statistical analyses, using the Student’s t-test, performed on the studied
parameters of collagen-free bone samples (set 1) and their corresponding sections, where
the results can be found.
Statistical analysis Section
Difference in parameters between all healthy and all IMO 5.3
Difference in parameters between bone sites 5.4
Difference in parameters between healthy and IMO of different bone sites 5.5
5.3 Results: comparing healthy and IMO bones
5.3.1 Density and Ca/P ratio bulk results
Figure 5.3 shows the bulk density measurements, in g/cm3. The average density,
across the whole sample, of the healthy bones (blue, filled circles) varies within
the range 2.22-2.45 g/cm3. This range is realistic as it is in within the range of
ashed (at 600 ◦C) and hydrated hydroxyapatite density (2.05 g/cm3) and ashed,
non-hydrated hydroxyapatite density (3.20 g/cm3) (Robinson [1975]). As shown by
Robinson [1975] the density of ashed and hydrated bones varies with the degree of
hydration.
In the IMO samples the bulk density results (red, open circles) varies within
the range 1.93-2.33 g/cm3. Comparing the healthy with the IMO density results, it
is clear that osteoporotic bone has on average a lower density than healthy bone.
A decrease in bone density has also been observed with age (Wall et al. [1979]), a
factor that contributes to the risk of fracture due to osteoporosis.
The Student’s t-test was used to determine the significance of any differences
between the bulk density of the healthy and IMO samples (table 5.2). A statistically
significant difference, defined as p<0.05, was thus found between the healthy and the
IMO bone samples. This difference supports that osteoporosis affects the density
of the apatite of the bone. This is in agreement with Wagner et al. [2011], who
has shown that bone material density is related to Young’s modulus and thus bone
quality.
What is worth noting here, as well as in similar results in subsequent sections, is
that the statistical significance found using the Student’s t-test does not provide any
information on the confidence in a single measurement. To obtain a confidence level
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Figure 5.3: The bulk densities of 18 collagen-free bone samples, with healthy samples
in red and IMO samples in blue, filled circles. Error bars have been excluded, for clarity,
as the standard error <0.002. Some samples had identical results: for IMO samples there
are two results at 2.23; for healthy samples there are two results at 2.24.
Table 5.2: Student’s t-test results of the bulk density and bulk Ca/P ratio, of the nine
healthy and nine IMO bone samples.
Density (g/cm3) Ca/P ratio
Variable Healthy IMO Healthy IMO
Mean 2.32 2.18 1.67 1.66
Observations 9 9 9 9
p-value 0.0143 0.0250
in a single measurement a bigger number of measurements is required as well as a
threshold level in the density (or Ca/P ratio, for sections below) that will separate
healthy and osteoporotic bone. The identification of a threshold level requires further
studies in bones of different quality (strength). The number of samples should
provide confidence in the distribution and variation of the density (or Ca/P ratio,
for sections below) for a particular bone site.
Figure 5.4 shows the bulk Ca/P ratios of the collagen-free healthy (blue, filled
circles) and IMO (red, open circles) bone samples. The average Ca/P ratios, of
the healthy bones vary within the range 1.65-1.69. These results are within real-
istic limits, as the stoichiometric ratio gives Ca/P ratio = 1.67 for healthy bone
hydroxyapatite (Tzaphlidou and Zaichick [2003]). Several authors have found Ca/P
ratio results in the range 1.62-1.77 for non-collagenous and/or defated (ashed or
acid-digested) bone: Aitken [1976]; Dickerson [1962] and Quelch, K et al. [1983] and
Woodart [1964].
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In the IMO samples the Ca/P ratio was slightly lower (1.63-1.68), also in agree-
ment with previous studies (Tzaphlidou et al. [2005],Speller et al. [2005], Kourk-
oumelis et al. [2011]). A possible explanation of a lower Ca/P ratio is given by
Zaichick and Zaichick [2010] and was discussed in section 1.4.2.
Table 5.2 shows the results for the statistical significance in the difference in the
bulk Ca/P ratio of the nine healthy and nine IMO bone samples, determined using
the Student’s t-test. A p-value of 0.0250, confirms there is a statistically significant
difference (defined as p<0.05), supporting the use of Ca/P ratio in bone apatite as
a possible osteoporosis indicator. As in the case of bone density, the Ca/P ratio
measurement could be correlated to bone apatite quality, through its correlation to
the Young’s modulus of the bone apatite.
Figure 5.4: The bulk Ca/P ratios of 18 collagen-free bone samples, with healthy samples
in red, open circles and IMO samples in blue, filled circles. Error bars have been excluded
for clarity, as the standard error <0.001. Some samples had identical results: for IMO
sameples there are three results at 1.65 and two at 1.68; for healthy samples there are
three results at 1.67.
Bulk density and Ca/P ratio measurements are easy to perform and are represen-
tative of the whole bone sample. The disadvantage of the bulk measurements is that
the signal from the low Ca/P ratio areas is ‘washed out’, therefore no information
is provided on where the osteoporotic regions are located.
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5.3.2 Density and Ca/P ratio in volumes of interest
The main advantage of a CT image is the ability to visualise a volume. The ad-
ditional advantage provided of a quantified CT image is the volume quantification.
Slice-by-slice CT-DEA analysis can provide useful qualitative and quantitative re-
sults.
Going through the slices of the density and Ca/P ratio colour maps of the bone
samples, possible osteoporotic areas can be visually identified. The effect of ρeff and
Zeff on µL and µH , is decomposed. This is not possible to achieve using the original
low and high energy microCT images. Figure 5.5 shows the (a) high energy and
(b) low energy images from a single microCT slice of a collagen-free, IMO, rabbit
rear tibia bone sample. The osteoporotic areas are not immediately obvious. The
CT-DEA decomposition on the given slices provides the density colour map, (c),
and the Ca/P ratio colour map, (d). Osteoporotic areas (selected region) are very
clearly visible as low density in (c) and low Ca/P ratio in (d).
Figure 5.5: One image slice of a front tibia bone sample at (a) low energy and (b) high
energy. The corresponding density colour map (c) and Ca/P ratio colour map (d) are
products of CT-DEA. Each voxel is 96 µm3.
Going through the density and Ca/P ratio colour-maps of healthy samples, it
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Figure 5.6: Ca/P ratio colour maps ((a) and (c)) and their corresponding density colour
maps ((b) and (d)), extracted from two different positions within a healthy rear tibia
sample image. The resolution of all colour maps is 96 µm. The red squares illustrate
VOIs, of volume 0.03 mm3 analysed quantitatively in table 5.3.
is clear that Ca/P ratio is not homogeneous everywhere. A possible reason is
the non-perfectly uniform mineralised bone. Bone undergoes dynamic mineral-
isation to maintain stable plasma electrolyte levels and to allow Calcium to be
moved to where it is needed in the body. For example, carbonate groups replace
a fraction of Phosphates and/or hydroxyl groups in the mineralised hydroxyapatite
(Ca10(PO4)6(OH)2), thus varying its crystallinity (Wilson et al. [2005], Pasteris et al.
[2008], Wopenka and Pasteris [2005]). However, the variable crystallinity depends
on the stage in the mineralisation process and age (Rauch and Schoenau [2001]).
Figure 5.6 shows two Ca/P ratio maps ((a) and (c)) and their corresponding
density maps ((b) and (d)), extracted from two different positions within a healthy
femur sample image. Lower density and Ca/P ratio can be seen in the more inferior
slice ((c)-(d)), compared to the more superior slice ((a)-(b)).
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Quantitative analysis was performed in VOIs, with a volume of 0.03 mm3 (6×6×1
voxels), as illustrated by the red squares in figures 5.6(a)-(d). Such a small VOI size
was selected, since the ideal case would be to identify osteoporosis before a large
bone region is affected by it. Specifically, a VOI size of 0.03 mm3 was selected as it is
in the order of the voxel size of a clinical CT scanner (section 1.3.3). Table 5.3 shows
the average density (in g/cm3) and Ca/P ratio of the VOIs. As Ca/P ratio decreases
density decreases too. Furthermore, the lower the density and the lower the Ca/P
ratio in the VOI, the higher the standard deviation, showing possible increased
non-uniformity in its distribution, due to variable crystallinity in the apatite form.
Table 5.3: Average density and Ca/P ratio results of the selected VOIs of a healthy rear
tibia, shown in figure 5.6.
Density (g/cm3) Ca/P ratio
Fig 5.6 Mean SD Mean SD
(a)-(b) 2.12 0.16 1.76 0.03
(c)-(d) 1.96 0.32 1.59 0.27
Going through the density and Ca/P ratio colourmaps of IMO samples, it can
be concluded that in IMO samples, osteoporosis does not appear homogeneously
in the sample. Figure 5.7 shows three Ca/P ratio maps ((a), (c) and (e)) and
their corresponding density maps ((b), (d) and (f)), extracted from three different
positions of an IMO femur sample image. As can be visualised there is a strong
variability in the density and Ca/P ratio along the bone. Slice 1 (a-b) looks almost
completely homogeneous in density and Ca/P ratio. Slice 2 (c-d) shows a decreased
density and Ca/P ratio compared, to slice (a-b). In slice 3 (e-f) there is an even
more decreased density and Ca/P ratio, as well as decreased cortical thickness. In
previous studies it has been shown that decreased cortical thickness could be a sign
of osteoporosis (Louis et al. [1995], Cohen et al. [2009]).
Quantitative analysis was performed in VOIs in these slices, all of volume 0.03 mm3,
illustrated by the red squares in figures 5.7(a)-(f). Table 5.4 shows the results of
the average density and Ca/P ratio of the VOIs. As Ca/P ratio decreases density
decreases too. The standard deviation increases the lower the density and the Ca/P
ratio in the VOI are. This suggests variable crystallinity in the apatite form and
increased non-uniformity in the Ca/P ratio and density distribution (Tzaphlidou
et al. [2005]).
The analysis of VOIs could be used in CT-DEA to assess the density and Ca/P
ratio to understand how they change in the particular region. For example, volumes
of interest could be potentially identified using the CT image in a fractured region
in a bone, and analysed using CT-DEA, to investigate how density and Ca/P ratio
vary in that region. However, VOI density and VOI Ca/P ratio measurements are
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Figure 5.7: Ca/P ratio colour maps ((a), (c) and (e)) and their corresponding density
maps ((b), (d) and (f)), extracted from three different positions of an IMO femur sample
image. The resolution of the colour maps is 96 µm. The red squares illustrate VOIs, of
volume 0.03 mm3, analysed quantitatively in table 5.4.
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Table 5.4: Average density and Ca/P ratio results of the selected VOIs, of an IMO femur,
shown in figure 5.7.
Density (g/cm3) Ca/P ratio
Fig 5.7 Mean SD Mean SD
(a)-(b) 2.22 0.12 1.70 0.14
(c)-(d) 1.98 0.13 1.30 0.17
(e)-(f) 1.90 0.18 1.29 0.24
not fully reliable for consistent diagnosis. This is because VOIs might not be repre-
sentative of the whole bone and the selection of the volume of interest is subjective.
5.3.3 Low Calcium/Phosphorus ratio proportion
The low Ca/P ratio range in bone was defined as 1.00-1.49, in accordance with
a study by Fountos et al. [1999]. Utilising such a threshold, the low Ca/P ratio
proportion across each bone sample was calculated. Figure 5.8 shows the results of
healthy (blue, filled circles) and IMO bone (red, open circles) samples. The results
showed a general increase in low Ca/P ratio proportions in IMO samples.
Figure 5.8: The low Ca/P ratio proportion of the 18 collagen-free bone samples. The
healthy samples are shown in blue, filled circles and the IMO samples in red, open circles.
Voxels within the low Ca/P ratio limits were present in both healthy (in the range
of 2.8-11.0%) and IMO (in the range of 4.1-17.1%) bone samples. As discussed previ-
ously, a possible reason for the presence of low Ca/P ratio in healthy samples, is the
non-perfectly uniform mineralised bone, due to its variable crystallinity. This is also
a contributing factor for the IMO samples, but inflammation-mediated osteoporosis
122
5. Bone 3D assessment
induces an increased number of low Ca/P ratio regions.
A statistically significant difference was found between the low Ca/P ratio pro-
portion of nine healthy and nine IMO bone samples (table 5.7), with a p-value of
0.0193. It can thus be concluded that low Ca/P ratio proportion could be used as
a possible osteoporosis indicator, since it’s p-value, in the statistical difference of
healthy and IMO samples (table 5.7), is lower than 0.05.
Table 5.5: Student’s t-test results of the low Ca/P ratio proportion, of the nine healthy
and nine IMO bone samples.
Low Ca/P ratio proportion
Variable Healthy IMO
Mean 7.10 11.33
Observations 9 9
p-value 0.0193
The low Ca/P ratio proportion is an easy parameter to quantify. In addition,
it has the advantages of representing the whole bone sample, and at the same time
being volume specific.
5.3.4 3D region-grown low Ca/P ratio
For the identification of possible osteoporotic areas and the assessment of the dis-
tribution of the low Ca/P ratio, a 3D region growing technique was applied to all
collagen-free bones samples.
The 3D region growing technique provided 3D Ca/P ratio maps in which the
interconnected low Ca/P ratio regions can be visualised. Figure 5.9 shows examples
of low Ca/P ratio grown regions for healthy rear tibia (a), femur (b) and front
tibia (c) bone samples, respectively. Voxels are shown by crosses, with the ‘low’
(1-1.49) Ca/P ratio range in red and the ‘high’ (1.5-1.8) Ca/P ratio range in blue.
Interconnected-low Ca/P regions are present in all healthy samples, possibly due to
the non-perfectly uniform mineralised bone. Similarly, figure 5.10 shows examples
of low Ca/P ratio grown regions for IMO rear tibia (a), femur and front tibia (c)
bone samples respectively. The larger low Ca/P ratio interconnected regions in IMO
(figure 5.10) samples, compared to healthy (figure 5.9) samples, can be clearly seen,
especially for rear tibia and femur. Front tibia presents a limited number of low
Ca/P ratio interconnected regions.
Figure 5.11 shows the region-grown low Ca/P ratio proportion in the collagen-free
nine healthy and nine IMO bone samples. There is a trend of increased region-grown
low Ca/P ratio proportion in IMO samples (0.7-15%) compared to healthy samples
(0-7.6%).
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(a)
(b)
(c)
Figure 5.9: Low Ca/P ratio grown regions for healthy rear tibia (a), femur (b) and front
tibia (c) bone samples. Voxels are shown by crosses, with the ‘low’ (1-1.49) Ca/P ratio
range in red, and the ‘high’ (1.5-1.8) Ca/P ratio range in blue.
124
5. Bone 3D assessment
(a)
(b)
(c)
Figure 5.10: Low Ca/P ratio grown regions for IMO rear tibia (a), femur (b) and front
tibia (c) bone samples. Voxels are shown by crosses, with the ‘low’ (1-1.49) Ca/P ratio
range in red, and the ‘high’ (1.5-1.8) Ca/P ratio range in blue.
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Figure 5.11: The region-grown low Ca/P ratio proportion of the 18 collagen-free bone
samples. The healthy samples are shown in blue, filled circles and the IMO samples in red,
open circles. Some samples had similar results, ovelapping on the plot: for IMO sameples
there is one result at 0 and one at 0.07.
Table 5.6: Student’s t-test results of the region-grown low Ca/P ratio proportion, of the
nine healthy and nine IMO bone samples.
Low Ca/P ratio proportion
Variable Healthy IMO
Mean 2.80 7.59
Observations 9 9
p-value 0.0209
A Student’s t-test showed a statistically significant difference between the region-
grown low Ca/P ratio proportion of nine healthy and nine IMO bone samples (table
5.6), with a p-value of 0.0209. This means that a higher volume of low Ca/P
ratio voxels in IMO samples is interconnected, compared with healthy samples.
Interconnected-low Ca/P ratio proportion can indicate osteoporosis.
Region-growing technique is a useful tool for the application of CT-DEA on
collagen-free samples. Interconnected possible osteoporotic areas can be identified
through visualisation as well as quantified analysis. The disadvantage of region
growing technique is the long processing time required, because (in theory) each low
Ca/P ratio voxel should be tested as a seed voxel. To reduce processing time in
this study, only voxels with Ca/P ratio in the middle of the low Ca/P ratio range
(1.24-1.25) were tested as possible seed voxels.
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Figure 5.12: The low Ca/P ratio homogeneity (region-grown (RG) low Ca/P ratio volume
to low Ca/P ratio total sample volume), of the 18 collagen-free bone samples. The healthy
samples are shown in blue, filled circles and the IMO samples in red, open circles.
5.3.5 Low Ca/P ratio homogeneity
For the investigation of the homogeneity of the low Ca/P ratio in bone, the region-
grown low Ca/P ratio volume was compared to the total sample low Ca/P ratio
volume. The proportion of the region-grown low Ca/P ratio volume to the whole
bone low Ca/P ratio volume was found for all bone samples. Figure 5.12 shows
the results for all 18 samples separated into healthy (blue, filled circles) and IMO
(red, open circles). It is difficult to find any clear difference between healthy and
IMO bone samples in this figure, but it is more clear if analysis is made on a site
by site basis, with details provided in section 5.5. A slightly decreased proportion
of region-grown to total volume low Ca/P ratio was found in healthy (31.6±28.2)
samples, compared to IMO (55.3±33.1) samples.
A Student’s t-test gave a p-value of 0.0608, suggesting a non-statistically signifi-
cant difference. However, this p-value still suggests a low probability of the difference
in healthy and IMO bone samples being by chance, suggesting it is still worth in-
vestigating the difference in the low Ca/P ratio homogeneity in healthy and IMO
bone samples further.
5.4 Results: comparing different bone sites
The density and Ca/P ratio parameters were compared between different bone sites
to find out if there are any differences between them and conclude on the importance
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Table 5.7: Student’s t-test results of region grown low Ca/P ratio volume to the whole
bone low Ca/P ratio volume, of the nine healthy and nine IMO bone samples.
Low Ca/P ratio homog.
Variable Healthy IMO
Mean 31.6 55.3
Observations 9 9
p-value 0.0608
Figure 5.13: The bulk densities of the collagen-free 6 rear tibiae (RT), 6 femurs (F) and 6
front tibiae (FT); healthy (red) and IMO (blue) samples. Error bars have been excluded,
for clarity, as the standard error<0.002. Some samples had identical results: for IMO
samples there are two results at 2.23; for healthy samples there are two results at 2.24.
of the analysis of each bone site separately, when diagnosing osteoporosis in bone
apatite (using density and/or Ca/P ratio as indicators). Figure 5.13 shows the bulk
densities for six rear tibiae, six femurs and six front tibiae (three healthy and three
IMO bone samples for each site). Healthy rear tibiae (ρ = 2.30±0.05), femurs (ρ
= 2.31±0.08) and front tibiae (ρ = 2.34±0.12) all have similar densities. In the
IMO samples, front tibiae presented increased bulk density results (ρ = 2.32±0.02),
compared to rear tibiae (ρ = 2.05±0.15) and femurs (ρ = 2.15±0.13). The average
values of each bone site are presented in table 5.9 for a more direct comparison.
The bulk density was compared, between the three different healthy bones sites,
individually, using a Student’s t-test (table 5.8). For healthy bone, results show that
there is not any statistically significant difference in density between the bone sites.
However, for IMO bones, there are statistically significant differences between rear
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Figure 5.14: The bulk Ca/P ratios of the collagen-free 6 rear tibiae (RT), 6 femurs (F)
and 6 front tibiae (FT); healthy (red) and IMO (blue) samples. Error bars have been
excluded, for clarity, as the standard error<0.001. Some samples had identical results: for
IMO samples there are three results at 1.65 and two at 1.68; for healthy samples there are
three results at 1.67.
tibia/femur and front tibia.
Similarly, figure 5.14 shows the bulk Ca/P ratio results of all animal bone
sites, analysed separately. The healthy front tibiae showed the highest values
(1.68±<0.001), then rear tibiae (1.67±<0.001), then femurs (1.66±<0.001). In
a study by Speller et al. [2005] rear tibiae also showed increased average Ca/P
ratio compared to femurs. Additionally, IMO front tibiae show a higher bulk
Ca/P ratio (1.68±<0.001) compared to IMO rear tibiae (1.65±<0.001) and femurs
(1.64±<0.001). This is in agreement with Kourkoumelis et al. [2011], who found
using EDX that the Ca/P ratio in femurs is affected the least by the inflammation-
mediated osteoporosis, compared to the other two bone sites.
For healthy bone, the Student’s t-test showed a statistically significant differ-
ence between rear femur and front tibia. For IMO bone, a statistically significant
difference was found between rear tibia/femur and front tibia.
The average low Ca/P ratio proportion in healthy bone samples was as follows:
femurs (9.4±1.9%), rear tibiae (7.1±1.2%) and front tibiae (4.7±1.8%). Similarly,
in IMO bone samples: femurs (15.3±1.8%), rear tibiae (13.6±0.3%) and front tibiae
(5.1±1.0%). Figure 5.15 demonstrates the results. As in the case of bulk Ca/P
ratio, for healthy bone, low Ca/P ratio proportion was only different between front
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Figure 5.15: The low Ca/P ratio proportion of the collagen-free six RT, six F and six
FT; healthy (red) and IMO (blue) samples.
tibia and femur. In the case of IMO bone, the low Ca/P ratio proportion in both
rear tibia and femur was different from that in front tibia.
Figure 5.16 presents the results of the region-growing technique. Healthy femurs,
rear tibiae and front tibiae showed 5.4±3.1%, 2.7±1.9% and 0.2±0.3% region-grown
low Ca/P ratio proportion, respectively. IMO femurs, rear tibiae and front tibiae
showed 12.6±2.6%, 9.3±2.4% and 0.8±0.7%, respectively. The statistical analysis
of the difference in the region-grown low Ca/P ratio between different bone sites,
concludes that it varies significantly between healthy front tibia and femur, and
between IMO rear tibia/front tibia and femur.
Statistically significant ifferences between the same bone sites were found in their
low Ca/P ratio homogeneity. The average values of low Ca/P ratio homogeneity
in healthy femurs, rear tibiae and front tibiae were 55.1±26.7%, 35.3±21.7% and
4.4±7.5%. respectively. In IMO healthy femurs, rear tibiae and front tibiae, the
low Ca/P ratio homogeneity results were 81.2±7.5%, 70.7±17.6% and 14.1±11.0%.
respectively. IMO bones,
In conclusion, results suggest a statistically significant difference in all the Ca/P
parameters between femur and front tibia. This might be due to femur and front
tibia located at different areas in the animal body (femur at the back leg, front tibia
at the front leg), therefore experiencing different loadings to which there might be
adaptations (Cowin [1984], Frost [1990]). Differences in the Ca/P ratios in different
rabbit bone sites could be explained by the evolutionary adaptation of each species’
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Figure 5.16: The region-grown low Ca/P ratio proportion of the collagen-free six RT,
six F and six FT; healthy (red) and IMO (blue) samples. There is an overlap in healthy
samples results: one at 0 and one at 0.07.
Figure 5.17: The low Ca/P ratio homogeneity (region-grown (RG) low Ca/P ratio volume
to low Ca/P ratio total sample volume), of the collagen-free six RT, six F and six FT;
healthy (red) and IMO (blue) samples.
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5. Bone 3D assessment
bone site to its everyday life activities. For example, the different rabbit bone
sites will experience different pressure and load conditions under different moving
activities, therefore each bone’s quality and strength, reflected in the Ca/P ratio,
will be different.
There is a small probability (p-value 0.0581) of any difference in bulk Ca/P ratio
between rear tibia and femur being due to chance. Comparing the rear tibia with
front tibia, there is no statistical difference, possibly due to being both tibiae, thus
experiencing similar loadings.
In the IMO bones, a statistically significant difference was observed between
the Ca/P ratio parameters of front tibiae-rear tibiae and front tibiae-femurs. This
suggests that front tibiae had a different reaction to osteoporosis to the other two
bone sites. Under the assumption that the inflammation affected all bone sites in
the same way, there is a different response from different bone sites to osteoporosis.
This response could be the result of the different loadings experienced by each bone
site, and which also affect the Ca/P ratio even when the bone is healthy.
In the diagnsosis of osteoporosis using bone mineral density (BMD), using DEXA,
was suggested that a particular osteoporotic bone site is only compared to its cor-
responding bone site (Kanis and Glu [2000], Grampp et al. [1997]). Similarly, in
any potential osteoporosis diagnosis using the Ca/P ratio each bone site should be
analysed separately.
5.5 Results: comparing healthy and IMO bones
for each bone site
Following the differences of the studied parameters found between different bone
sites, the Student’s t-test was also used to assess the statistical significance in the
difference in the bulk density (in g/cm3), the bulk Ca/P ratio, the low Ca/P ratio
proportion, the region-grown low Ca/P ratio proportion and the low Ca/P ratio
homogeneity, between the healthy and IMO bone samples, for each bone site sepa-
rately. Table 5.9 shows the number of observations and p-values for each bone site,
together with the average values, which were discussed above.
A statistically significant difference was found for all studied parameters be-
tween healthy and IMO rear tibiae (p-values: density 0.0470, Ca/P ratio 0.0132,
low Ca/P ratio proportion 0.0026, region-grown low Ca/P ratio proportion 0.0119,
low Ca/P ratio homogeneity 0.0481). Similarly, a statistically significant difference
was found for all studied parameters between healthy and IMO femurs (p-values:
Ca/P ratio 0.0286, low Ca/P ratio proportion 0.0088, region-grown low Ca/P ratio
proportion 0.0210), except for the bulk density and low Ca/P ratio homogeneity (p-
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5. Bone 3D assessment
values: density 0.0821, low Ca/P ratio homogeneity 0.1137). Front tibiae showed no
statistically significant differences, between healthy and IMO, for any of the param-
eters tested (p-values: density 0.3728, Ca/P ratio 0.4038, low Ca/P ratio proportion
0.3750, region-grown low Ca/P ratio proportion 0.1469, low Ca/P ratio homogene-
ity 0.1378). In a study by Kourkoumelis et al. [2011] front tibiae also showed the
smallest decrease of Ca/P ratio after inflammation-mediated osteoporosis compared
to rear tibiae and femurs.
From the above results, it can be concluded that care has to be taken on the
selection of the bone site for osteoporosis diagnosis as some bone sites might be more
susceptible to osteoporosis and thus might be able to provide more information for
the disease than others.
Moreover, it is worth noting that the density p-value in the comparison of healthy
and IMO bone samples, for a specific bone site, is always bigger than the p-value
of the Ca/P ratio of the same bone site. This is because the standard deviation
in density, is bigger than than in Ca/P ratio (section 5.4). This suggests that the
individual variation in density is lower than that in Ca/P ratio. The specificity of
Ca/P ratio in a particular bone site may be more reliable for diagnosis of osteoporosis
in bone apatite. However, no definite conclusions can be made unless a sufficiently
high number of bone samples is being tested.
5.6 Summary
CT-DEA provides simultaneous bone (material) density and Ca/P ratio qualitative
and quantitative results. One of the aims of this chapter was to investigate different
analysis methods of the density and Ca/P ratio results, for a given set of data, using
CT-DEA. The different analysis methods applied on a different scale in the sample
provided different parameters.
The bulk density and bulk Ca/P ratio across the whole sample is a simple analysis
method that provides results representative of the whole bone. The analysis of small
ROIs against the bulk density is not representative of the whole sample and the
selection is subjective for osteoporosis diagnosis. Low Ca/P ratio proportion is a
useful and easy analysis method that quantifies the amount of possible osteoporosis
in bone with respect to the whole sample. It is representative of the whole bone
sample and it involves the analysis of a volume of interest (possible osteoporotic
region), but without the need for the user to select the region to analyse (removing
subjectivity). Region-growing technique is a more advanced version of low Ca/P
ratio proportion that locates the low Ca/P ratio regions and only selects those that
are interconnected. The disadvantage of region-grown low Ca/P ratio parameter is
the long processing time required to assess it, but it does decrease the possibility of
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noise affecting the results.
In this chapter, the magnitude and distribution of density and Ca/P ratio in
healthy and IMO bone samples were investigated using the above parameters. CT-
DEA application on collagen-free bone samples and a Student’s t-test between all
healthy and all IMO bone samples showed a statistically significant difference in the
average density and Ca/P ratio across the whole bone sample and in the average
density and Ca/P ratio across volumes of sizes 0.03 mm3 (6×6×1 voxels). The low
Ca/P ratio proportion, the region-grown low Ca/P ratio proportion and the low
Ca/P ratio homogeneity were also significantly different between all healthy and all
IMO bone samples.
Different bone sites show different ranges of Ca/P ratio, in agreement with pre-
vious studies. A Student’s t-test between the different bone sites of samples showed
a statistically significant difference between most of the Ca/P ratio parameters of
different bone sites, but not the density.
The above results support the further study of bulk density, bulk Ca/P ratio,
low Ca/P ratio proportion, region-grown low Ca/P ratio proportion and Ca/P ho-
mogeneity, in intact bone, as possible osteoporosis indicators. Furthermore, the
analysis of each bone site separately is supported.
The non-invasive measurement of bone (material) density is unique to CT, and
to date it has not been measured by DEXA. Ca/P ratio can be measured using
planar DEA (Fountos et al. [1999]). However, the advantages of CT-DEA are that
soft tissue and bone marrow can be omitted from analysis, using thresholding, and
that VOIs can be selected, therefore providing knowledge for the low Ca/P ratio
proportion and the distribution of Ca/P ratio in bone.
The technique so far has only been applied to animal healthy and inflammation-
mediated osteoporotic bones. Both bone density and Ca/P ratio can be used to
provide knowledge for their correlation to bone apatite quality. All the above con-
clusions support the use of the developed technique for further in vitro studies, in
order to better understand the behaviour of density and Ca/P ratio in collagen-free
healthy and osteoporotic cadaveric human bone apatite.
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Chapter 6
Density and Ca/P ratio
assessment in healthy and
osteoporotic intact cortical bone
6.1 Overview
In this chapter the results of the application of CT-DEA on intact cortical bone
samples are presented.
Eighteen healthy (nine) and inflammation-mediated osteoporotic (nine) rabbit
intact (collagen present) cortical bone samples were imaged using the microCT sys-
tem and analysed using CT-DEA. Their density and Ca/P ratio results were anal-
ysed and compared, aiming to investigate the magnitude of density and Ca/P ratio
in healthy and IMO bones. This chapter presents these results and concludes on the
feasibility of distinguishing healthy and IMO intact bone samples using CT-DEA.
In section 6.2, the methods followed are explained. In section 6.3 the results of
the three studied parameters are presented and discussed, including the statistical
analysis for the comparison of the studied parameters in healthy and IMO bone
samples. In section 6.4, statistical analysis on the comparison of different bone
sites is presented. The results of the comparison of healthy and IMO bone sites on
different bone sites separately are shown in section 6.5. A summary of the chapter is
given in section 6.6. Conclusions are made on how the magnitude and distribution
of density and Ca/P ratio in intact cortical bone, change in osteoporosis.
6.2 Experimental methods
Bone samples of set 2 (table 2.4), 18 rabbit cortical intact bone samples, were pre-
pared as explained in section 2.5.3. In half of the animals, inflammation-mediated
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osteoporosis (IMO) was induced. All 18 bone samples were imaged using the mi-
croCT system at the same conditions at which collagen-free bone samples were
imaged (table 3.3). Similarly, the same reconstruction, centre of rotation correc-
tion and binning processing methods were used (section 5.2.1). Thresholding was
also applied to the images to remove any background voxels and any voxels suf-
fering from edge (partial volume) artefacts. The threshold density limits applied
were; background: ρ≤0, sample-edge: 0.01<ρ≤1.25 and ρ>3.60 and bone sample:
1.25<ρ≤3.60. Figure 6.1 shows an example of thresholding on a CT slice of a rear
tibia bone sample.
(a) (b)
Figure 6.1: (a) Original low energy image of a rear tibia bone sample, and (b) its
corresponding density map after thersholding. Yellow (ρ≤0) and red (0.01<ρ≤1.25 and
ρ>3.60) areas were rejected, while blue areas (1.25<ρ≤3.60) were used for bone analysis.
CT-DEA (section 2.4.5) provided simultaneous quantitative and qualitative re-
sults on the density and Ca/P ratio of the samples. The density and Ca/P ratio
data was analysed using the methods 1-3, listed in section 5.2.2. The advantages and
disadvantages of each of these parameters was discussed in chapter 5. The region-
growing technique was not applied in bone samples with collagen, due to the long
processing time required (longer time than collagen-free samples analysis, section
6.3.3).
The statistical analyses performed, using the Student’s t-test, on the studied
parameters), of all bone samples with collagen, was the same as in chapter 5, and
is summarised in table 6.1.
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Table 6.1: Statistical analyses, using the Student’s t-test, performed on the studied
parameters of intact bone samples (set 2) and their corresponding sections where the
results can be found.
Statistical analysis Section
Difference in parameters between all healthy and all IMO samples 6.3
Difference in parameters between bone sites 6.5
Difference in parameters between healthy and IMO of different bone sites 6.6
Figure 6.2: The densities (g/cm3) of the 18 intact bone samples, with healthy samples in
red and IMO samples in blue. Error bars have been excluded as the standard error<0.002.
6.3 Results: comparing healthy and IMO bones
6.3.1 Density and Ca/P ratio bulk results
The average density and Ca/P ratio were determined across the total volume (varies
between 44-136 mm3 in the 18 intact bone samples) of each of the nine healthy and
nine IMO intact bone samples. Figure 6.2 shows the bulk density measurements, in
g/cm3. The average density, across the whole sample, of the healthy bones (blue)
varied within the range 2.91-3.15 g/cm3. In the IMO samples the bulk density
results (red) varied within the range 2.90-3.06 g/cm3.
Figure 6.3 shows the bulk Ca/P ratios of the intact healthy (blue) and IMO
(red) bone samples. The average Ca/P ratios, of the healthy bones varied within
the range 1.67-2.07. These results are within the Ca/P ratio range (1.46-2.25) in
intact bone found in previous studies (Zaichick and Tzaphlidou [2002], Hyvo¨nen-
Dabek et al. [1979], Grynpas et al. [1987], Fountos et al. [1999]). In collagen, the
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Figure 6.3: The Ca/P ratios of the low-density (1.25-3.60 g/cm3) region of 18 intact
bone samples, with healthy samples in red and IMO samples in blue. Error bars have
been excluded as the standard error<0.001.
Table 6.2: Student’s t-test results of the bulk density (g/cm3) and bulk Ca/P ratio, of
the 9 healthy and 9 IMO bone samples.
Density (g/cm3) Ca/P ratio
Variable Healthy IMO Healthy IMO
Mean 3.06 2.99 1.84 1.66
Observations 9 9 9 9
p-value 0.0137 0.0030
amounts of Calcium and Phosphorus are lower than in bone apatite, and are also
variable (Zaichick and Tzaphlidou [2002], Speller et al. [2005]). This results in a
deviation from the stoichiometric Ca/P ratio of bone apatite (1.67) (Tzaphlidou
and Zaichick [2003]), and this deviation might vary for different animals and bone
sites. In the IMO samples the Ca/P ratio was slightly lower (1.58-1.79), in agreement
with previous studies (Tzaphlidou et al. [2005], Speller et al. [2005], Kourkoumelis
et al. [2011]).
Table 6.2 shows the significance in the differences between the density and Ca/P
ratio of the healthy and IMO samples. P-values of 0.0137 and 0.0030, were found for
density and Ca/P ratio respectively, suggesting a statistically significant difference
in them between the healthy and the IMO bone samples.
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Figure 6.4: Density maps, ((a) and (c)), and their corresponding Ca/P ratio maps,
((b) and (d)), of one healthy (top) and one IMO (bottom) rear tibia intact cortical bone
sample. The resolution of all maps is 96 µm.
6.3.2 Density and Ca/P ratio in volumes of interest
Going through the density and Ca/P ratio maps of healthy samples, it is evident the
that Ca/P ratio is not homogeneously distributed, same as in the case of collagen-
free samples. Similarly, going through the density and Ca/P ratio maps of IMO
samples, it was found that osteoporosis does not appear in the whole of the sample.
An example of a density and a Ca/P ratio map, from one healthy and one IMO
bone sample are shown in figure 6.4. A lowered density and Ca/P ratio can be
visualised across the IMO bone slice, compared to the healthy bone slice.
Quantitative analysis was performed in ROIs, with a volume of 0.03 mm3, as
illustrated by the red squares in figure 6.4(a)-(d). Table 6.3 shows the average
density (in g/cm3) and Ca/P ratio of the ROIs. As Ca/P ratio decreases density
decreases too.
141
6. Intact Bone 3D assessment
Table 6.3: Average density and Ca/P ratio results of the selected ROIs of a healthy rear
tibia, shown in figure 6.4
.
Density (g/cm3) Ca/P ratio
Bone type Fig 6.4 Mean SD Mean SD
Healthy (a)-(b) 3.48 0.28 2.18 0.52
IMO (c)-(d) 3.19 0.21 1.62 0.23
Figure 6.5: The bulk Ca/P ratios of the intact 9 healthy (red) and 9 IMO (blue) samples,
after thresholding with density.
6.3.3 Low Ca/P ratio proportion
Figure 6.5 shows the low Ca/P ratio proportion in the intact nine healthy (blue)
and nine IMO bone (red) samples. The results show a trend of increased low Ca/P
ratio proportion in IMO samples (26.3%-63.6%) compared to healthy bone samples
(12.7%-69.1%). A p-value from a Student’s t-test of 0.1132 was found (table 6.2),
suggesting a probability of 0.1132 of any difference in low Ca/P ratio proportion
being due to chance.
Table 6.4: Student’s t-test results of the low Ca/P ratio proportion, of the nine healthy
and nine IMO bone samples.
Low Ca/P ratio proportion
Variable Healthy IMO
Mean 35.86 44.28
Observations 9 9
p-value 0.1132
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The low Ca/P ratio proportion of collagen-free bone samples compared to intact
bone samples is up to 12 times higher, on a site by site analysis. Due to the large
amount of voxels with low Ca/P ratio it would require a long processing time to
analyse all the possible seed voxels in the low Ca/P region and perform the region-
growing technique. For this reason, the application of region growing technique on
intact bone samples was omitted.
6.4 Results: comparing different bone sites
In this section the variability of density and Ca/P ratio between different intact
cortical bone sites is discussed. An investigation was made on how the presence
of collagen affects the differences between density and Ca/P ratio in different bone
sites.
All the average results discussed below are summarised in table 6.6. The average
density of healthy and IMO femurs were 3.09±0.02 and 2.97±0.12 respectively. Sim-
ilarly, for rear tibiae density was, healthy ρ = 3.08±0.07 and IMO ρ = 2.99±0.03,
and front tibiae, healthy ρ = 3.03±0.05 and IMO ρ = 3.00±0.06. As in the case
of the collagen-free samples, there was not any difference in the densities of bulk
different bone sites.
In the analysis of the Ca/P ratio, as detailed in table 6.6, healthy the Ca/P ratio
of femurs was 1.92±<0.20). Healthy rear tibiae had a Ca/P ratio of 1.82±<0.02,
and healthy front tibiae 1.77±<0.15. Similarly, for the IMO samples: IMO fe-
murs showed the highest Ca/P ratio (1.76±<0.04) compared to IMO rear tibiae
(1.63±<0.02) and IMO front tibiae (1.69±<0.05). In the collagen free bone sites,
front tibiae presented the highest Ca/P ratio compared to rear tibiae and femurs. A
possible reason for femurs showing the highest Ca/P ratio in inctact cortical bone,
is the different amount of collagen possibly present in each bone site, for example,
under the requirement of some bone sites being more flexible than others. A dif-
ferent proportion of collagen in different bone sites would have the following effect.
The CT-DEA process was calibrated with the assumption of 15% weight of collagen
present in the samples and it was assumed that this is the case for all of the bone
sites. A different weight fraction of collagen present in a sample would affect its
Ca/P ratio result, forcing it to be calculated lower or higher than it is. This would
change the order of the different bone sites with respect to the bulk Ca/P ratio.
Another possible explanation for femur showing a higher Ca/P ratio compared to
the other bone sites, is the presence of more Calcium and/or less Phosphorus in
collagen, compared to the other bone sites.
For the low Ca/P ratio proportion the following results were observed for healthy
bone samples; front tibiae (51.0±15.0%), rear tibiae (49.6±3.3%) and femurs (30.3±
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Table 6.5: Student’s t-test results of the studied parameters, between the 3 healthy
and 3 IMO rear tibia, femur and front tibia intact cortical bone samples. The number of
observations in each analysis was three.
Bone Type Variables Density p-value Ca/P ratio p-value Low Ca/P prop
Healthy RT and FT 0.2143 0.3179 0.0647
RT and F 0.4406 0.2294 0.2045
FT and F 0.1868 0.1764 0.0334
IMO RT and FT 0.2951 0.2734 0.3285
RT and F 0.3523 0.0047 0.0084
FT and F 0.2373 0.0064 0.0246
11.2%). Similarly, for IMO bone samples; front tibiae (52.2±10.9%), rear tibiae
(31.1±2.6%) and femurs (24.3±5.9%).
Table 6.5 presents the p-values produced after the Student’s t-test analysis, for
the comparison of density, Ca/P ratio and low Ca/P ratio proportion in different
intact cortical bone sites.
The results suggest no difference in bulk density or bulk Ca/P ratio between any
sites, in healthy bone samples, except for the low Ca/P ratio proportion between
femurs and front tibiae. In the IMO bone samples however, a difference was found
between the bulk Ca/P ratio and low Ca/P ratio proportion between IMO rear
tibiae and femurs, and front tibiae and femurs.
These reults suggest that even with the presence of collagen differences between
different IMO bine sites can be identified. As discussed in section 5.4, there is
a different response to osteoporosis between different bone sites. At present, it
is unknown if the difference responses found between different bone site are the
result of an error introduced in the Ca/P ratio due to a wrong collagen proportion
assumption, for a specific bone site, or if it is due to a different amount of Calcium
and Phosphorus present in collagen of each bone.
6.5 Results: comparing healthy and IMO bones
for each bone site
Table 6.6 shows the mean values, observations number and p-values of the compar-
ison of healthy and IMO bone samples, for each bone site separately.
A statistically significant difference was found for bulk density and Ca/P ratio
between healthy and IMO rear tibiae in the analysis of all bone samples sites together
(table 6.2). A statistically significant difference was also found in the Ca/P ratio
studied parameters between the three healthy and three IMO rear tibias (table
6.5). Femurs and front tibiae showed no statistically significant differences, between
healthy and IMO samples, for any of the parameters tested.
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Table 6.6: Student’s t-test results of the studied parameters, of the three healthy and
three IMO rear tibia, femur and front tibia bone samples.
Density (g/cm3) Ca/P ratio Low Ca/P ratio prop.
Bone site Variable Healthy IMO Healthy IMO Healthy IMO
Rear tibia Mean 3.08 2.99 1.82 1.63 31.1 49.6
Observations 3 3 3 3 3 3
p-value 0.1086 0.0439 0.0204
Femur Mean 3.09 2.97 1.92 1.76 24.3 30.3
Observations 3 3 3 3 3 3
p-value 0.1008 0.1628 0.3893
Front tibia Mean 3.01 3.00 1.77 1.69 51.0 52.2
Observations 3 3 3 3 3 3
p-value 0.3317 0.1430 0.2615
Any variable amount of collagen within the bone would affect the accuracy of
the results, and thus the statistical significance given by the Student’s t-test. A
bigger number of samples would help conclude if there are any differences between
healthy and IMO bone samples for each bone site separately.
6.6 Summary
The accuracy of planar DEA when applied on intact bone is restricted mainly by the
presence of fat, marrow and collagen present in the bone. As shown experimentally,
DEA marrow and fat can be a source of considerable error (Fountos [1997], Bolotin
and Sieva¨nen [2001]). However, this problem could be easily overcome in CT imag-
ing, by analysing the cortical bone only, after the application of thersholding to the
3D images.
As far as the presence of collagen in concerned, it is still unknown to what degree
the variable amount of collagen in bone affects the accuracy of the results. However,
it was shown in this chapter that CT-DEA application on intact bone samples can
provide qualitative analysis of density and Ca/P ratio on intact bone. Possible
osteoporotic areas can be visualised, located and quantified. It is possible to produce
realistic results of bone density and Ca/P ratio in intact bone, and provide sufficient
accuracy for distinguishing between healthy and IMO bone samples. However, in the
case of the analysis of each bone site separately, any error introuduced due to the
presence and/or variability of collagen in the sample, together with the standard
deviation introduced by the small number of samples, superimpose the precision
required to distinguish between healthy and IMO bones. A bigger number of samples
would help conclude if there are any differences between healthy and IMO bone
samples for each bone site separately.
In the analysis of all samples together, statistically significant differences were
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found in bulk density and Ca/P ratio, between healthy and IMO bone samples.
This conclusion supports the use of the developed technique for further in vitro
studies, in cadaveric human bone samples, to better understand density and Ca/P
ratio magnitude and distribution in healthy and osteoporotic bone. This is further
discussed in chapter 7 of this thesis, together with the potential of the technique for
in vivo applications.
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Chapter 7
Concluding remarks and future
potential of CT-DEA for density
and Ca/P ratio 3D assessment
This thesis presented the development, optimisation and evaluation of a 3D CT-
DEA method for density and Ca/P ratio assessment, as well as its application to
bone apatite and intact rabbit cortical bone. The qualitative and quantitative data
available from the technique could be used to: (i) study the correlation of density
and Ca/P ratio to bone mechanical properties (and thus bone quality) in vitro, (ii)
investigate the use of density and Ca/P ratio as new osteoporosis indicators, first
in vitro, then in vivo (using a conventional CT). In turn, an improvement could be
made on understanding and/or diagnosing osteoporosis.
In section 7.1, a summary of the results obtained in this study and the limitations
of the developed technique will be discussed. In section 7.2 and 7.3, suggestions
are given for how to develop the technique towards its use for the study of the
correlation of density and Ca/P ratio to bone mechanical properties and its clinical
implementation. Finally, in section 7.4, the final conclusions of this study are made.
7.1 Prospects for CT-DEA system: current limi-
tations and future developments
7.1.1 Progress achieved in present study
Two prototype theoretical frameworks of CT-DEA were developed for the 3D as-
sessment of density and Ca/P ratio using a microCT scanner. The two theoretical
frameworks were aimed for their application in: (i) the mineral content of bone,
in vitro for collagen-free bone samples, (ii) intact (contains collagen) bone, in vitro
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or in vivo. Possible qualitative and quantitative measuring parameters of the tech-
nique were identified. Qualitative (for visualisation) parameters include: 2D and 3D
density and Ca/P ratio maps. Quantitative parameters include: bulk density, bulk
Ca/P ratio, ROI density, ROI Ca/P ratio, low Ca/P ratio proportion, region-grown
low Ca/P ratio proportion and low Ca/P ratio homogeneity. In future studies more
measuring parameters could be developed.
The developed technique was optimised for its application to an X-tek benchtop
microCT system. A framework for the optimisation of the geometry of the system,
and thus of the sample position, accounting for the effects of both the focal spot
and the detector, determined simultaneously from one set of measurements, was
developed. The optimum sample position found fulfilled the resolution requirement
of trabecular bone (150 µm). Additionally, all possible sources of error were min-
imised to ensure that uncertainty on the Ca/P ratio is not greater than the required
accuracy in the measured quantity. The optimum low and high average energies for
the particular imaging system were identified as 35 keV and 71 keV. These were
achieved using a tube voltage pair of 100 kVp and 50 kVp, and respective tube cur-
rents of 100µA and 150µA, after filtering with 5 mm Al and 0.5 mm Sn, scanning
parameters of: magnification = 10, 360 projections and 128 frames.
The evaluation of computed tomography dual energy analysis (CT-DEA) for
3D density and Ca/P ratio assessment in bone apatite was performed. The theo-
retical precision of the technique in the calculation of density and Ca/P ratio was
assessed through simulation. The experimental precision was found by applying the
technique in bone phantoms of known density and Ca/P ratio. It was concluded
that the technique can assess the Ca/P ratio to a sufficiently high accuracy for
identifying some, but not all osteoporotic regions. For the investigation of the fea-
sibility of the technique on the assessment of Ca/P ratio in bone apatite, healthy
and inflammation-mediated osteoporotic (IMO) rabbit cortical bone samples were
used. The Ca/P ratio results assessed using CT-DEA in 58 different regions in
eight bone samples were compared to the Ca/P ratio results of the same regions
assessed using electron-dispersive X-ray spectroscopy. The mean difference in the
Ca/P ratio between the two techniques was 0.11±0.08 (8±6%) and the correlation
was R2=0.69, suggesting sufficient confidence in the experimental capabilities of the
CT-DEA technique.
Density and Ca/P ratio were assessed simultaneously in 3D for the first time in
this study. The two parameters were firstly assessed in collagen-free bone samples,
which represent bone apatite, the part of the bone which is mechanically considered
to be have the highest Young’s modulus. Nine healthy and nine IMO bone samples
were assessed. Density and Ca/P ratio changes in bone apatite due to osteoporosis
were investigated. It was concluded that bulk density and bulk Ca/P ratio can
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be considered as possible osteoporosis indicators. Also, it was found that there is a
higher difference in density and Ca/P ratio, between healthy and IMO bone samples,
when studied in regions of interest, than when performing bulk measurements of
these parameters in bone. Low Ca/P ratio proportion, interconnected low Ca/P
ratio proportion and low Ca/P ratio homogeneity were all higher in IMO bone
samples. Furthermore, it was shown that there are statistically significant differences
between bone sites. It was concluded that Ca/P ratio parameters in different bone
sites should be studied separately. All the above results support the use of the
developed technique for further in vitro studies, in order to better understand the
behaviour of density and Ca/P ratio in collagen-free healthy and osteoporotic human
cadaveric bone apatite.
Density and Ca/P ratio were also assessed using CT-DEA in intact cortical bone.
The technique provided realistic density and Ca/P ratio results. Bulk density and
low Ca/P ratio proportion in healthy and IMO bone samples were shown to be
statistically significant. Low Ca/P ratio proportion was not statistically significant.
In the case of of the analysis of each bone site separately statistical significances were
found only between a few of the studied parameters. A bigger number of samples
would improve the confidence in the results. The conclusions support the use of
the developed technique for further in vitro studies, in order to better understand
density and Ca/P ratio magnitude and distribution in healthy and osteoporotic
human bone. Furthermore, they are promising results for future implementations of
CT-DEA in vivo for osteoporosis diagnosis.
7.1.2 Limitations of the current CT-DEA technique and re-
sults
The CT-DEA has promise as a density and Ca/P ratio 3D assessment technique and
it is ready to be used for more in vitro studies. However, a number of limitations
exist in the technique itself and the results that currently prevent clinical transfer
of the technique.
Trials: Limitations arose from the lack of testing the technique on human
healthy and osteoporotic bone tissues. IMO has so far proved to be a good sub-
stitute for osteoporosis. Ca/P ratio results obtained from rabbit healthy and IMO
bone samples from this one, and other studies, compare well with results obtained
from human healthy and aged or osteoporotic bone samples. However, all previous
work on human bone Ca/P ratio was performed in 2D only. The extension to 3D
poses many challenges, particularly with reference to how the injection distributes
itself throughout the body. Results have shown that osteoporosis does not affect
149
7. Concluding remarks and future potential of CT-DEA
bone homogeneously, and each bone site at the same degree, but it is not yet known
if this is caused by the injection uptake or is a property of the disease itself. This
technique allows for 3D assessment, but question marks over the injection lead to the
need for real osteoporotic bones to be studied. The technique is currently adequate
but the conclusions made in this study do not necessarily apply to human bone.
Furthermore, the technique to date has only been applied to cortical bone and
has not been tested on trabecular bone samples. This could be part of future work.
The technique has been optimised so that it can provide sufficient resolution for the
analysis of trabecular structure.
Instrumentation: One of the main instrumentation limitations of CT-DEA
technique is the low power that can be achieved by the microCT system. This
limits the accuracy that the technique can provide.
Furthermore, the beam width is small and so there is a limit to the total volume
of a sample. At the optimum conditions used, the biggest sample that can be imaged
is approximately 1 cm×1 cm×1 cm. This is sufficient when working with animal
bone samples. However, one might need to be selective when working with human
bone samples or other bigger bone samples. Currently, only a sample of a maximum
diameter of <1 cm can be used. Alternative solutions include the cutting of bones
to the appropriate size or the use of a different sample magnification/position. The
last solution would provide less than 16 µm resolution in the images however. Com-
promises will need to be made on sample size and resolution, if the current system
will be used.
CT-DEA algorithm: In the development of CT-DEA for Ca/P ratio assess-
ment, the assumption was made that the chemical composition of bone varies in the
same way that the chemical composition varies between the bone phantoms. This
assumption provided realistic results for collagen-free bone samples. However, it is
unknown how representative this variation is for human healthy and osteoporotic
bone.
Furthermore, the assumption was made that intact bone is made up of 15%
collagen. This assumption provided realistic results for intact bone. However, in
literature the weight fractions found for bone vary up to 40% (Bauer and Link
[2009]).
The above approximations were necessary for the purposes of this study. More
accurate relations for the chemical composition variation might be able to be found
using electron-dispersive X-ray spectroscopy measurements on bone samples.
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7.2 Future system developments towards mechan-
ical testing
Healthy and osteoporotic bone samples non-invasively assessed using CT-DEA can
also be used to assess their mechanical properties, using biomechanical tests. Then,
the correlation of density and Ca/P ratio to Young’s modulus of bone can be in-
vestigated. In that case there are some factors which will need to be considered for
the sample selection and preparation. There are different kinds of biomechanical
tests; tensile, bending and compression. The bone site and bone size that will be
chosen determines to a large extent what biomechanical tests can be accomplished.
The mechanical properties of bone vary according to variations in the testing con-
ditions. Therefore, important factors of the testing conditions including specimen
preservation, hydration, and temperature and strain rate have to be considered. As
far as hydration is concerned, it has been suggested that for accurate testing results
it is best to test bone in its hydrated condition, by keeping them in physiological
saline or wrapping them with saline-soaked gauze during the test. Finally, the rate
at which strain is applied during biomechanical testing of bone is important. The
resistance of the bone shock absorbed to load varies proportionally to the rate at
which the load is applied, so the mechanical properties of wet bone vary slightly
with strain rate. If one is trying to simulate physiological conditions, the strain rate
should be between 0.01/s and 0.08/s, which is the range of strain rates that occur
in vivo (Turner and Burr [1993]).
Similarly, Finite Element Analysis (FEA), using a dedicated software, can be ap-
plied on the same bone samples to investigate the correlation of density and Ca/P
ratio to the mechanical properties of bone non-invasively and in 3D. The general
procedure for the production of an FEA model includes the acquisition of a CT
image, the production of a mesh (subject to sample geometry and CT value (den-
sity/composition)) of the CT image, the application of the mechanical properties
(Young’s modulus (function of CT number), Poisson’s ratio (can be found in liter-
ature)), and the loading of the mesh with normal loads on the sample (Wirtz et al.
[2000]). The outcome of this will be the mechanical properties of bone. Different
degrees of osteoporosis can be assessed by CT-DEA as a function of density and
Ca/P ratio as well as by FEA as a function of the mechanical properties of bone.
The relation between the two can then be studied.
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7.3 Future system developments towards clinical
implementation
The CT and CT-DEA have recently received a lot of attention (Wang et al. [2008],
Karc¸aaltncaba and Akta [2011]). Improvements in CT and CT-DEA would increase
the potential for CT-DEA for Ca/P ratio and density assessment in bone. For ex-
ample, improvements can be made on the image reconstruction method. Due to in-
creased computational power, iterative reconstruction promises significant improve-
ments in image quality (Wang et al. [2008]). In addition, iterative reconstruction can
eliminate the requirement of a second image acquisition, in DEA, by incorporating
prior information. Furthermore, technological advances in CT make it possible for
simultaneous acquisition of volumetric DEA data within seconds.
For the technique to be widely used in a clinical scenario, the factors to be con-
sidered include dose, cost and effectiveness compared to other osteoporosis diagnosis
techniques.
Dose is an important factor that needs to be taken into account, if the technique
is to be applied in vivo with a conventional CT system. Compromises will need to
be made between dose and the optimum spectra selection, system power and signal
to noise ratio.
Furthermore, compromises might need to be made on the body part and imag-
ing system that will be scanned and diagnosed for osteoporosis. For example, the
technique could potentially be clinically applied to a small area of the body, away
from sensitive tissues, such as the wrist, using pQCT (section 1.4) (dose < 2 µSv),
with comparable/lower dose than that of DEXA (around 0.07-5.9 µSv depending on
scan mode) (Langton [2010]).
Finally, the usefulness of the technique compared with other available osteoporo-
sis diagnosis techniques will need to be investigated. For example, DEXA gives a
dose of 4.6 µSv (Lewis et al. [1994]). Fountos’ DEA technique that measures the
Ca/P ratio in bone for osteoporosis diagnosis in 2D gives a dose to the skin of be-
tween 44-66 µSv (Fountos et al. [1999]). For 3D DEA as in this study, this figure
will be higher. Consideration of the enhancement in the diagnosis of osteoporosis
using CT-DEA will need to be weighed up against the potentially considerable extra
dose.
7.4 Conclusions
In this study the development, optimisation and evaluation of CT-DEA for den-
sity and Ca/P ratio in bone 3D assessment, using an X-Tek microCT system were
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achieved. The developed technique was applied to healthy and IMO cortical bone
samples, both collagen-free and intact. The results showed that the technique can
distinguish between some healthy and IMO bone regions/samples. Furthermore,
it was shown that there are statistically significant differences in the density and
Ca/P ratio between healthy and IMO bone samples. This suggests that the two
parameters could be used as osteoporosis indicators.
Possible improvements of the technique include the use of a higher power system
and real bone calibration. Even without this, in its current state, the technique is
ready to be used for further bone studies in vitro, including the application to human
bone samples. CT-DEA, in combination with biomechanical tests or FEA, can be
used to investigate the correlation of density and Ca/P ratio to bone mechanical
properties. Finally, the potential of the technique for osteoporosis diagnosis can
be investigated, by taking into consideration patient dose, cost and effectiveness
compared to other osteoporosis diagnosis techniques.
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